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Background: The way that prescription veterinary medicines (PVM) are used on UK dairy 
farms is currently poorly understood, despite the importance of understanding 
antimicrobial use in agriculture and its potential impact on antimicrobial resistance.  
Methods: This research includes a cross-sectional study of PVM storage practices across 
27 UK dairy farms, a method agreement analysis of the three most common ways to 
quantify on-farm use of PVM to determine the best measurement method and a 
qualitative ethnographic study exploring the values of dairy farmers and the on-farm 
context and culture in relation to the use of PVM. 
Results: UK dairy farmers stored PVM in a broadly ‘correct’ way, although in varying 
quantities. Storage of expired and unlicensed medicines was common, and occasionally 
inappropriate medicines were present on farms. Veterinary sales data showed the best 
levels of both clinical agreement and reliability with a gold standard of the three 
measuring methods tested; medicine waste bins showed moderate agreement with the 
gold standard and on-farm medicine records did not agree with the gold standard for use, 
and, as such, are not an effective way of reliably measuring actual PVM use. The attitudes, 
values and contexts most relevant to medicine use practice can be broadly divided into 
four dominant themes: knowledge, trust, autonomy of treatment practice and a duty of 
care. The way these themes can impact on medicine use is not straightforward, and 
occasionally seem contradictory. It is important, however, to realise that changing 
medicine use practices requires an understanding of all factors involved in treatment 
decisions. 
Discussion: This thesis demonstrates an important contribution to the scientific 
knowledge of veterinary medicine use through innovative methods and provides an 
evidence base from which to further develop models of treatment decision and 
behavioural intervention aimed at improving responsible medicine use alongside 
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Prescription veterinary medicine (PVM) use in UK agriculture is a subject that has come 
under increasing scrutiny over the past decade. This has been largely driven by a growing 
global awareness of the threat posed by antimicrobial resistance to the human 
population, as illustrated by the following quote: 
 “We have reached a critical point and must act now on a global scale to slow down 
antimicrobial resistance.”  
– Professor Dame Sally Davies, UK Chief Medical Officer 
Antimicrobials have been used in agriculture almost since their inception, and their use 
to treat bacterial infection has historically been intertwined with prophylaxis and have 
even been used for growth promotion. Although antimicrobial resistance (AMR) in the UK 
has been recognised as a problem for several decades, progress in reducing the use of 
antimicrobials in agriculture and a push towards more responsible antimicrobial use 
(AMU) is relatively recent and was driven in the UK in part by the government-
commissioned independent review on AMR, published in 2016 and led by Lord Jim O’Neill, 
so known as the O’Neill Report (O'Neill, 2016). This report made several 
recommendations, two of which were aimed specifically at the use of antimicrobials in 
agriculture: to improve global surveillance of drug resistance and antimicrobial 
consumption in humans and animals, and to reduce unnecessary use of antimicrobials in 
agriculture and their dissemination into the environment. Since its publication, the 
political and public pressure to reduce AMU in farmed animals in the UK has increased, 
and the industry has responded through numerous initiatives aimed at improving 




Whilst improving the measurement and understanding of AMU in order to reduce 
consumption in agriculture is arguably the most important goal, understanding the use of 
all PVM on farms gives a more complete picture. The use of antimicrobials is inextricably 
linked to the use of other PVM such as anti-inflammatories, vaccines and mechanical teat 
sealants, and, as such, attempting to understand and change the use of one without the 
others is likely to have limited impact. As outlined in the literature review in Chapter 2, 
there is a lack of scientific evidence on the use and storage of non-antimicrobial PVM or 
the combined use of antimicrobials and other PVM. Therefore, this thesis argues that by 
considering all PVM together, the resulting knowledge gain is likely to be greater than the 
sum of its parts. 
The dairy industry is the third largest user of veterinary antimicrobials in UK livestock 
agriculture, after the poultry and pig industries (Veterinary Medicines Directorate, 2018c).  
In 2016 (the time period during which much of the research in this thesis was conducted), 
the UK dairy industry comprised approximately 13,200 farms, with a total population of 
1.9 million adult milking cows and an average herd size of 143 (Agriculture and 
Horticulture Development Board, 2016, Department for Environment Fisheries and Rural 
Affairs, 2018). The total UK milk production was 14.96 billion litres with the average yield 
standing at 7559 litres per cow per year (Agriculture and Horticulture Development Board, 
2016). In 2016, the average milk price was 22.7 pence per litre (ppl) while the cost of 
production for 2016/2017 was 25.5 ppl, meaning that on average, UK dairy farmers were 
losing 2.8 pence for every litre of milk produced. Understanding the on-farm context, 
including economic and market pressures such as these, is vital if we are to comprehend 




 Aim of this thesis 
This research explored the ways in which PVM were being stored, measured and used on 
UK dairy farms. It builds on and contributes to the body of work on the use of PVM in 
agriculture, specifically in the UK dairy industry. The current literature has tended to focus 
on quantitative surveys and measurements of AMU through on-farm treatment records, 
medicine waste bins or veterinary sales data. A dearth of truly qualitative work 
investigating medicine-use behaviours has been identified, as discussed in Chapter 2. To 
the author’s knowledge there have been no studies examining the way in which PVM are 
stored on UK dairy farms, and it is postulated that this may be a significant factor in 
understanding the use of PVM on-farm. There is also a lack of research to validate the use 
of veterinary sales data, on-farm medicine records or medicine waste bins as proxies for 
actual use despite a recent move towards using veterinary sales data for AMU surveillance 
by the Veterinary Medicines Directorate (VMD) (Veterinary Medicines Directorate, 2017, 
Veterinary Medicines Directorate, 2018c).  
This thesis aims to provide some of the data necessary to begin addressing this knowledge 
gap. The research described within aimed to address that knowledge gap by using a 
mixed-methods approach to investigate the following research questions on UK dairy 
farms: 
i. How are PVM being stored on UK dairy farms?  
ii.  Can veterinary medicines sales data, on-farm medicine records or medicine 
waste bins be used to accurately estimate on-farm medicines use on the study farms? 
iii. What are the values and practices of dairy farmers and what are the on-farm 




This thesis utilises qualitative research and ethnographic techniques to better understand 
PVM use in dairy cattle and combines this data with quantitative work examining PVM 
storage and the way in which PVM use is measured. The analytic focus of this thesis on 
resource availability, recording methods, qualitative interviews and observational data 
provides an important contribution to the literature on veterinary medicine use in 
agriculture. 
 Thesis outline 
This thesis is divided into seven chapters. The first three chapters provide an introduction 
to the thesis, the context of the research problem and the methodology and methods 
used. The next three chapters describe three separate research studies aimed at 
addressing each of the three research questions of the thesis. The final chapter brings 
together the overall outcomes of the thesis and discusses its implications on the future of 
policy and research in the area.  
The outline of the thesis is as follows: 
Chapter 2: This chapter provides an introduction to the context within which this thesis 
was written and lays out the thesis rationale. It provides a background on the legislation 
and current use of PVM in the UK and leads on to a critical review of the major literature 
currently available in this area. This literature review spans PVM use, approaches to the 
understanding of farmer decision making and behaviour, and some of the major literature 
available in human health research which can be used to inform knowledge in the area of 
medicine use behaviours. Following on from this, the limitations in the available literature 




Chapter 3: This thesis uses a mixed-methods approach to understanding PVM use, and 
Chapter 3 introduces the research paradigm and the methodological basis for the work. 
The strengths and limitations of mixed-methods research are described and the validity 
for the nature of this enquiry is justified. Additionally, this chapter outlines the research 
methods used to answer each of the three main research aims of the thesis and the pilot 
work used to inform these methods.  
Chapter 4: On-farm storage of PVM, this chapter argues, plays an important role in the 
use practices of PVM. Farmers are constrained or enabled by the resources available to 
them, in this case the medicine resources available on farm. Through a cross-sectional 
study of veterinary medicine cupboards on the participating farms, Chapter 4 describes 
the ways in which farms were storing their PVM, the composition of the types of PVM 
being stored and the quantities stored.  
Chapter 5: The accurate measurement of PVM use has implications for informing the 
wider One Health agenda as well as impacting on agricultural policy, benchmarking and 
targets. This is explored in Chapter 5 by measuring on-farm use through medicine waste 
bin auditing, veterinary sales data and on-farm medicine treatment records, and 
comparing these data with a pre-determined ‘gold standard’ measure of actual use 
through a longitudinal method comparison study.  
Chapter 6: This substantial chapter uses an ethnographic approach in order to begin to 
describe and understand UK dairy farmer motivations, values, drivers, behaviours and 
practices surrounding the use of PVM in cattle. Through a combination of semi-structured 




dairy farms, this chapter explores thematically the way in which participating farmers’ 
motivations and values affected their medicine use practices.  
Chapter 7: The overall conclusions of the entire body of work are chronicled in Chapter 7, 
along with the potential impact and policy implications of the thesis. This chapter also 
suggests further work that could lead on from this research and discusses the future of 
research in this area.  
 










Chapter 2 Literature review and thesis rationale 
  









This literature review has been divided into four sections, each giving an overview of the 
current literature and providing the context from and within which this thesis has 
emerged. The first section will discuss the background of prescription veterinary 
medicines (PVMs), and the UK legislation and guidelines that form the framework in which 
veterinary surgeons and dairy farmers must operate. The second section gives an 
overview of some of the ways in which PVMs have been measured, benchmarked and 
reported (in the UK and internationally) by governments and by research scientists. This 
includes a discussion of the strengths and limitations of measuring and reporting use in 
these ways, the importance of reliable data on antimicrobial use and the paucity of data 
on non-antimicrobial medicine use. The third section gives an outline of the large body of 
literature available on farmer behaviour and decision making and goes on to examine 
more specifically the literature on behaviour and decision making relating to medicine use 
in livestock. Finally, there is a review of some of the major literature from the human 
health sector focussed on medicine prescribing decisions in primary care and on patient 
compliance.  
Following on from these overviews, this chapter discusses the knowledge gaps that have 
been identified from the literature and describes the research questions that have 
emerged, and which form the basis of this thesis.   
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 Prescription Veterinary Medicines 
 Prescription veterinary medicines in the UK 
Veterinary medicines in the UK are defined by the Veterinary Medicines Regulations 2013 
as “any substance or combination of substances presented as having properties for 
treating or preventing disease in animals; or any substance or combination of substances 
that may be used in, or administered to, animals with a view either to restoring, correcting 
or modifying physiological functions by exerting a pharmacological, immunological or 
metabolic action, or to making a medical diagnosis.” - Veterinary Medicines Regulations 
2013 (S.I. 2033) Section 2.1 (b). 
Veterinary medicines are further categorised into different classes: 
POM-V: These medicines can only be supplied on prescription by a veterinary surgeon.  
POM-VPS: These medicines can only be supplied on prescription by a Registered Qualified 
Person (i.e. a veterinary surgeon, pharmacist or Suitably Qualified Person, SQP).  
NFA-VPS: These medicines for non-food producing animals may be supplied by a 
veterinary surgeon, a pharmacist or SQP without prescription. 
AVM-GSL: These medicines have no restrictions and are commonly called ‘over the 
counter medicines’ (Royal College of Veterinary Surgeons, Updated 2018). 
According to the Veterinary Medicines Directorate (VMD) published list (Veterinary 
Medicines Directorate, 2018b) in the UK as of 1st January 2018 there were 1876 POM-V 
class medicines, of which 142 were licensed solely to treat cattle and 455 were licensed 
to treat multiple species including cattle. These include antimicrobials, hormones, anti-
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inflammatories (i.e. non-steroidal anti-inflammatory drugs [NSAIDs] and corticosteroids), 
some vitamin and mineral preparations, neurological agents and miscellaneous other 
drugs.  
There were 233 different antimicrobial preparations licensed for use in cattle, of which a 
total of 75 were classed as highest-priority critically important antimicrobials (HP-CIA) to 
human health. The World Health Organisation (WHO) produce a list of antimicrobials 
considered of critical importance to human medicine for the purposes of risk 
management and responsible antimicrobial use in the face of global antimicrobial 
resistance (World Health Organisation, 2016). The 2017 revision contains some 
antimicrobials licensed for use in cattle, specifically fluoroquinolones, 3rd and 4th 
generation cephalosporins, macrolides, and colistin (licensed for use in calves). However, 
the European Medicines Agency (EMA) to date only classify fluoroquinolones, colistin and 
3rd and 4th generation cephalosporins as HP-CIA (European Medicines Agency, 2014). For 
the purposes of this thesis, the EMA definition of HP-CIA was used and, as such, 
macrolides were not considered to be HP-CIA. In cattle, there were 43 fluoroquinolones, 
19 3rd generation cephalosporins and 12 4th generation cephalosporins licensed for use at 
the time of this study along with five colistin products licensed for calves. All 
fluoroquinolones were in injectable form, two 3rd generation cephalosporins were 
intramammary preparations and the other 17 were injectable. Seven 4th generation 
cephalosporins were intramammary preparations leaving five injectable solutions. Four 
colistin products were oral solutions, the remaining product was an oral powder. 
For those non-antimicrobial medicines licensed for use in cattle, there were 57 anti-
inflammatories, 21 hormones, 43 vaccines, 31 neurological agents (sedatives, local 
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anaesthetics, etc.), 11 anti-protozoals, nine vitamin/mineral preparations, one 
endectocide and miscellaneous other drugs. 
At the time of the study there were 66 controlled drugs (CDs) listed in Schedules 1-5 of 
the Misuse of Drugs Regulations 2001 S.I. 3998 (Secretary of State, 2001) and licensed for 
use in animals in the UK: 16 Schedule 2 medicines, 35 Schedule 3 medicines and 15 
Schedule 4 medicines. Of these 66 CDs, 16 were licensed for use in cattle: three Schedule 
2 medicines, nine Schedule 3 medicines and five Schedule 4 medicines. Veterinary 
medicines only contain CDs in Schedules 2-5 and only those in Schedule 2 and 3 are 
subject to addition storage and prescription requirements. The Schedule 2 and 3 
controlled drugs available for use in cattle were those used for euthanasia (cinchocaine 
hydrochloride, secobarbital chloride solution and pentobarbital sodium) or for 
anaesthesia (ketamine). These medicines should not be left on farm for use by the farmer 
and should only be used by a veterinary surgeon.  
There were 319 POM-VPS medicines licensed in the UK, of which 158 held a license for 
treatment of cattle. These included most anthelmintic (worming) treatments and some 
vaccines. These medicines can be sold by SQPs through non-veterinary outlets and by 
human pharmacists, and veterinary practices will often have SQPs as part of the staff in 
order to prescribe and dispense POM-VPS medicines without the need for a veterinary 
surgeon’s authorisation. The SQP status requires training and examination followed by  
registration through the Animal Medicines Training Regulatory Authority (AMTRA). There 
are currently around 7000 SQPs registered in the United Kingdom (Veterinary Medicines 
Directorate, 2018a).  
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 Legislation and guidelines  
Prescription veterinary medicines are subject to many regulations in the United Kingdom, 
and the government body with responsibility for maintaining these standards is the VMD. 
The use of PVMs in the UK is legislated through the Veterinary Medicines Regulations 
2013  and comes under several EU Directives (European Union, 2009). 
Prescription veterinary medicines in cattle must be licensed for use in that species, with 
licensing applied for by the pharmaceutical company manufacturing the PVM. The drug 
must also have a published Maximum Residue Limit (MRL) (European Union, 2009) which 
is used to set a milk and meat withdrawal time: the length of time after which the meat 
or milk is safe for human consumption (Veterinary Medicines Directorate, 2014b). For 
PVMs licensed in cattle, medicines must state the meat and milk withdrawal periods 
during which time it is illegal for the meat or milk to enter the human food chain. These 
withdrawal periods apply only when the product is used according to the use 
recommendations laid out in the summary of product characteristics (SPC) and product 
datasheet. In some cases, PVMs may be licensed only in cattle that are not producing milk. 
In the event that there is no suitable product licensed for use in a species or licensed for 
use to treat a specific diagnosed disease, veterinary surgeons may prescribe another drug 
according to the Prescribing Cascade (Veterinary Medicines Directorate, 2015b). This 
allows for veterinary surgeons to ‘cascade’ to medicines licensed in the correct species 
but for treating a different disease or, failing that, to medicines licensed for treating 
different species. The use of medicines licensed in cattle for the disease in question but 
used in a way which differs from that laid out in the datasheet is also considered Cascade 
use. In the case of food-producing animals, use of the Cascade is only allowed where those 
PVM being cascaded to have published MRLs (European Union, 2009). Where medicines 
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are prescribed under the Cascade the longer of the two following withdrawal periods 
should be observed; the minimum statutory meat and milk withdrawal periods (28 days 
and 7 days respectively) or the withdrawal period set out in the SPC (Veterinary Medicines 
Directorate, 2015b). 
According to the Veterinary Medicines Regulations 2013, veterinary surgeons may only 
prescribe PVM to “animals under their care”. Due to a perceived lack of clarity the Royal 
College of Veterinary Surgeons (RCVS), the professional regulating body for veterinary 
surgeons, published guidelines with their interpretation of what “animals under their 
care” meant which state that: 
“The veterinary surgeon must have been given the responsibility for the health of the 
animal or herd by the owner or the owner's agent, that responsibility must be real and 
not nominal, the animal or herd must have been seen immediately before prescription or 
recently enough or often enough for the veterinary surgeon to have personal knowledge 
of the condition of the animal or current health status of the herd or flock to make a 
diagnosis and prescribe and the veterinary surgeon must maintain clinical records of that 
herd/flock/individual” (Royal College of Veterinary Surgeons, Updated 2018, Section 4.9). 
In practical terms, this threshold is likely to be exceeded on most dairy farms due to the 
nature of the farming system usually requiring semi-regular veterinary visits. However, in 
beef and sheep farming it is often the case that veterinary surgeons only visit the farm on 
an annual basis to meet the requirements for prescribing. Veterinary surgeons are 
required to keep records of all prescriptions and PVM sales, including information about 
the farm, the species for which it was prescribed, the quantity and the date. There is 
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currently no standardised format for this and there are many different practice 
management software packages that maintain these records. Although there is no legal 
requirement for veterinary surgeons to dispense PVM which have been labelled, the RCVS 
and the VMD consider it good practice. The Veterinary Medicines Regulations 2013 states 
that labels should contain the name and address of the recipient and the veterinary 
practice, the animal(s) intended for treatment, the date, medicine name, quantity, 
strength and the treatment instructions, expiry date of the medicine, meat and milk 
withdrawal period, batch number and the phrase “For animal treatment only” (Veterinary 
Medicines Regulations, 2013). 
The Veterinary Medicines Regulations 2013 also lay out the legal requirements for 
medicine record-keeping by owners of food-producing animals. Records must contain the 
name of the product, quantity and the batch number, the date of acquisition and the 
name and address of the supplier. At the time of administration, the name of the product, 
quantity, date, withdrawal period and identity of animal(s) treated must be recorded, and 
if medicines are discarded, records of the unused medicines must also be kept of the 
quantity, date and method of disposal. These records should be kept on the premises for 
five years.  
Ninety-eight percent of UK dairy farms are registered with the Red Tractor Farm 
Assurance Scheme (Responsible Use of Medicines in Agriculture Alliance, 2017), with a 
few other less common schemes also available. These schemes are voluntary; however, it 
is often a requirement of milk-buying companies that their suppliers participate in 
assurance schemes. These schemes were introduced as a quality assurance method to 
audit farms and ensure that they were meeting certain animal health, welfare, hygiene 
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and management criteria set by the regulatory body (Red Tractor Assurance, 2017). The 
schemes have a variety of  different requirements and in general require an annual or 18-
monthly visit from a farm assurance assessor who will audit the farm’s records, 
management practices and other details depending on the requirements of that specific 
scheme.   
One of the stipulations of most farm assurance schemes is that farms keep records of PVM 
treatments given to cattle. These records are expected to be complete and made available 
to the assessor upon farm assurance audit. The most common method for auditing the 
medicine records is by visualising the records and selecting a specific animal to view the 
treatments it has received during the audit period.  
The government Code of Practice for Responsible Use of Medicines on Farm provides 
guidelines on storing medicines safely including the need to store veterinary medicines in 
lockable medicine cupboards or refrigerators, as appropriate, on farms (Veterinary 
Medicines Directorate, 2014a). Farm assurance audits include assessment of storage 
practices (Red Tractor Assurance, 2017). 
 Out of date products 
All PVM are dispensed with a batch number (for traceability) and an expiry date. This 
expiry date is determined by the manufacturer based on efficacy testing, however it is not 
necessarily reflective of the date at which point the efficacy decreases; it is more accurate 
to describe this date as the latest date at which a positive efficacy test was conducted. It 
is not necessarily in the interests of the pharmaceutical companies to have extended 
shelf-lives for their products, and testing is expensive. There is therefore a balance to be 
reached between achieving a satisfactory shelf life that veterinary practices and farmers 
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are willing to store the medicines for use at a later date and a short enough shelf life that 
extensive efficacy testing is minimised.  
According to the VMD “It is illegal to supply a product (even if free of charge) after the 
expiry date shown on the pack. Any out of date products should be disposed of in 
accordance with the wording on the product literature. 
Some products (for example injectables), once they are opened, must be discarded after 
a period of time stated on their packaging. This is due to EU and national legislative 
requirements to ensure the stability and safety of the product. The expiry date is usually 
28 days after opening but it can be shorter or longer.” (Veterinary Medicines Directorate, 
2015c, Section: Out of Date Products) 
While it is illegal to supply an expired product, their presence is still common on farms 
(Chapter 4). This is largely due to medicines expiring through lack of use within the 
available window. Although storing medicines on farm for use at a later date is common 
practice, some medicines which are used less often are at higher risk of expiring before 
they have been used. It is not illegal for a farmer to use expired medicines for her/his 
animals, however this would technically be classed as unlicensed use, hence minimum 
statutory meat and milk withdrawal periods should be observed as described by the VMD 
(Veterinary Medicines Directorate, 2015b). The presence of expired antimicrobials is one 
of the points often checked during a farm assurance visit, therefore farmers are aware 
that they should not be present on farm. There is, however, a lack of any published data 
about the use or disposal of expired PVM on farms, either in the UK or internationally.  
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There is equally very little literature on the efficacy (or lack thereof) of expired medicines 
in the veterinary or the human medical spheres. It is commonly and logically assumed that 
with increased time after manufacture the efficacy of a product would decrease. 
However, the stability of different active ingredients means the rate of decrease should 
vary between medicines. Expiry dates for drug products are set based on real-time 
stability testing at appropriate storage conditions to determine whether the drug 
substance meets its individually set specification (European Medicines Agency, 2003). A 
specification “establishes the set of criteria to which a drug product should conform to be 
acceptable for its intended use” (European Medicines Agency, 1999, Bottom of page 14).  
Information on stability of products beyond the expiry date is scant. The US Food and Drug 
Administration (FDA) ran a shelf-life extension program (SLEP) which produced evidence 
that many medicines have stability beyond their stated expiry date, although this stability 
is highly variable  (Lyon et al., 2006). The author is unaware of any comparable literature 
on long-term stability of veterinary medicines beyond their labelled expiry date.  
Perhaps of more practical importance than the expiry date stated on PVM is the shelf-life 
once broached. While this is often 28 days for injectable products and 24 hours for 
vaccines, anecdotally dairy farms rarely observe these expiry dates due to most injectable 
medicines being sold in 100 ml or 250 ml multi-dose bottles, and individual animals’ 
treatment courses requiring varying volumes of medicine, for instance a one-off dose of 
12 ml. This type of dose would leave 88 ml of product with a shelf-life of 28 days, during 
which time it is, in the author’s experience, unlikely that the medicine would be used 
entirely. While anecdotally it seems that these broached expiries are not observed in 
practice on farms, there is currently no published literature about the compliance with 
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broached expiries. Similarly, for vaccines - whose shelf-life once broached is usually within 
24 hours – a broached multi-dose bottle would need to be used within one day. This can 
make vaccination schedules (which often require small groups of animals to be vaccinated 
according to a reasonably strict calendar on different days) difficult to design. In recent 
years pack size options have improved and a farmer can now buy vaccines in packs of five, 
10, 25, 50 or 100 doses, which is assumed to have resulted in less waste.  
The reason for a broached expiry date is the fact that once a bottle’s rubber seal has been 
broached with a needle, it can no longer be guaranteed to be sterile. The contamination 
of PVM with bacteria may lead to decreased microbiological stability and growth of 
bacterial colonies and is therefore more likely to be a cause for concern than the presence 
of sealed but expired medicines (Metcalfe, 2009).  
The storage temperature of medicines is another important variable which can affect 
shelf-life and stability. Most veterinary medicines are required to be stored at 
temperatures not exceeding 25°C and most refrigerated medicines require storage 
between +2°C and +8°C (National Office of Animal Health, 2018b). In the Unites States, 
research has shown that storage conditions regularly exceed the recommended 
temperature ranges during the summer months (Ondrak et al., 2015). In the UK, a study 
of on-farm refrigerator temperatures found that the majority failed to maintain the 
correct temperature range over an eight-month period, meaning the quality of medicines 
which require refrigeration such as vaccines would deteriorate (Williams and Paixao, 
2018).  
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Loss of pharmaco-chemical stability is a problem for a number of reasons. The first is, of 
course, the reduced effect of the medicine which is in itself a welfare concern, particularly 
where it leads to lack of pain relief or treatment of disease. Reduced efficacy of 
antimicrobials is also a concern due to the presumed effect on the development of 
antimicrobial resistance (AMR). Where a dose of antimicrobial is given, if that 
antimicrobial is less efficacious, then there may be an unintended relative under-dosing 
of the product. Under-dosing can increase the pressure for selection of resistant 
organisms and therefore increasing the risk of development of AMR (O'Neill, 2016).  
 Responsible antimicrobial use 
In order to understand the way in which PVMs are being used it is important to first 
understand the context within which dairy farmers are operating. While there are 
numerous guidelines and legislations in place regulating the purchase, storage, 
administration and recording of PVMs as described previously, more recently the global 
threat of AMR has caused a shift in focus in the agricultural industry towards reduced and 
defensibly responsible antimicrobial use. Responsible antimicrobial use is defined by the 
British Veterinary Association (BVA) as “Correct antimicrobial: As little as possible, as 
much as necessary” (British Veterinary Association, 2015, Top of page 1).  
As mentioned earlier, the WHO have produced a list of all the classes of antimicrobials 
available in both human medicine and agriculture and have classified these antimicrobials 
according to their importance to human medicine (World Health Organisation, 2016). In 
practical terms for UK agriculture, the WHO classifications of the HP-CIA specifically 
involve the use of 3rd and 4th generation cephalosporins, fluoroquinolones, colistin and 
macrolides. The EMA’s decision not to include macrolides in their list of HP-CIA  has a 
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significant impact on the UK situation because macrolides (particularly those which are 
used for their long-acting properties) are commonly used in UK livestock agriculture. The 
decision of the EMA not to include macrolides is justified based upon the common and 
historical use of macrolides as a first-line treatment against a number of animal diseases 
(European Medicines Agency, 2011). However, the EMA recognises the importance of 
minimising the use of macrolides where possible. 
Of the HP-CIAs defined by the EMA, all have historically been in common use in UK 
agriculture, and with the exception of colistin this is particularly true in the dairy sector. 
This is in part due to the licensing of parenteral ceftiofur, a 3rd generation cephalosporin 
which carries a zero-hour milk withdrawal period, as a treatment for numerous diseases 
in cattle. The use of HP-CIAs is therefore often cost-effective as using them negates the 
need for discarding milk following treatment. From a management perspective, using an 
antimicrobial with a zero-hour milk withdrawal period frees the farmer from needing to 
“dump” milk – removing milk from the human food-chain to safeguard against antibiotic 
residues – and enables milking to occur smoothly without the risk of human error leading 
to milk containing antimicrobials contaminating the bulk tank. HP-CIA were heavily 
marketed to both veterinary surgeons and farmers until recently, however an increasing 
awareness of the importance of HP-CIA among both veterinary surgeons and farmers 
combined with an increased top-down pressure from government and various 
stakeholders led to a 50% reduction of the use of HP-CIAs in UK dairy sector between 2015 
and 2017 (Veterinary Medicines Directorate, 2017). As of 1st October 2013, it was no 
longer legal to advertise antimicrobials to professional keepers of animals (Veterinary 
Medicines Directorate, 2015a).  
Literature review and thesis rationale 
24 
 
It has also been the case that some HP-CIAs (marbofloxacin, cefquinome) have historically 
been the only products licensed to treat certain conditions in dairy cattle, therefore in 
theory a veterinary surgeon could only prescribe HP-CIA where this disease was diagnosed 
in order to conform to the Veterinary Medicines Regulations 2013. The RCVS and VMD 
have since clarified that responsible prescribing of antimicrobials is a valid reason for using 
the Cascade in order to prescribe different, non-HP-CIAs in these cases. 
In 2016 the O’Neill Report on AMR, a UK-funded independent report on antimicrobial 
resistance, concluded that although the use of antimicrobials in humans was the greatest 
driver of AMR in humans, agricultural use was also very important, and improvements 
needed to be made (O'Neill, 2016). This report specifically highlighted the need for 
improved data collection and quality for measuring current use, along with advocating 
targeted reduction across the various agricultural sectors. Following this report, the UK 
government committed to decreasing overall antimicrobial use (AMU) in agriculture to 50 
mg/kg by 2018. At that time the AMU data available for the UK was for the 2014 period 
and sat at 62 mg/kg, meaning a 19% reduction in overall AMU in four years (O'Neill, 2016).  
Public interest in the O’Neill report was strong, with much press coverage. 
The Chief Veterinary Officer, Nigel Gibbons, wrote that veterinary surgeons had a crucial 
role to play in efforts to tackle this global issue (Gibbens, 2016). This increasing public 
awareness of AMR in turn led supermarkets and other sellers of agricultural products to 
focus their attention on the use of antimicrobials, in particular HP-CIA, by their producers 
and suppliers. Dairy farmers generally sell their milk either to large milk-buying 
cooperatives or directly to supermarkets, with some supermarket contracts paying a 
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premium price, for which farmers must comply with certain additional regulations as set 
by the buyer. These regulations were initially aimed at improved milk quality; a premium 
would be paid for milk with low bulk tank somatic cell counts for instance. However more 
recently it has become increasingly common for milk buyers to stipulate regulations 
promoting certain antimicrobial use behaviours aimed at improving responsible use. For 
example, Arla, the largest milk buyer in Europe and the largest dairy company in the UK, 
introduced a requirement through its farm assurance initiative, Arlagården, in 2015 for its 
suppliers to use selective dry cow therapy in a certain percentage of the herd when drying 
off lactating cattle (Arlagården, 2017). That is, a certain number of cattle per year should 
be dried off at the end of their lactation using only a non-antimicrobial teat sealant. This 
is in contrast to the historically more commonly used ‘blanket’ dry cow therapy where all 
cows that were dried off at the end of their lactation received an antimicrobial 
intramammary infusion, with or without the use of a teat sealant, in order to treat existing 
and prevent new bacterial udder infections during the dry period. A recently published 
study involving a questionnaire of Dutch veterinary surgeons showed that they believed 
their dairy farmer clients used selective dry cow therapy (Scherpenzeel et al., 2016). 
Veterinary surgeons are also under increasing pressure to prescribe antimicrobials more 
responsibly, with recent guidelines published by the British Veterinary Association (BVA), 
The British Cattle Veterinary Association (BCVA) and the Responsible Use of Medicines in 
Agriculture Alliance (RUMA) on responsible prescribing practices (British Veterinary 
Association, 2015, British Cattle Veterinary Association, 2017, Responsible Use of 
Medicines in Agriculture Alliance, 2015). In other countries such as the Netherlands, 
veterinary practices and even individual veterinary surgeons’ antimicrobial prescribing 
practices are being monitored and benchmarked, with interventions occurring at certain 
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levels of “inappropriate” prescribing. A recent systematic review and meta-analysis has 
shown a reduction in antimicrobial resistance amongst both animal and human 
populations where antimicrobial use in agriculture was restricted (Tang et al., 2017). 
In the UK veterinary prescribing of antimicrobials is largely unregulated and unmonitored 
from a ‘responsible prescribing’ point-of-view. Veterinary practices are often private 
businesses with no umbrella body such as human medicine’s National Health Service 
(NHS) within which benchmarking could take place. However, the recent change in the 
demographics of veterinary businesses with a move towards corporatisation has led to 
some multi-practice initiatives and benchmarking. RUMA have published sector-specific 
antimicrobial use targets to be achieved by 2020 which include a reduction in HP-CIA 
injectables and intra-mammary use by 50% and an overall reduction in all AMU of 20% 
compared with figures for 2015 (Responsible Use of Medicines in Agriculture Alliance, 
2017). These pressures on veterinary surgeons to move away from prescribing HP-CIA and 
reduce overall use of antimicrobials may have variable success depending on the nature 
of the practice. Those whose business models depend heavily on PVM sales and who feel 
unable or unwilling to actively reduce use may respond differently to those who see the 
promotion of health planning, preventive medicine and the reduction of antimicrobial use 
as an opportunity and a marketing strategy. It has been advocated that veterinary 
businesses need to move away from a sales-driven business model towards a more 
preventative healthcare model (Statham and Green, 2015). 
Veterinary surgeons are the main source of information about prescribed antimicrobial 
use for dairy farmers and are therefore pivotal to the agenda of improved responsibility 
in AMU (Jones et al., 2015). However, veterinary surgeons are perceived to instigate 
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discussions about animal health only 15% of the time (Hall and Wapenaar, 2012). 
Veterinary surgeons have several options for communicating information about 
responsible medicine use to their farming clients; face-to-face contact during herd health 
planning visits, routine fertility or tuberculosis testing visits, by email or by letter in the 
form of practice newsletters and via client information evenings and farmer meetings.  
In addition to the influence of dairy veterinary surgeons on the use of antimicrobials on 
dairy farms, farmers are also influenced by industry bodies. For example, the Agriculture 
and Horticulture Development Board’s Dairy division (AHDB Dairy) is a not-for-profit, levy 
funded organisation working on behalf of the dairy industry. This organisation has a remit 
which includes funding research specifically aimed at improving the dairy industry and for 
communicating this research with dairy farmers, along with providing products and 
services to improve the sustainability of British dairy farming (Agriculture and Horticulture 
Development Board, 2018). AHDB Dairy have produced many booklets, guides and tools 
via their website and via agricultural shows, postal mailings and farmer meetings aimed 
at reducing antimicrobial use and promoting responsible use. Training materials and 
resources in responsible medicine use have also been made available to farmers by other 
organisations The City & Guilds qualification in responsible medicine use, MilkSure 
training to help farmers avoid medicine residues in milk and the 2018 launch of the 
National Office of Animal Health’s Animal Medicines Best Practice training package are 
worthy examples (City and Guilds, 2017, British Cattle Veterinary Association, 2018, 
National Office of Animal Health, 2018a), although involvement in initiatives such as these 
often require a degree of engagement with the subject and occasionally monetary 
investment from the farmer.  
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Dairy farmers therefore have many different sources of information on and drivers for 
responsible antimicrobial use, however these can vary widely depending on the 
veterinary practice with which they are registered, the individual veterinary surgeon with 
responsibility for herd health management decisions on their farm, their milk buyer’s farm 
assurance stipulations and their own awareness of and engagement with the debate 
through industry bodies, farming and national press, their peers and their own healthcare 
providers.  
 Prescription Veterinary Medicine Use 
 Measuring medicine use 
Due to the importance of AMR to the global community, the UK community and 
specifically the UK agricultural community, the focus of data gathered on veterinary 
medicine use is usually on antimicrobials. The use of other prescription veterinary 
medicines such as hormone treatments, non-steroidal anti-inflammatory drugs (NSAIDs) 
and vaccines has received less attention despite an understanding of the use of these 
other medicines being extremely important to the AMR debate. Accordingly, there is 
scant data available for quantifying the veterinary prescription of these other PVM. These 
other medicines, when combined with management changes, offer potential alternatives 
to using unnecessary antimicrobials in treating and preventing disease (Responsible Use 
of Medicines in Agriculture Alliance, 2015). 
One of the seven key intervention areas identified in the O’Neill Report was the need to 
“improve global surveillance of drug resistance and antimicrobial consumption in humans 
and animals” (O'Neill, 2016, bottom of page 5). Currently in the UK, veterinary 
antimicrobial consumption is estimated in the Veterinary Antimicrobial Resistance and 
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Sales Surveillance (VARSS) report, published annually by the VMD (2018c). Historically 
sales data provided by pharmaceutical companies are converted to a proxy of use by 
dividing the total sales by a population correction unit (PCU) to provide consumption data 
in mg/PCU (which they equate to mg/kg in the report) of food producing animals in the 
UK. Since 2017, the VARSS report has moved toward using veterinary practice sales data 
to estimate use in the dairy sector (Veterinary Medicines Directorate, 2017, Veterinary 
Medicines Directorate, 2018c). 
The original system of using national level data has advantages – it is relatively 
straightforward and provides data that conform with EMA requirements and are directly 
comparable with other EU member states via the European Surveillance of Veterinary 
Antimicrobial Consumption (ESVAC) project who also publish reports annually (European 
Medicines Agency, 2017). It does however also have many limitations. Where a medicine 
is licensed in more than one species, it can be very difficult to ascribe the mg/PCU 
correctly to each species. This system also does not account for Cascade or unlicensed 
medicine use - it lacks granularity and assumes the total weight of antimicrobials sold to 
veterinary practices reflects the total weight administered to animals. This lack of 
granularity means that although the data are very useful at an international level for 
comparing total consumption, it has very limited use for understanding veterinary 
medicine use within the UK. It is acknowledged that this high-level data does not provide 
sufficient information to allow more detailed species-specific analysis of use and methods 
for the collection of data on prescription and administration of antimicrobials in different 
livestock sectors are under development (Bondt et al., 2013, Borriello and Sharland, 
2015).  
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The 2016 and 2017 VARSS reports (the most recent available at the time of writing) 
suggest a moving picture, with total antimicrobial sales in all food-producing species 
decreasing from 57 mg/PCU in 2015 to 45 mg/PCU in 2016 and 37 mg/PCU in 2017, 
achieving the target set out in the O’Neill report two years early.  Sales of HP-CIA also 
decreased between 2015 and 2017, with fluoroquinolones reducing from 0.34 mg/PCU to 
0.16 mg/PCU, and 3rd and 4th generation cephalosporins from 0.17 to 0.12 mg/PCU. The 
majority of total weight of antimicrobials sold in the UK in 2016 were tetracyclines, beta-
lactams and trimethoprim/sulphonamides (Veterinary Medicines Directorate, 2017, 
Veterinary Medicines Directorate, 2018c).  
While estimating species- or sector-specific AMU figures is difficult due to multi-species 
licensing of some medicines and poor data granularity, the 2016 and 2017 VARSS reports 
published dairy sector AMU estimates which were based on veterinary sales data for the 
first time. In 2016 this data was obtained from a single source, with a coverage of 33% of 
the UK dairy population and over-represented veterinary practices in Northern Ireland 
while under-representing those in Wales. The report found that there had been an 
increase in the total weight of intramammary antimicrobials used from 1.64 kg in 2015 to 
1.94 kg in 2016. It theorised that this was due to a move away from HP-CIA, with their 
lower weight of active ingredient per course towards more responsible intramammary 
antimicrobials which have a higher weight of active ingredient per course (Veterinary 
Medicines Directorate, 2017). 
Public Health England and the VMD produced a joint ‘One Health’ report on antimicrobial 
use, sales and resistance which placed the UK as mid-range when compared to other EU 
countries for both human and animal use, with humans being responsible for 56% of total 
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antimicrobial use in the UK (Borriello and Sharland, 2015). This report highlights the need 
for standardised recording and species-level data in the future. A recent UK study aimed 
to quantitively evaluate AMU on UK dairy farms through veterinary sales data or farm 
medicine records gathered from 358 farms for a 12-month period (Hyde et al., 2017). This 
study found a median AMU of 15.97 mg/PCU (range 0.36-97.79 mg/PCU).  
 Antimicrobial use metrics 
Multiple different metrics for the measurement of antimicrobial use have been developed 
in human and animal health, with historically little cohesion. Chauvin and colleagues 
(2001) published a paper making the case for using Animal Defined Daily Doses (ADD) (a 
variant on the human method of recording use) as the standardised measure of 
quantifying medicine consumption while comparing it with other measures. Animal 
Defined Daily Doses or Defined Course Doses were the most common measure of 
antimicrobial use in the recent literature (Santman-Berends et al., 2014, Ferner et al., 
2014, Pardon et al., 2012, Gonzalez Pereyra et al., 2015, Aarestrup et al., 2010, Pol and 
Ruegg, 2007, Merle et al., 2014, Hyde et al., 2017) however there are many other 
measures that have been used either alongside or instead of ADD, such as antimicrobial 
use rate (Saini et al., 2012), absolute weight of ingredient (Ferner et al., 2014), Used Daily 
Dose (Pardon et al., 2012, Merle et al., 2014) as well as more descriptive data about most 
commonly used antimicrobials (Sawant et al., 2005, Hill et al., 2009, Zwald et al., 2004). 
The methods of recording antimicrobial use on farm also varies between studies, with on-
farm records being the most commonly used recording system (Pardon et al., 2012, 
Menendez Gonzalez et al., 2010, Merle et al., 2012), while veterinary sales data to 
individual farms (Santman-Berends et al., 2014, Ferner et al., 2014, Merle et al., 2012, 
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Hyde et al., 2017), farmer recall (Redding et al., 2014) and bin audits (Saini et al., 2012, 
Redding et al., 2014, Nobrega et al., 2017) are also used. It has been recognised that 
various factors such as recall bias, non-compliance, incomplete and inaccurate recoding 
are associated with all methods of recording farm-level medicine use (Zwald et al., 2004, 
Sawant et al., 2005, Raymond et al., 2006, Pol and Ruegg, 2007, Saini et al., 2012). 
The RUMA Targets Taskforce was set up to develop sector specific antimicrobial reduction 
targets and improve and standardise the measurement of AMU in food-producing animals 
and published its first report in 2017.  In addition to government and industry bodies, 
private software developers have also seen a market for improved medicine record 
keeping. This has instigated a wave of new software aimed specifically at dairy farmers 
and dairy veterinary surgeons with improved PVM recording (ease-of-use, graphics, data 
analysis, etc.) as a marketed benefit, e.g. VetIMPRESS, Uniform-Agri etc. One of the 
outcomes of this relatively sudden influx of new approaches to measuring medicine use 
at the veterinary practice or farm level has been the concurrent development of many 
different AMU metrics including total mg, mg/kg, daily dose and course dose metrics. A 
recently published paper comparing different AMU benchmarking metrics in the UK dairy 
industry concluded that “UK-specific, UK-standardised versions of the daily dose and daily 
course AMU metrics would bring a balance between data requirements, accuracy to the 
UK, ease of use and understanding,” thus advocating the development of a  new metric 
specifically tailored to meet the requirements of the UK dairy industry (Mills et al., 2018, 
bottom of page 8).  
In the UK, daily dose metrics are currently in use by major UK retailers, and course doses 
are being used by veterinary practices and retailers (Mills et al., 2018). Internationally, 
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there are many metrics used for measuring AMU, with the Netherlands and Denmark both 
using daily dose metrics tailored for their national situation for measuring and 
benchmarking purposes (Bos et al., 2015, Statens Serum Institut and National Food 
Institute, 2018). 
The recent paper also highlighted the important point that metrics which measure total 
number of mg, and reduction targets based upon these metrics “may drive users towards 
HP-CIAs which often have a lower dose rate and thus make total AMU appear lower for 
the metrics where total mg is used instead of explicitly accounting for dose or course. 
Therefore, use of HP-CIAs should be reported separately to total use and it may also be 
beneficial to have additional targets for HP-CIAs.” (Mills et al., 2018, Page 1) 
Given the different legislation surrounding veterinary medicine prescriptions and 
licensing internationally, it is very difficult to accurately compare the overall use patterns 
of the UK’s POM-V medicines with their equivalents abroad. Prescription veterinary 
medicine licensing varies between countries and most countries do not publish figures for 
use of NSAIDs, anthelmintics, vaccines or hormones. It is therefore only plausible to 
discuss PVM internationally in relation to antimicrobials.  
Comparing antimicrobial consumption between countries is a complex and difficult task 
(Chauvin, 2001). Many countries publish total AMU data in some form, however there is 
little standardisation of the methodology or metrics for measuring use (Carnevale and 
Shryock, 2006). In addition to this, farming systems, disease burdens, licensed medicines 
and livestock breeds make direct comparison unhelpful. A paper by Hillerton and 
colleagues (2016) compared the official government reports of veterinary AMU of 30 
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Western countries in 2012. This study placed Norway, Iceland and New Zealand as the 
lowest users at 3.8, 5.9 and 9.4 mg/PCU respectively. The highest users were Cyprus, Italy 
and the United States of America (USA) at 396.5, 341.0 and 266.2 mg/PCU respectively. 
The UK fell mid-table with an AMU of 66.3 mg/PCU. These reports were largely based on 
national sales data and subject to the same limitations as discussed previously in the UK’s 
surveillance data.  
Veterinary sales data has been utilised to estimate AMU in several countries, including 
the UK (Hyde et al., 2017), the Netherlands (Bos et al., 2015), Denmark (Bondt et al., 2013) 
and Germany (Merle et al., 2012). Antimicrobial use has been estimated at the farm-level 
in many countries internationally, including the UK, the Netherlands, Belgium, Denmark, 
Sweden, Austria, the USA, Canada and Argentina (Hyde et al., 2017, Stevens et al., 2016, 
Gonzalez Pereyra et al., 2015, Hill et al., 2009, Ortman and Svensson, 2004, Meek et al., 
1986, Pol and Ruegg, 2007, Sawant et al., 2005, Santman-Berends et al., 2014). The USA 
studies have been largely based on questionnaires and surveys utilising recall, whereas 
other studies have used existing on-farm records or have been longitudinal studies 
introducing novel record-keeping methods. German, Swiss and Austrian studies have 
found that veterinary sales data were superior to on-farm record keeping but that both 
are feasible ways of monitoring use (Merle et al., 2012, Menendez Gonzalez et al., 2010, 
Ferner et al., 2014). However, a Belgian study found that the most accurate data was 
obtained from on-farm records due to routine deviation from prescribed dosing (Pardon 
et al., 2012).  
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 Farmer behaviour and decision making 
An understanding of farmer decision making and behaviour is extremely important in 
order to inform policy and ensure effective interventions when seeking to change 
behaviour (Garforth, 2015, Escobar and Buller, 2014). A 2017 review of determinants of 
farmers’ adoption of management strategies to prevent or control infectious disease 
concluded that so called ‘socio-psychological factors’ are key in instigating behaviour 
change (Ritter et al., 2017). 
 Previous literature 
Classically, research of farmer behaviour and decision making has been mostly of a 
quantitative nature, with Likert-type psychometric scales or structured questionnaires 
forming the majority of the literature on farmer motivations, attitudes and beliefs 
(Kaupinnen, 2010, Burton, 2004, Willock et al., 1999, Beedell and Rehman, 2000, 
Dernburg et al., 2007, Richens et al., 2013). The origins of this approach lie in economic 
models and in health psychology, and although Edwards-Jones argues in his 2006 paper 
that “traditional economic approaches are most suited for making predictions about 
decisions which are dominated by financial transactions at a broad scale” (Edwards-Jones, 
2006, top of page 784), he and others believed that farmer behaviour is governed by a 
more complex picture and that emphasis needs to be placed on other influencing factors 
(Escobar and Buller, 2014, Burton, 2004, Willock et al., 1999). The inherent problems of 
designing health interventions based on surveys of ‘attitudes and beliefs’ are discussed in 
Pool & Geissler’s book Medical Anthropology, where they state that “standardised 
instruments such as survey questionnaires produce a standard set of decontextualized 
local beliefs” (Pool and Geissler, 2005, middle of page 37). 
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Most published studies of farmer behaviour employed Ajzen’s Theory of Planned 
Behaviour (TpB) (Ajzen, 1991), which was developed to improve the Theory of Reasoned 
Action (TORA) (Fishbein and Ajzen, 1975) as a model for decision making and behaviour 
(Beedell and Rehman, 2000, Garforth and Rehman, 2006, Garforth et al., 2006, Garforth 
et al., 2013, Rehman et al., 2007, Rehman et al., 2008, Ritter et al., 2017). However, it has 
been suggested that agricultural research using the TpB has focussed too much on 
attitudes, without due consideration for other important ‘external’ factors such as 
‘subjective norm’ and ‘perceived behavioural control’ (Escobar and Buller, 2014, Burton, 
2004, Burton et al., 2012). The Theory of Planned Behaviour frames behaviour as an 
outcome that can be determined in advance by an individual’s internal mind-map 
(Escobar and Buller, 2014) although Ajzen himself concedes that predicting intentions 
does not necessarily predict actual behaviour due to other (external) factors (Ajzen, 2015).  
Another approach commonly used was that of the Health Belief Model, developed by 
social psychologists as a research and intervention tool (Janz and Becker, 1984). In 
essence, it assumes that people’s beliefs determine their behaviour in a direct and 
rational fashion and by understanding beliefs we can understand and change behaviour. 
Anthropologists argue that this is simplistic and flawed. Beliefs are relative and context 
dependent, and they do not drive behaviour in any direct way but are subject to structural 
constraints (Pool and Geissler, 2005). 
Gasson’s seminal paper identified four sets of values that underpin farmer behaviour and 
motivation (1973). These values were ‘instrumental’ (those concerned with financial and 
business goals), ‘social’ (relating to prestige and tradition), ‘expressive’ (creative values 
and self-expression) and ‘intrinsic’ (the independence and enjoyment of farming). A 2008 
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study identified five different types of behavioural motivation as ‘family orientation’, 
‘business/entrepreneur’, ‘life-stylers’, ‘enthusiast/hobbyist’ and ‘independent/small 
farmers’ (Rehman et al., 2008). This model was further refined in the Department for the 
Environment, Fisheries and Rural Affairs (DEFRA)’s ‘segmentation model’ which 
categorised and estimated the proportion of farmers in each section as follows: ‘modern 
family business’ (41%) which are focussed on making a profit and ensuring the future of 
the enterprise, ‘custodians’ (23%) who are influenced by environmental and heritage 
factors, ‘pragmatists’ (22%) that wish to balance a viable business with a love of farming, 
‘life-style choice’ (6%) who are more motivated by farming than making money and 
usually have other sources of income, and ‘challenged enterprise’ (7%) which are 
struggling and pessimistic about the future survival of the business (Pike, 2008). 
Quantitative approaches to understanding decision-making and predicting behaviours 
such as the Edinburgh Study of Decision Making on Farms (Willock et al., 1999) have aimed 
to create multivariable models using Likert-type scales to model attitudes, objectives and 
behaviours although these models have not been widely used since.   
Segmentation theory has been very popular for many years, however in a recent report 
to DEFRA, Escobar and Buller reason that although quantitative analysis based on these 
farmer segmentation models tend to be favoured by policy makers, more emphasis 
should be placed on other methodologies such as ethnographies, biographical and 
narrative approaches and in-depth interviews (amongst others) in order to provide a 
richer and more detailed picture of farmer behaviour (Escobar and Buller, 2014). 
Additionally, in-depth interviews of farm workers, share-milkers and farm owners in New 
Zealand led Burton and colleagues to propose that farmer behaviour be reconceptualised 
as part of a self-reinforcing culture in which animals, humans and the physical 
Literature review and thesis rationale 
38 
 
environment all contribute to farm-specific behaviours (2012). This ‘cultural turn’ from 
behavioural approaches using quantitative research methodology to qualitative 
methodology in agricultural science has been lagging behind when compared to other 
behavioural sciences (Burton, 2004). 
 Medicine-specific behaviour 
Values, perceptions and behaviours surrounding the use of veterinary medicines by 
farmers is an area with an overwhelming need for further research (Buller et al., 2015). It 
has been shown that farmers regularly exceed datasheet guidelines for treatment 
duration of clinical mastitis because they feel insecure about how to treat mastitis 
effectively (Swinkels et al., 2015), and Belgian and Austrian studies have shown both 
overdosing and underdosing of medications to be common in pigs (Timmerman et al., 
2006, Trauffler et al., 2014). It is therefore likely that other veterinary prescription 
medicines are not used according to datasheet guidelines on farms, despite this 
assumption being made in all current estimates of use. Similarly, it has been shown in 
human medicine that a variety of social and cultural influences and beliefs can affect 
compliance when prescribing medicines (Martin, 2005). Understanding the reasons why 
this may be the case requires a qualitative methodology in order to investigate this 
phenomenon further and to inform future policy interventions.  
Social norms also play a key role in medicine-use behaviours. It has been said that “every 
medicine is given particular, often varying and changing, meanings in any given context, 
producing a multiplicity of ideas and practices” (Pool and Geissler, 2005, top of page 89). 
Swinkels and colleagues explored the social influences on the duration of antimicrobial 
treatment in mastitis and found that extending treatment duration had become the social 
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norm (2015). A study of small animal veterinary surgeons in the UK also found social 
norms influenced prescribing behaviour, particularly verbally agreed protocols (Mateus 
et al., 2014). Client pressure was identified in the UK, the Netherlands and Ireland as 
playing a role in veterinary surgeons’ antimicrobial prescribing (Coyne et al., 2014, 
Gibbons et al., 2013, Speksnijder et al., 2015) A recent UK questionnaire-based study 
linked increasing frequency of veterinary contact with more responsible antimicrobial use 
and greater knowledge of AMR (Higham et al., 2018).   
A study analysing the UK press’ coverage of agricultural antimicrobial use and AMR in 
recent years (Morris et al., 2016) showed a clear disagreement between relevant actors. 
Groups such as the Soil Association and Alliance to Save our Antibiotics framed the issue 
as system failure, while policy makers, regulatory bodies and farmers believed there was 
little evidence about the contribution of agricultural use to the growing problem of AMR. 
In the farming press, voluntary action in order to protect the public image emerged as a 
theme. The study advocated strongly for the use of ethnographic and interview-based 
techniques in order to research actual use of antimicrobials on-farm. 
Of the small body of qualitative literature on PVM use not based on health-psychology 
approaches, the use of semi-structured in-depth interviews has been the most common 
research method. A Danish study interviewed 16 dairy farmers to identify factors involved 
in mastitis treatment and found that decisions were made on three levels: the symptom 
level, the cow level and the herd level (Vaarst et al., 2002). A Norwegian study explored 
farmers’ use of homeopathy through interviews, with personal experience proving 
important and decisions made both at the cow and the herd level (Hektoen, 2004).  A 
study of UK dairy farmers’ motivations for vaccination use found the veterinary surgeon 
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played an important role in decision making in the implementation of vaccination 
strategies (Richens et al., 2015). 
 Human medicine use 
One of the most common health care interventions in the UK is the prescribing of 
medicines in primary care, and over 1.1 billion items were prescribed and dispensed by 
the NHS in 2016 (National Health Service, 2017). Given that these prescriptions occur 
under the umbrella of the NHS and given the greater scale, impact and funding available 
within human medicine it is unsurprising that there is a far larger body of literature about 
medicine use behaviours and prescribing decisions in this area. Reviewing some of the key 
elements of this literature can provide an insight into factors that may be of equal 
importance if applied to veterinary medicine use in the farm context. 
 Measuring use 
Within NHS Primary Care in England, prescription data from general practitioners is 
gathered continuously with analysis of trends in medicine use being used for 
benchmarking, feedback and policy interventions (National Health Service, 2018). Data on 
prescriptions dispensed in the community are published annually (National Health 
Service, 2017) and Clinical Commissioning Group (CCG) prescribing, practice-level 
prescribing and Primary Care Trust prescribing data are all made publicly available. The 
availability of core information technology (IT) systems, combined with the centralised 
reimbursement of pharmacies for prescriptions dispensed provides a standardised and 
valid source of data on medicines dispensed into the community from general 
practitioners although may fail to capture some medicines prescribed by out-of-hours 
services and those prescribed by dentists. Traditionally, prescribing has been measured 
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using the number of items prescribed and the associated costs. Patient population data 
can be drawn from patient lists and allows the publication of data on items per patient, 
cost per patient and cost per item. In addition to these statistics, other measures have 
also been developed, including measures of volume, Defined Daily Doses (DDDs), Average 
Daily Quantities (ADQs) and patient denominators (Jones et al., 2004). 
While measuring medicine prescribing and dispensing is relatively simpler in human 
medicine than in veterinary medicine in the UK for the reasons outlined above, measuring 
actual medicine use (i.e. the medicines actually taken by the patient) in the human 
population in primary care is an equally complex issue to measuring use in veterinary 
medicine. Self-report questionnaires - while common and simple to implement - have not 
been validated or standardised and are open to the fallacy of memory (Lafleur and 
Oderda, 2004).  
 Decision making and medicine use behaviours 
There is a large body of evidence showing that prescribing decisions and medicine use 
behaviours in human health are influenced by many factors (Public Health England and 
Department of Health, 2015). The majority of the published research relates specifically 
to the prescription and use of antimicrobials which is unsurprising given the relative 
importance of understanding and reducing antimicrobial prescribing compared with other 
medicines. Given the link between antimicrobial prescribing and resistance has been 
made (Costelloe et al., 2010), one focus now is on qualitative research in order to better 
understand the root causes of antimicrobial use. 
Social norms were identified as having a significant effect on prescribing. Clinicians’ 
prescribing in hospitals was influenced by the perceived prescribing norms and 
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encompasses risk-aversion and hierarchical structures (Broom et al., 2014, Lewis and 
Tully, 2009). Parents’ and clinicians’ expectations and decisions about antimicrobial use 
in children were influenced by the subjective norms of perceived child vulnerability and 
the clinicians’ role in ensuring child safety (Cabral et al., 2015). 
Uncertainty was identified as a strong driver of prescribing behaviour. Uncertainty and 
diagnostic complexity could lead to unnecessary prescribing of antimicrobials in cases of 
acute cough in adults and respiratory tract infections in children (Lucas et al., 2015, 
Whaley et al., 2013). Prescriber anxiety about the consequences of not prescribing (i.e. 
risk averse behaviour) was a dominant theme highlighted by the Department of Health’s 
literature review of antibiotic prescribing in primary care (Public Health England and 
Department of Health, 2015). As such, antibiotics were used to mitigate uncertainty. 
Inappropriate prescribing can therefore, in turn, reinforce health-seeking behaviour 
whereby a patient feels validated in seeking treatment and will subsequently be more 
likely to seek similar treatment. 
Lived experience is important and it has been shown that if a similar illness resolved with 
antimicrobial treatment in the past, there was a greater expectation of future 
antimicrobial treatment (Ingram et al., 2013). Perceived patient expectation of 
antimicrobial prescribing influences prescribing behaviour.  Clinicians prescribe when 
they feel pressured to do so, when they feel there is a clear indication and also when they 
feel uncertain, “just in case” (Lucas et al., 2015, Whaley et al., 2013).  Clinicians avoid 
prescribing when concerned about side effects or resistance, when they are certain 
antimicrobials are not needed or when there was no pressure to prescribe (Lucas et al., 
2015). However, it has also been shown that clinicians are not particularly adept at 
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identifying when patients do expect antibiotic treatment (Mangione-Smith et al., 1999). 
A study by Little and colleagues in 2004 showed that clinicians’ decisions were more 
strongly associated with perceived medical need, and this effect confounded all others. 
However perceived patient pressure was a strong independent predictor of clinicians’ 
behaviours in relation to investigations, be they referral or prescribing (Little et al., 2004).  
More generally, there has been work looking at the use of medicines other than 
antimicrobials in human health. It has been shown that side effects can influence use as 
well as convenience, ease-of-use and availability. Non-adherence to prescribed use can 
be caused by ‘medicine burden’ where prescription of several medicines leads to a feeling 
of burden (Katusiime et al., 2016). Conversely, satisfaction with treatment and medicines 
is positively associated with medicine use (Barbosa et al., 2012).  
“There is a recognised need for health systems to understand and monitor patients’ 
experiences (of medicine use), to improve quality of care.” (Katusiime et al., 2016, bottom 
of page 158). 
This philosophy can be applied equally to the care of farmed animals and the need to 
understand and monitor farmers’ experiences of medicine use to improve the health and 
welfare of the animals under their care.  
 Knowledge Gaps 
It is clear from the review of literature surrounding veterinary medicine use on UK dairy 
farms that there remain many areas requiring investigation. Several knowledge gaps have 
been identified, and some of them form the basis for this thesis: 
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Need for data on prescription medicine storage practices. Very little is currently known 
about the way medicines are stored on UK dairy farms and farmers are assumed to be 
storing and disposing of medicines appropriately by policy makers, academics and 
veterinary surgeons.  
Lack of granularity of data. While measuring veterinary medicine use in the UK is 
improving in granularity with a move from national-level data collection towards 
veterinary practice level data, data at the farm and individual cow level on medicine use 
is lacking despite the requirement that farmers keep detailed medicine records for each 
individual animal. There is no currently published research seeking to validate veterinary 
practice sales data or on-farm medicine records and therefore, even with a move towards 
granularity, it is currently unknown how well these data reflect actual use.  
Need for data on non-antimicrobial PVM use. The lack of literature on quantifying the 
use of NSAIDs, vaccines, hormones and other PVM in UK dairy cattle despite their 
importance in a holistic approach to herd health management and responsible medicine 
use suggests this is an area with an urgent need for research. 
Need for ethnographic study of medicine use behaviours. While measuring medicine use 
provides vital information for benchmarking purposes, design and implementation of 
policy interventions requires an understanding of the reasons for medicine use 
behaviours and decisions by farmers. This has been identified as an area with an 
“overwhelming need for further research” as previously mentioned (Buller et al., 2015, 
middle of page 65). Additionally, the context and culture within which medicine treatment 
decisions are being made on farms has not been previously investigated.  
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These identified knowledge gaps justify the aims of this thesis and the research paradigms 
from which the methodologies used were drawn. Due to the lack of available data with 
which to form a hypothesis for testing, this thesis is largely theory-generating and 
exploratory and, as such, focusses on achieving rich in-depth data, based on a small 
number of farms rather than providing a representative sample from which conclusions 
can be drawn and inferred upon the entire population. 
  















Chapter 3 Methodology and Methods 
  








It has been suggested that mixed methods and interdisciplinary approaches are best 
suited to answer complex questions as they have an ability to be tailored for the needs of 
the research questions (Pope and Mays, 2006). It is important when designing, 
implementing and analysing rigorous scientific research that the researcher is aware of 
the research paradigm within which (s)he is working. A research paradigm is defined as 
“the set of common beliefs and agreements shared between scientists about how 
problems should be understood and addressed” (Kuhn, 1962, top of page 44). Once the 
methodology and research paradigm have been defined, it is then possible to design and 
prescribe the specific research methods with which to investigate the research questions. 
This chapter presents the ontology and epistemology of the thesis, explores the strengths 
and potential limitations of mixed-methods research and the research methodologies 
utilised, sets out the theoretical framework and finally describes the research methods 
employed to investigate the research questions laid out in Chapter 2. 
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 Ontology and epistemology 
A research paradigm can be broken down into the ontology and epistemology of the 
researcher. 
The ontology refers to the researcher’s view on the nature of reality, and, in its most basic 
form, ranges from realism (there is one reality, and everyone experiences it in the same 
way) to relativism (there is one reality, but there are many different ways of experiencing 
it) to solipsism (the is no reality, it is merely a product of the mind). The epistemology 
refers to how the researcher believes that reality can be known (Wahyuni, 2012).  
Epistemology can be broadly divided into three main groups:  
Positivism - There is a single reality which can be measured and known. Positivism is most 
likely to result in quantitative research methodologies. 
Constructivism/Interpretivism - There is no single reality or truth, and therefore reality 
needs to be constructed and interpreted. Researchers with a constructivist/interpretivist 
epistemology are more likely to use qualitative methods to capture those multiple 
realities.  
Pragmatism - Reality is constantly renegotiated, debated and interpreted, and therefore 
the best method to use is the one that solves the problem. Mixed methods research is 
often pragmatic in epistemology (Pope and Mays, 2006). 
Due to the complexity of the research questions at hand, this thesis aligns most readily 
with a pragmatist epistemology and, as such, uses a mixed methods design.  
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The measurement of actual PVM use on UK dairy farms and the comparison of veterinary 
sales data with on-farm medicine records and medicine use as recorded by medicine 
waste bins is positivistic in nature as it assumes that there is one knowable truth – there 
is one correct figure for medicine use and measures for that figure can be contrasted with 
the hypothesised truth. This is realist in ontology. However, this thesis also aims to 
understand the beliefs and values of dairy farmers, and the context and culture within 
which PVM use behaviours occur. The ontology of this enquiry is more relativist and is 
interpretivist in epistemology - it seeks to interpret the social construction of reality in 
order to provide insight and explanation for decision-making behaviour. Therefore, taken 
as a whole, this thesis is written from a pragmatic epistemology, where research 
methodology was chosen depending on the specific research questions. 
 Mixed methods research 
Mixed methods research has been defined as “Research where the researcher mixes or 
combines quantitative and qualitative research techniques, methods, approaches, 
concepts or language into a single study” (Johnson and Onwuegbuzie, 2004, bottom of 
page 17). Its use is increasingly popular in healthcare research (Tashakkori and Teddlie, 
2010, O'Cathain et al., 2013) although in some fields it remains controversial due to a 
belief in the principle that methods should not be mixed (Howe, 1988). 
Quantitative research paradigms emphasise objectivity, measurement, standardisation 
and minimising bias, whereas qualitative paradigms focus on understanding, flexibility, 
insight, subjectivity and are highly reflexive. This can, by definition, make mixed methods 
research a dichotomy that is difficult to reconcile, however its use is driven by pragmatism 
rather than principle and is motivated by a perceived deficit of either quantitative or 
Methodology and methods 
52 
 
qualitative methods alone to address complexity in health care research (O'Cathain et al., 
2007). In this sense, mixed methods research can counterbalance and complement the 
strengths and limitations of both qualitative and quantitative research; these methods 
can address complexity and can help to reduce the knowledge-practice gap, enhancing 
the impact and usefulness of scientific research (Bryman, 2006). 
The identified knowledge gaps that prefaced the development of the research questions 
at the heart of this thesis naturally lend themselves to mixed methods research. 
Understanding veterinary medicine use on UK dairy farms cannot be achieved through 
one research methodology alone and is inherently complex. Through a mixed methods 
approach, the research questions can be answered in different ways, with integration and 
triangulation of data analysis providing robust and valid answers. Qualitative research 
findings can help with interpretation and explanation of quantitative data and vice versa, 
leading to a sum greater than its parts and providing “additional perspectives and insights 
that are beyond the scope of any single technique” (Borkan, 2014, top of page 4). As 
summed up by Mason in 2006, “Mixing methods…offers enormous potential for exploring 
new dimensions of experience… and intersections between these. It can encourage 
researchers to see differently, or to think ‘outside the box’, if they are willing to approach 
research problems with an innovative and creative palette of methods of data 
generation” (Mason, 2006, top of page 10). 
 Methodological Triangulation and Pluralism 
Pluralism (or methodological triangulation) is the ultimate purpose of mixed methods 
research. While investigating a problem using different methods is useful, its power lies 
in the triangulation of these different techniques and in their combined interpretation. 
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Pluralism can therefore enable a rich and comprehensive picture of the research question 
(Foss and Ellefsen, 2002) and increase the robustness and validity of any single dataset by 
seeking to compare and contrast it with other methodological ways of answering complex 
questions (May et al., 2017). In essence pluralism is asking whether the results make sense 
given the wider context, and it has been argued that in using data from opposing 
epistemological backgrounds it is possible to “explore different, sometimes even 
contradictory, layers of meanings of realities”(Hoque et al., 2013, middle of page 1173).  
 Quantifying medicine use 
The two most common ways that researchers have used to quantify veterinary medicine 
use on farms have been through use of veterinary practice sales data and on-farm 
medicine records. Most studies have retrospectively measured these data; (Davies et al., 
2017, Hyde et al., 2017, Hill et al., 2009, Gonzalez Pereyra et al., 2015, Pol and Ruegg, 
2007, Zwald et al., 2004, Ferner et al., 2014, Merle et al., 2012, Bondt et al., 2013) 
however, some have provided new recording systems (medicine waste bins, computer or 
smartphone software, medicine record sheets) and prospectively and longitudinally 
measured use (Stevens et al., 2016, Ortman and Svensson, 2004, Menendez Gonzalez et 
al., 2010). This thesis aimed to compare veterinary sales data with on-farm medicine 
records and medicine waste bins in order to measure the agreement between different 
recording methods and to determine the relative strengths and limitations of each 
technique compared with a defined “gold standard”. 
3.3.2.1 Veterinary sales data 
Veterinary sales data is currently seen as the data of choice to measure veterinary 
medicine use by researchers, government bodies and veterinary practices (Veterinary 
Medicines Directorate, 2018c). This is due to the relative ease of obtaining data from 
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practice management software, the fact that these data should already exist for every 
farm in the UK, and the perception that the data is likely to be reasonably valid. This 
validity is assumed because prescription veterinary medicines are recorded every time 
they are dispensed to a farm and it is in the interests of veterinary practices (which in the 
UK are private businesses) to accurately record medicine sales in order to correctly charge 
for them.  
The use of veterinary practice sales data has potential limitations. Many farms are mixed-
species enterprises and medicine sales are not always accurately ascribed to the correct 
species. Additionally, veterinary sales data over any given time-frame does not necessarily 
equate to veterinary medicine use and does not account for medicines bought and stored 
on farm for use at a later date. This time-lag between purchase and use of veterinary 
medicines means it is difficult to know whether a medicine was used or stored during the 
time-period being studied. Veterinary medicine sales data also fail to capture medicines 
which are discarded or wasted, either through human error (dropped/broken/lost 
medicines) or medicines discarded due to contamination or expiry. 
Another potential drawback of veterinary sales data as a measure of medicine use is the 
acquisition of PVM by other means. Farmers are able to use online pharmacies in order 
to purchase PVM. These pharmacies require a written prescription before being legally 
allowed to dispense PVM, but these prescriptions may not be captured within the sales 
data obtained from veterinary practices. Most anthelmintics and many vaccines licensed 
for use in UK cattle (13 out of a total of 55) are classed as POM-VPS and as such can be 
acquired through an SQP from veterinary practices or other outlets and therefore their 
sale will not necessarily be captured (Veterinary Medicines Directorate, 2018b). There is 
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also the possibility for administrative error when inputting veterinary sales into practice 
management software, and errors by a factor of ten or one hundred have been reported 
anecdotally by the farmer participants in historical veterinary invoices. While it is likely 
that these errors will be noticed and corrected by the farmer upon receiving the invoice 
if the error overestimates the actual sale and therefore overcharges, where errors 
underestimating the volumes sold are present these may be more likely to be unreported 
and unresolved. In addition to this, there is anecdotal evidence of illegal purchase and/or 
import of PVM to dairy farms in the UK (British Broadcasting Corporation, 2005, Vet Times, 
2018). Where this has occurred, veterinary sales data will not represent all PVM acquired 
by a farm. 
3.3.2.2 Medicine records  
As previously described, all dairy farms in the UK are required to keep veterinary medicine 
treatment records including details of the animal treated, the drug, treatment date and 
quantity. In theory, therefore, these records should provide superior data for actual use 
of veterinary medicine in dairy farming as they are not subject to the limitations of 
veterinary sales data (discussed above) and provide greater granularity and detail. 
However, it has been established  that farmers do not prioritise medicine record keeping 
(Escobar, 2016). The various other time pressures of dairy farming along with a perceived 
lack of value of these records can lead to medicine records being completed 
retrospectively and solely to meet the requirements of farm assurance without accurately 
reflecting actual use.  
Given the retrospective nature of record keeping on many farms, in practice on-farm 
veterinary medicine records come with many limitations. The possible recall bias and 
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reliance on memory - of the medicines used, the volumes, and the animals’ identities - 
are likely to reduce the quality and accuracy of the records progressively with the passage 
of time. Farms where records are completed at the time of treatment are likely to be most 
accurate. Farms where records are completed daily may still correlate well with actual 
use; however, on farms where medicine records are completed weekly, monthly or even 
annually before a farm assurance inspection they are unlikely to accurately reflect use on 
farm. Given that farmers have an awareness that farm assurance cannot determine 
between accurate veterinary medicine records and fabricated veterinary medicine 
records, there is likely to be little motivation to maintain up-to-date and accurate records. 
On-farm medicine records can be kept in many different forms, with computerised 
records and paper-based records both common (Escobar, 2015).   
3.3.2.3 Medicine waste bins 
The use of medicine waste bins to record medicine use is relatively novel, with a Canadian 
mastitis treatment study using waste bins to record all mastitis treatments across 89 dairy 
farms for twenty months (Saini et al., 2012). This study, however, did not compare 
medicine waste bin data with on-farm records or veterinary sales data. A related 
publication compared the quantification of antimicrobial use across 51 Canadian dairy 
herds using treatment records or medicine waste bins and found bins to be superior; 
treatment records underestimated use significantly (by >50% across all participating 
herds) but were positively correlated with medicine bin inventories (Nobrega et al., 2017). 
A recent study investigating the use of veterinary medicines on 20 Peruvian farms used 
waste bins as a proxy for medicine records because farms did not routinely keep records 
of veterinary treatment (Redding et al., 2014). This study found that bins were more 
accurate than self-reporting for bottles of antibiotic, but self-report was superior when 
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measuring intramammary tubes. It also found that there was very little agreement 
between the two methods. 
Veterinary medicine waste bins aim to improve the measurement of medicine use data 
from veterinary sales data by being more time-sensitive and accounting for wasted and 
discarded medicine. They also aim to mitigate against the limitations of farm medicine 
records by not relying on memory and being simple and easy for farmers to use. The use 
of medicine bins does, however, ask farmers to alter their behaviour from disposing of 
veterinary medicines either in normal waste or in clinical waste bins. Hence, this method 
of data collection is subject to a reliance on farmers to remember to dispose of the 
medicines in the correct bins.  
For this study, medicine bins were chosen as a third measuring tool in order to quantify 
the difference in the three most common methods of medicine recording (veterinary 
prescription records, on-farm medicine records and medicine waste bins), and to compare 
them to a ‘gold standard’ for actual medicine use as defined in Chapter 5. When used in 
terms of method agreement analysis, the term ‘gold standard’ does not in fact refer to a 
perfect measure by which all others can be compared. That is known as the ‘ground truth’.  
Instead, “a gold standard in its true meaning, derived from the monetary gold standard, 
merely denotes the best tool available at that time to compare different measures” 
(Claasen, 2005, middle of page 1121).  
 Qualitative research 
Qualitative research “is a form of social enquiry that focuses on the way people interpret 
and make sense of their experiences and the world in which they live” (Holloway, 1997, 
middle of page 54). Qualitative research is also an umbrella term for many different 
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research methodologies and paradigms, including psychology, sociology, anthropology 
and geography.  
The field of veterinary science has long relied on quantitative research methods in order 
to answer the “what, when and where” questions pertaining to the profession. However, 
when it comes to investigating why and how people behave the way they do, many 
questions are best answered using a qualitative approach (Richens et al., 2013, Christley 
and Perkins, 2010) as this approach can “reach the parts that other methods cannot 
reach” (Pope and Mays, 2006, page 22). In human medicine, qualitative research methods 
have been used for many years to investigate motivation, uptake of advice, risk 
behaviours and other social aspects of human health (Green, 1998) and there is a research 
journal, Social Science in Medicine, dedicated to its use in human healthcare. Medical 
sociology and medical anthropology are important scientific fields in their own right, 
providing invaluable insights into the beliefs, values, behaviours and contexts within 
which health decisions and practices are conducted. It has become accepted within the 
human medical field that design of any clinical trial or health intervention will also include 
investigation of sociological aspects and that qualitative techniques will inform the design 
of quantitative research (Pope and Mays, 2006).  
Historically, qualitative research has not been a popular methodology amongst veterinary 
researchers, with veterinary peer-reviewed journals consisting almost exclusively of 
quantitative research until recent years. While other scientific fields such as those of rural 
studies and rural geography have long studied farming through qualitative methods, 
these research findings very rarely filter into the veterinary community and are published 
in journals that have little direct impact on veterinary practice.  
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Although qualitative methods have not been popular amongst veterinary researchers in 
the past, a paradigm shift appears to be occurring and these methods are beginning to 
make their way into the veterinary consciousness. For example, ethnographies and 
participant observation have been used in order to investigate the local differences in 
application of tuberculosis testing protocols between veterinary practices, arguing against 
a ‘one-size-fits-all’ approach (Enticott, 2012). Qualitative in-depth interviews have been 
used to investigate perceptions and practices of farm record keeping and have shown a 
distinct difference between what regulators believe records are used for and how farmers 
use them (Escobar, 2015). In-depth interviews have also been used in a study of how 
farmers perceive the veterinarian’s role in vaccination strategies on dairy farms and show 
an opposing viewpoint between veterinarians and farmers (Richens et al., 2015) amongst 
many other studies as discussed in Chapter 6. It is therefore clear that these 
methodological approaches can answer some questions that quantitative methods 
cannot, particularly in identifying cultural and social differences between values, 
perceptions and behaviours. 
 Ethnography 
Ethnography is both a methodology and a theoretical framework. As a research 
methodology, ethnography has been used by geographers to explore rural contexts and 
by medical anthropologists to investigate human health behaviours. As a theoretical 
framework, ethnography seeks to learn about people, not to study them, through 
immersion in the population of interest (Jones, 2017). It has traditionally been associated 
with prolonged periods of immersive participant observation, although it in fact describes 
data collection through a wide range of different methods. Ethnography is not, however, 
another word for qualitative research. The use of semi-structured in-depth interviews, 
Methodology and methods 
60 
 
questionnaires, discourse analysis, informal interviews and quantitative data can all 
contribute to an ethnography, although it is still generally accepted that a significant 
amount of data should be gathered through participant observation in order to 
contextualise and validate the other data sources (Savage, 2000).  
Savage (2000) argues in the British Medical Journal that modern ethnography can be 
defined as “any small-scale social research that is carried out in everyday settings, uses 
several methods; evolves in design throughout the study; and focuses on the meanings of 
individuals' actions and explanations, rather than their quantification.” Ethnography as a 
methodology is recognised as being difficult to define. In O’Reilly’s book “Ethnographic 
Methods” (2012), she argues for the definition of ethnography as a methodology 
informed by a theory of social life as practice. Hammersley and Atkinson (2007, middle of 
page 3) describe it thus: “Ethnography usually involves the ethnographer participating … 
in people’s daily lives for an extended period of time, watching what happens, listening 
to what is said, and/or asking questions through informal and formal interviews…. In fact, 
gathering whatever data are available to throw light on the issues that are the emerging 
focus of inquiry”. 
Within the fields of veterinary medicine and agriculture, the use of ethnographic 
methodologies has been relatively limited and mostly confined to the disciplines of rural 
geography, education or epidemiological fieldwork in low and middle-income countries 
(Mariner and Paskin, 2000). Examples of some of these ethnographic studies include work 
by Enticott (2012), who has used an ethnographic approach when investigating the 
relationship between bovine tuberculosis, government disease surveillance, biosecurity, 
veterinarians and farmers in endemic areas. Other work has sought to understand the 
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effect of robotic milking technologies upon on-farm culture (Holloway et al., 2014), the 
culture within a veterinary hospital (Atwood-Harvey, 2003), and a ‘focused ethnography’ 
to study veterinarian decision-making around diagnostic sampling in Alberta, although 
this consisted of only a small number of in-depth interviews (Sawford et al., 2013).  
Patricia Morris’ (2012) book “Blue Juice: Euthanasia in veterinary medicine” was the 
product of her ethnographic research over 18 months in numerous North American 
veterinary establishments and examines how veterinarians “deal with the responsibility 
of ending their patients’ lives”. This selection illustrates the broad applicability of 
ethnography as applied to veterinary medicine and animal health and highlights the 
potential for much greater use of the methodology in this field. 
In human medicine, ethnographies have the potential to be impactful on medical practice 
and are seen as providing valuable evidence on which to base policy decisions and health 
interventions, although it has been argued that their use is overlooked (Savage, 2000, 
Goodson and Vassar, 2011, Jones, 2017). Medical anthropologists commonly use 
ethnographic methodologies to explore health behaviours, contexts and cultures (Savage, 
2000). These have included autoethnographies describing the experience of being a 
patient (Greenhalgh, 2017), ethnographies investigating causes of intravenous 
medication errors (Taxis, 2003), nursing older patients (Costello, 2001) and the seminal 
medical anthropology work “Boys in white: student culture in medical school” by Becker 
and colleagues (1961). While there are numerous other examples of the methodology’s 
usefulness to human healthcare, when viewing this selection through the lens of 
veterinary medicine it again highlights how ethnography could be used more widely to 
address under-researched areas of veterinary work. 
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3.3.4.1 Semi-structured in-depth interviews 
One of the most commonly used research methods in qualitative research is the semi-
structured in-depth interview. In contrast to structured interviews and questionnaires 
where pre-specified questions are asked in a pre-determined order (often with Likert-
Scale type response options), semi-structured in-depth interviews follow a loose structure 
using open-ended questions. These ‘guided conversations’ combine structure with 
flexibility, allowing the interview to be interactive and generative. These interviews 
should be conducted face-to-face in order to maximise their value, and they explore the 
area of research interest in rich depth, often lasting around an hour (Whiting, 2008). Their 
ultimate aim is to investigate the experiences and perspectives of an individual of interest 
on a chosen subject (Dicicco-Bloom and Crabtree, 2006). The flexibility of this method 
allows the interviewer to adapt the questioning and interview focus and to probe areas 
of interest depending on the interviewee’s responses. 
 Semi-structured in-depth interviews aim to obtain vivid accounts of the interviewee’s 
experiences and narratives, to gain insights into the interviewee’s perspectives on a topic 
and to explore areas that may not have been foreseen by the interviewer when preparing 
for the interview. In order to maintain some focus and consistency between interviews, a 
topic guide is created containing a loose framework for the topics which the interviewer 
wishes to cover. These topic guides are mainly used as an aide-memoire to avoid 
neglecting to ask about specific areas of interest, however their use is inductive, and the 
topic guides can change and develop as more interviews are conducted.  
Interview questions are open-ended in order to allow the participant to express their 
perspectives and thoughts without imposing a framework or agenda, according to what 
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they feel is important. Questions can be broadly categorised into content-mapping 
questions and content-mining questions. Content-mapping questions seek to identify the 
issues relevant and important to the participant, through encouraging a narrative, 
focussing more narrowly on the areas of interest and prompting the participant to 
consider other issues. Content-mining questions aim to explore the meaning and gain an 
in-depth understanding of the participant’s responses through further probing by seeking 
clarification, amplification or explanation.  
In veterinary research, the use of semi-structured in-depth interviews has increased in 
recent years, with Richens (2013) undertaking a rapid-evidence review on the methods 
used to collect farmers’ attitudes towards cattle production which showed that while the 
majority of studies used questionnaires, over a third of studies used interviews to collect 
data.  
Semi-structured in-depth interviews must be conducted and analysed reflexively, with a 
tacit understanding that simply by asking the question the researcher is affecting the 
responses. Participants may respond based on what they believe is the “correct” answer, 
or the answer expected of them. Interview situations are by their nature artificial and this 
can influence responses. Interviews are best conducted face-to-face in order to establish 
a rapport, build empathy and enable non-verbal communication and cues to be seen. An 
interviewer must avoid using leading or loaded questions and allow the participant to 
express him-/herself without fear of judgement. By summarising a participant’s response 
and reflecting it back, the interviewer can allow the participant to validate his/her 
response and the interviewer’s understanding. When conducted correctly and analysed 
in light of the limitations and pitfalls of interviewing, semi-structured in-depth interviews 
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have been acknowledged to provide valuable, robust and valid data (Whiting, 2008). 
Qualitative interviews are often a rewarding experience for both the interviewer and the 
participant. Liamputtong and Ezzy (2005, page 214) report that “in-depth interviewing is 
a privilege…we often find it surprising and humbling that people are prepared to share so 
much of their lives with someone”. 
3.3.4.2 Participant observation 
Participant observation is the cornerstone of modern social anthropology. Its origins lie 
with Malinowski who conducted fieldwork on the Trobriand Islands between 1915-1918 
and it was refined in the 1920s and 1930s by the Chicago School of Urban Sociology 
(Malinowski, 1922). The characteristic of participant observation is the focus on the 
context, where the researcher becomes a part of the social world being studied.  
Participant observers immerse themselves for prolonged periods of time within the social 
environment which they wish to study. This is generally informal, overt and involves active 
participation in activities and the development of relationships with the observed 
participants. Observational data is collected through the maintaining of ethnographic 
fieldnotes. Participant observation aims to collect valid observational data, to understand 
a context and culture through embodied experience, to understand participant’s 
viewpoints and to enable the researcher to directly compare what people say with what 
they do. “A good way to learn about any of these worlds is to submit oneself to the daily 
round of petty contingencies to which they are subject” (Goffman, 1961, ix-x). Participant 
observation can be used to help identify distinctions between participants’ and 
“outsiders’” perspectives. It can explore the meanings people attach to events, act ions 
and decisions. 
Methodology and methods 
65 
 
Ethnographic fieldwork can be time-consuming and difficult to focus due to the extensive 
nature of the research and the large volume of data that is collected. It is important to 
narrow the research questions inductively and iteratively throughout the duration of the 
fieldwork in order to focus down onto the real areas of interest. Data can be collected 
from the environment, from objects, from social interactions as well as from documents, 
images and photographs.  
Ethnographic fieldnotes involve a different kind of writing (Emerson et al., 2011) where 
first impressions are noted, and an attempt is made to ‘make the familiar strange’ (i.e. 
describing something as if seeing it for the first time, without preconceptions). Initial 
notes are taken by the researcher while in the field and contain key events, quotes and 
impressions. These are written in shorthand initially, and then written up as fieldnotes 
within a limited period of time so as not to lose any valuable information. These fieldnotes 
typically focus on context, timelines, the people present, their roles and relationships with 
each other, what is said and what is done. They distinguish between observed events and 
the researcher’s impressions of events, which are often kept in a separate research diary 
(Pope and Mays, 2006). 
The presence of the researcher can have a modulating effect on the behaviour of the 
observed participants (the so-called ‘Hawthorne effect’), although this effect appears to 
reduce over time and is one of the reasons why prolonged fieldwork is necessary in 
participant observation (Holden and Bower, 1998). It is important to be reflexive in 
observational studies, and the positioning of the researcher and their characteristics (for 
example whether the researcher is male or female, young or old) must be considered as 
these characteristics will influence the data collection. The researcher needs to gain 
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access to, and become accepted by, the participants. They must, however, avoid ‘going 
native’: a scenario where the researcher becomes so immersed in the researched world 
that they are no longer able to objectively analyse the setting (Pope and Mays, 2006).  
 Theoretical framework 
The theoretical framework and perspective of this thesis must be understood in order to 
appreciate the research methodologies used and the subsequent analysis of these data. 
As previously discussed, ethnography is a term that can be used to refer to a research 
methodology or a theoretical framework. Here the other contributing theories and 
methods that comprise the theoretical framework utilised in this thesis will be discussed; 
grounded theory, thematic analysis and the data analysis software itself.  
 Grounded Theory 
Glaser and Strauss (1999) introduced grounded theory in order to describe the inductive 
way in which coded qualitative data could be analysed by identifying themes that 
‘emerged from the data’. A pivotal feature of grounded theory is that it is cyclical and 
inductive, with each stage informing the next. Therefore, the initial data informs the 
further collection of data and allows for testing of emerging theories. This theoretical 
sampling allows the researcher to select participants to test new theories based on the 
findings of initial data. As such it is a theory-generating methodology and does not seek 
to test existing theories (Lingard et al., 2008). An important element of grounded theory 
is that the researcher approaches the data from a place of ignorance. There should be no 
predetermined hypothesis, no expectation of the results and no understanding of other 
work that might influence the research. In reality this can be difficult to achieve, and some 
would argue that it is counter-productive (Pope and Mays, 2006). For example, the 
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practicalities of truly approaching a research study with no understanding or knowledge 
of the literature surrounding it is almost impossible in academia given the need for 
literature reviews as part of funding applications. 
In practice, most qualitative research is a kind of modified grounded theory, or ‘grounded 
theory-lite’, where researchers move between data collection and data analysis using a 
mixture of induction and deduction. The process of ascribing codes to all of the initial data 
is known as open coding and this develops the coding framework for subsequent data 
analysis. Axial coding (relating codes to each other) and selective coding (choosing a 
concept and relating codes to this concept) are then used in order to move towards the 
development of analytical categories through a process of constant comparison (Pope and 
Mays, 2006). 
 Thematic Analysis 
In 2006 Braun and Clarke refined and defined a framework for analysis of qualitative data 
known as thematic analysis which is based upon grounded theory’s inductive approach to 
identifying themes which emerge from the dataset (Braun and Clarke, 2006). It has been 
described as arguably the simplest form of analysis of qualitative data, and as such is the 
most commonly used in healthcare research (Braun and Clarke, 2014). In its most basic 
form it is “a method of identifying, analysing and reporting patterns (themes) within data” 
(Braun and Clarke, 2006). However, simply defining the themes that emerge from the data 
does not provide rich and useful data. A robust thematic analysis is then required to 
explore the inter-relation between the themes and to explain how these themes may or 
may not fit into different theoretical frameworks or models.  
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 Computer-Assisted Qualitative Data Analysis Software 
The process of ascribing codes to the qualitative data that has been gathered (in the form 
of transcripts or ethnographic fieldnotes) was historically a manual process involving 
index cards, Post-it® notes and a large space for mapping out codes and themes (Basit, 
2010). The advent of computerised software designed to facilitate coding of qualitative 
data has improved efficiency (Bryman, 2008) and these software packages are collectively 
known as computer-assisted qualitative data analysis software (CAQDAS).  
Text from interview transcripts, documents or fieldnotes can be highlighted and tagged 
with a code, and once coding is complete it is possible to view all text to which that code 
has been attached collectively, thus aiding the identification of emergent themes. While 
CAQDAS is useful in helping to collate coded text, it does not replace the role of the 
researcher in creating the codes, identifying the themes and analysing the data. While 
some have welcomed the advent of CAQDAS in qualitative data analysis for its potential 
to improve the rigour of the methods, others have criticised its potential to quantify 
qualitative research (Hesse-Biber and Leavy, 2010) and are concerned that it may lead to 
the researcher losing touch with the context in which the data were generated (Buston, 
1997). It has, however, become the accepted method for coding qualitative data and is a 
mainstay of Campbell’s paper (2013) presenting a standardised procedure for improving 
inter-coder reliability and agreement.  
 Methods 
 Ethical approval 
The studies outline in this thesis gained ethical approval from the University of Bristol 
Faculty of Health Sciences Research Ethics Committee, reference number 33021. The 
participant information sheets and consent forms can be viewed in Appendices 1 - 3. 
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Additionally, a veterinary UIN (ethical approval for an investigation involving animals) was 
issued for the study by Bristol University’s Animal Welfare Ethical Review Body (Reference 
UB/16/051 Expiry 20/09/2019). 
 Selection and recruitment 
For the measures of agreement between veterinary sales data, medicine book records 
and medicine bins, a sample size calculation was carried out a priori as described in 
Chapter 5. This suggested that a minimum of 23 farms were required, assuming a drop-
out rate of 20%, therefore a target of 25-30 farms was agreed. Given the mixed methods 
nature of the project and the fact that there was a lone researcher collecting data across 
a large geographical area, a balance needed to be struck between a large enough sample 
to show significance for the quantitative work and a small enough sample size to 
realistically be able to complete the data collection within the timeframe and budget. 
Additionally, it was agreed that >25 farms were likely to provide a large enough pool of 
farmers for semi-structured in-depth interviews to achieve data saturation. However, if 
more interviews were required, additional recruitment of eligible farmers would be 
possible. 
For the intensive participant observation work, a discussion was had between the lead 
researcher (GR), a human geographer (HB) and medical anthropologist (HL) about the 
number of farms required. Again, a balance was needed between having a large enough 
number of farms to be able to reflect the very different farm sizes and types in the UK 
while a small enough number was necessary in order to gather the rich data required of 
this type of research. While participant observations are usually focussed on one culture 
and context for their entirety (Emerson et al., 2011), it was decided that by including three 
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farms within the same broader context of geographical area, veterinary practice and 
social network but with different herd sizes, management types and production goals, a 
rich dataset which could better translate to the industry could be obtained.  
Twenty-seven dairy farms from South West England and South Wales were recruited to 
the study. Farms were purposively recruited using maximum-variation sampling through 
a combination of direct approach, approach of a farm animal veterinary practice within 
the study area or by self-nomination following advertising on social media and at local 
agricultural shows. Where deemed appropriate, an approach to the veterinary practices 
was made by a Professor of Bovine Medicine (DB) in the first instance in order to improve 
the chances of a positive response and help with recruitment. 
Nine veterinary practices within an approximately one-hour radius of Bristol Veterinary 
School at Langford, North Somerset and four veterinary practices within a one-hour radius 
of Carmarthen, Carmarthenshire were approached by email or telephone to request their 
assistance in recruiting farms to the project. A recruitment poster and flyers were 
provided which the practices could distribute to clients (APPENDIX 4). All veterinary 
practices agreed to advertise the project to their clients and/or nominate specific farms 
for enrolment. They were requested to nominate dairy farms of varying size, management 
type, production goals and medicine use.  
The recruitment poster was made available online at the University’s farm animal 
research group pages and was shared on social media sites, where any farmers within the 
study area who were interested were encouraged to get in touch.  
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Twenty-six farms were identified through their veterinary practices, with a further four 
farms making contact and expressing interest in enrolling in the study having seen or 
heard it advertised. All farmers identified were contacted by telephone in order to explain 
the scope and objectives of the research. Two farms decided not to enrol in the project 
after the initial contact, stating a lack of time. For farms that were interested during the 
telephone conversation, a time was arranged for a visit to the farm in order to discuss the 
details of the project further. All farmers were then sent a copy of the participant 
information sheet (APPENDIX 1 & 2) and consent form (APPENDIX 3) a minimum of 48 
hours before being visited in person during June, July and August 2016. During this visit, 
the participant information sheet was explained, and farmers were encouraged to raise 
any questions or concerns they had about involvement in the project. One farm decided 
at this stage that they could not commit the time necessary to be involved in the wider 
project and declined involvement. The remaining 27 farms confirmed willingness to enrol 
in the project and consent forms were signed.  
During the initial visit it was stressed that in order to ensure the success of the project it 
was important to maintain medicine purchase, storage and records in a normal, day-to-
day way and not to deliberately change, improve or “tidy-up” the medicine cupboards or 
record books. The purpose of the study to observe and measure normal medicine use 
behaviours was emphasised, and participating farmers were reminded that the research 
was purely academic and in no way associated with farm assurance certification schemes 
or the usual medicine auditing to which farmers would be accustomed. 
Farmers were also told that they would be asked to participate in a semi-structured in-
depth interview about their use of veterinary medicine records at some point during the 
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next year which would last around an hour. Two farmers stated at this point that they 
would not be willing to participate in these interviews. 
During these initial visits, three farms were identified as suitable for more in-depth 
participant observation. As described above, these farms were purposively sampled from 
the recruited pool of farmers to match the inclusion criteria: being located within the 
same geographical area (North Somerset), using the same veterinary practice and having 
the same wider social context (North Somerset dairy farmers) while also having different 
herd sizes, management types and production goals. These farmers were provided with a 
second participant information sheet tailored specifically for those farms involved in 
participant observation. The nature of their involvement in the participant observation 
was discussed and it was explained that the researcher would attend the farm on a semi-
regular basis in order to participate in day-to-day activities and observe medicine use. This 
would involve visits approximately monthly over a 12-month period which would last a 
varying amount of time but usually around 4-6 hours at a time. It was explained that it 
was envisaged these visits would take place at different times, but the timings, lengths 
and nature of the visits would be inductive and iterative and later visits would therefore 
be targeted at time periods of high medicines use as determined during earlier visits. One 
farm was lost to the study after the initial inventory visit because they went out of  
business, so 27 farms took part in the cross-sectional study and 26 farms took part in the 
year-long medicine audit. 
 Farm medicine audits 
In order to conduct the 12-month farm medicine audits, an initial medicine inventory was 
undertaken on each participating farm. This inventory is explained in greater detail in 
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Chapter 4 but briefly consisted of visiting each farm on the first day of the study and 
searching for, measuring and recording all PVM found. Record was made of medicine 
name, quantity, number of individual items, storage location and expiry date. Pictures 
were taken of the medicine storage areas and a structured questionnaire was completed 
gathering information on farm demographics, herd health and management protocols 
(Appendix 5). This initial visit followed a pre-prepared visit checklist (Appendix 6). 
Farmers were then offered a choice of medicine waste bin size and number, with the 
option of either 60-litre or 120-litre bins depending on their estimate of the volume of 
waste medicines they would produce quarterly and depending on location convenience. 
Once selected, these bins were placed in areas identified by the farmer as being most 
convenient for use. Laminated signs were placed around the farm, especially near the 
medicine waste bins and any other disposal areas, reminding staff to use the medicine 
waste bins and providing a reminder of what to place in the bins (Appendix 7). Farmers 
were then asked to place all empty medicine packs (bottles, tubes, packaging, etc.), as 
well as any waste medicines being discarded into these bins from that point onwards. Bins 
were then emptied from each farm approximately every quarter (90 days +/- 20) at the 
farm and researcher’s convenience. Bin audit farm visits followed a pre-prepared checklist 
(Appendix 8). The final visit was conducted at day 365 (+/- 3 days to accommodate for 
farmer and researcher convenience). This final visit involved removing all medicine waste 
bins and contents and conducting an exit inventory identical to the initial day one 
inventory.  
Participating farmers were asked not to change anything about the way they recorded 
medicine purchase and use for the duration of the study unless this was intended for 
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reasons external to the project. On the final visit, participating farms were asked to 
provide the medicine records in whichever form they took. After the final visit, all nine 
veterinary practices were contacted, provided with a copy of the appropriate completed 
consent forms, and asked to provide the veterinary sales records for the duration of the 
study for each farm.  
 Semi-structured in-depth interviews 
All recruited farmers who identified themselves as the primary treatment decision-maker 
were asked to participate in a semi-structured in-depth interview exploring their thoughts 
on medicine use, with the exception of the three farms involved in the participant 
observation study who provided numerous unstructured interviews throughout the 
course of the project. Interviews were conducted iteratively, with two initial pilot 
interviews followed by a further 18 interviews over the following 18 months. All 
interviews were conducted on the respective farm, face-to-face, by the author. The 
interviews were recorded using an encrypted dictaphone (Olympus DS-3500 Audio Voice 
Recorder), with additional notes taken as required. An interview topic guide was 
developed by the author in consultation with supervisors who could provide extensive 
experience either in dairy medicine (KR & DB) or semi-structured interview methodology 
(HB). This topic guide was piloted and adjusted as described in the subsequent section 
and can be found in Appendix 9.  
Interviews were conducted in a semi-formal manner, usually in the farm office or 
farmhouse kitchen over a cup of tea. Participating farmers were all given the same 
introduction to the process, emphasising that there were no right or wrong answers, it 
was not a test and the focus of the interview was on their thoughts and opinions about 
Methodology and methods 
75 
 
the way veterinary medicines were bought, stored, used and recorded on their farms. At 
the end of the interview, each participant was asked whether they had anything else to 
add or could think of any area that the interview had not covered which they thought was 
important.  
 Participant observation 
The three participating farms which were recruited for the participant observation in 
addition to the medicine audit underwent the same Day One visit with inventory and 
placement of medicine waste bins. At this visit a subsequent participant observation visit 
was arranged, and the primary contact was asked what the most appropriate method of 
contact would be to arrange visits. Visits were initially scheduled to be monthly; however, 
the exact frequency was allowed to be flexible in order to accommodate for the focus on 
medicine use to represent the varying schedule and seasonal nature of dairy farming and 
therefore medicine use.  
It was decided that the initial participant observation visit should involve attending a 
morning milking session at each of the three farms. The reasoning for this decision was 
multifactorial. Morning milking is a routine activity carried out across all three farms and 
was expected to provide insight into the management practices on each of the farms. 
Morning milking is the first time the farmer will see their cows each day and potentially 
identify animals requiring treatment; the task at hand also provides some opportunity for 
participation alongside observation. It was also postulated that attending morning milking 
(which began at 4 am, 5 am and 6.30 am on the three farms) would increase trust and 
help to build a relationship between the farmer and the observer.  
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After this first participant observation visit, subsequent visits were arranged by text 
message with the primary contact. Visits occurred as often as every three weeks and as 
infrequently as every eight weeks depending on the season and the specific context 
throughout the 12-month study period. Visits were arranged to encompass morning 
milking, afternoon milking, calf management, youngstock management, drying off and 
one veterinary fertility visit for each of the farms. During the initial visits, morning milking 
was confirmed as being the most useful source of data on medicine use practices and 
decisions, therefore the majority of the subsequent visits focussed on attending and 
participating in morning milking routines.  
During the visits, it was decided that ethnographic field notes would be taken 
contemporaneously in order to maintain as accurately as possible a record of the 
observed events. Where possible, the author participated in routine activities, for 
example by wiping or pre-dipping teats in the milking parlour or by helping to carry 
buckets and make up feeds for the calves.   
 Piloting the research methods 
Prior to commencement of the study, the research methods were piloted at the University 
of Bristol’s dairy farm. This farm had 220 cows in milk, was run by a herd manager who 
made the overarching decisions about medicine and treatment protocols with the aid of 
one herdsman who was in charge of the milking and the majority of treatment 
administration, and one other staff member who was in charge of calf management.  
An initial inventory of all the medicines present on each farm was conducted, followed by 
placement of one 120-litre medicine waste bin and two 60-litre bins. The large bin was 
placed in the dairy with one smaller bin in the milking parlour and the other in the calf 
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shed. Staff were asked to place all used medicines in these bins for a 30-day period during 
July 2016. Signs were placed near other waste bins on farm reminding staff to use the 
research bins for medicine waste, and signs were placed near the medicine bins explaining 
which medicines the bins should be used for.  
After 30 days the bins were emptied, and the contents were counted. Expiry dates were 
checked and medicines which had expired prior to the start of the pilot study were noted. 
Any wasted medicines still within the packs was quantified and recorded. Medicine 
records for the 30-day period were obtained from the pilot farm’s on-farm computerised 
records, and the veterinary sales data for the study period was downloaded from the 
University Farm Animal Practice’s computerised clinical records. These data were 
collected with the aim of piloting the research design and therefore this data was not 
analysed further to assess agreement between methods. 
Semi-structured in-depth interviews were conducted with the farm manager and the 
herdsman. A topic guide for these pilot interviews was prepared in consultation with the 
supervisors and sought to investigate the beliefs and values relating to the topics of 
veterinary medicine purchase, storage, recording and use. The interviews were conducted 
face-to-face in the farm office and recorded using an encrypted dictaphone (Olympus DS-
3500 Audio Voice Recorder). The first interview lasted 69 minutes and the second lasted 
61 minutes. Both interview recordings were sent to an external professional transcription 
service (Bristol Transcription Services Ltd.) to be transcribed. The transcripts were 
discussed with the supervisors and it was agreed that the topic guide had successfully 
elucidated interesting and pertinent information. Hence, it was agreed that the topic 
guide would remain unchanged for the subsequent interviews, albeit with scope to adjust 
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iteratively as the interviewing and analysis progressed. HB, a supervisor with extensive 
experience in the use of semi-structured in-depth interviews, provided positive feedback 
on interview technique and some guidance on improving technique such as using non-
verbal encouragement rather than saying “OK” as it is less intrusive.  
Participant observation was also piloted on this farm, with two morning milking sessions 
attended for a total duration of eight hours. This was in order to provide experience and 
practice in the techniques and to identify any major concerns with the practicalities of 
note-taking and observing on a working dairy farm. The only practical detail of note was 
the tendency for any notes taken to become contaminated with faecal material due to 
the sunken pit where the researcher and farmer stood in the milking parlour. Also, the 
noise of the milking machines was occasionally loud enough to obscure some of the 
conversation, but this was not considered a major issue.  
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Prescription veterinary medicine (PVM) use in the United Kingdom is an area of increasing focus for 
the veterinary profession. While many studies measure antimicrobial use on dairy farms, none report 
the quantity of antimicrobials stored on farms, nor the ways in which they are stored. The majority of 
PVM treatments occur in the absence of the prescribing veterinarian surgeon, yet there is an 
identifiable knowledge gap surrounding PVM use and farmer decision making. To provide an evidence 
base for future work on PVM use, data were collected from 27 dairy farms in England and Wales in 
Autumn 2016. The number of different PVM stored on farms ranged from 9-35, with antimicrobials 
being the most common therapeutic group stored. Injectable antimicrobials comprised the greatest 
weight of active ingredient found while intramammary antimicrobials were the most frequent unit of 
medicine stored. Antimicrobials classed by the European Medicines Agency as critically-important to 
human health were present on most farms, and the presence of expired medicines and medicines not 
licensed for use in dairy cattle was also common. The medicine resources available to farmers are 
likely to influence their treatment decisions, therefore evidence of the PVM stored on farms can help 
inform understanding of medicine use.   
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 Introduction  
Farmers in the UK are in the relatively privileged position of being able to purchase and store 
prescription veterinary medicines on farm for use at a later date. While these medicines must have 
been specifically prescribed for an animal or group of animals in order to treat diagnosed disease, 
there is little knowledge about the way these medicines are being used once they leave the veterinary 
practice. This knowledge gap extends to the storage practices on farm, and there is very little evidence 
available describing the quantity, composition or locations of medicines stored on farms.  
In order to understand the way in which dairy farmers in the UK are using PVM, it seems logical to 
begin by measuring what PVM resources farmers have available when making treatment decisions on 
farm. A number of sociologists and cultural anthropologists have recently begun to point out that 
material objects – their presence, availability and accessibility – are increasingly recognised as playing 
an important role in the organisation, performance and normalisation of daily practices and labour 
(Riggins, 1994, Shove and Southerton, 2000). In this chapter, medicines, medicine bottles and 
medicine cupboards – their materiality and their accessibility – contribute directly, it is argued, to the 
treatment decisions and practices undertaken on the farm. A farmer is unable to treat an animal with 
a medicine he or she does not have. Equally, the availability of particular product will influence the 
subsequent treatment practice.  
These resources provide some of the context within which treatment decisions are made and 
necessarily influence such decisions since a farmer is unable to treat an animal with a medicine he or 
she does not have. Of course, farmers are able to drive to their veterinary practice during opening 
hours to collect medicines as long as they are prescribed to the farm, or they are able to call a 
veterinary surgeon to the farm and obtain medicines in this way. However, on a routine, day-to-day 
basis the treatment decisions on the farm are limited to the medicines that farm has readily available.  
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In addition to understanding the resources available to farmers when making treatment decisions, 
examination of the current literature addressing medicine storage and use has identified various other 
knowledge gaps. Medicine storage on farms is an important part of compliance with Health and Safety 
Executive and farm assurance guidelines (Health and Safety Executive, 2012, Red Tractor Assurance, 
2017), which require PVM to be placed in a secure, lockable location away from children, animals and 
thieves (Carr and Smith, 2013). In addition, medicines should be stored at the temperature 
requirements stated on the packaging. Despite this, a recent study found that vaccines were routinely 
being stored at inappropriate temperatures on UK farms (Williams and Paixao, 2018). There is 
currently little evidence available to determine whether PVM are used in the way the prescribing 
veterinary surgeon intended, or whether farmers are making decisions based on other factors while 
using stored PVM which may be expired or not licensed for use in dairy cattle.  
That prescription medicines are often stored in the home for use at a later date has been documented 
in human medicine, despite the prescription intending immediate use (Tsiligianni et al., 2012, Abou-
Auda, 2002). In fact, it has been shown that a proportion of patients deliberately plan to stop taking a 
course of prescribed antibiotics early in order to have a supply for self-use in the future (Hawkings et 
al., 2008, Shehadeh et al., 2012). Non-compliant use of medicines is commonly seen and there is a 
broad evidence base demonstrating that medicines are taken in ways other than that indicated by the 
prescriber (van der Geest et al., 1996). Patient nonadherence to prescribed treatment regimens has 
been framed as a complex and pervasive challenge. Either through misunderstanding, forgetting or 
ignoring healthcare advice, patients are commonly non-adherent, and this behaviour is influenced by 
subjective norms, beliefs, attitudes and the cultural context (Martin, 2005).  
Household medicine storage is an area which has attracted some research in the human medical field, 
although often in countries with less rigorous prescription legislation and easier access to over-the-
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counter or illicit medicines. A study of medicine storage in rural Cretian households showed that 
people stored a large amount of medicines under inappropriate conditions and regularly shared 
medicines between family and friends (Tsiligianni et al., 2012).  
There are many studies measuring antimicrobial use on dairy farms, however none report the quantity 
of antimicrobials stored on farms directly, nor the way in which they were stored. Equally there is a 
dearth of information about the storage of other PVMs, vaccines and endectocides.  
As described in Chapter 2, 98% of dairy farms are members of the Red Tractor Farm Assurance Scheme 
(Responsible Use of Medicines in Agriculture Alliance, 2017) and, as such, are required to undergo 
annual farm assurance audits, as set out in the Red Tractor Dairy Standards (Red Tractor Assurance, 
2017). The ultimate aim of farm assurance is to provide the consumer with a guarantee that producers 
of food meet minimum standards of food safety, animal welfare and myriad other attributes (Bailey 
and Garforth, 2014). However, there is evidence to show that these farm assurance visits and the 
associated health plans are seen as a “waste of time” and “tick box exercise” by some producers 
(Escobar, 2015) while others find some inherent value (Bailey and Garforth, 2014) Either way, the 
occurrence of these visits has led to an expectation that medicine storage will be scrutinised on a semi-
regular basis.  
In order to provide data on the storage practices of PVM on UK dairy farms and to investigate the 
quantity and composition of PVM being stored a cross-sectional study of medicine cupboards on 27 
dairy farms was conducted in September and October 2016. Farm demographic and management 
data were collected alongside a full audit of the PVM present on the farm on the study day. 
  




This chapter was written according to the Strengthening the Reporting of Observational Studies in 
Epidemiology statement for scientific reporting of cross-sectional studies (Elm et al., 2008). Participant 
recruitment, ethical approval and consent are as previously described in Chapter 3, subsections 3.5.1 
and 3.5.2. 
 Data collection 
All 27 participating farms were visited once between 13th September and 18th October 2016. This visit 
occurred at a date and time convenient for the farmer and was arranged in the preceding week by 
telephone. On the day of the visit, the author (GR) explained the purposes of the study once more to 
the participant, along with the initial visit objectives as described in Chapter 3. A structured interview 
was conducted, and the designated medicine cupboard was examined first along with certain high-
probability storage areas that were directly enquired about (e.g. household refrigerator, calf shed, 
milking parlour). Permission was also requested to search for PVM anywhere on the farm. A 
photograph of the medicine cupboard was taken and fieldnotes written as an aide memoire about the 
storage systems.  
4.3.1.1 Medicine database 
A database of all POM-V medicines licensed for use in cattle in the UK was created by the researcher 
(GR) before commencement of the study (Appendix 10). The Veterinary Medicines Directorate (VMD) 
publish a list of UK-licensed veterinary medicines (Veterinary Medicines Directorate, 2018b) in Excel 
(Microsoft Office 365) which was downloaded and modified to contain only those medicines used in 
cattle. Additional data were added to this database, including the concentration of the active 
ingredient present, the minimum, maximum and median dose rate and course length, the dose unit 
(mg/kg, tube/cow etc) and the pack unit (ml, g, dose). These additional columns in the spreadsheet 
were added manually and populated with data sourced from either the Specified Product 
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Characteristics (SPC) which are published for every licensed veterinary medicine in the UK, or from the 
NOAH Compendium of Datasheets 2017. These data entries were checked by the author by selecting 
the last two medicines beginning with each letter of the alphabet and double checking that there were 
no data entry errors. This database was then further validated by a research associate (HS) from the 
University of Bristol who selected a random sample of 10% of the data and ensured the inputted 
values were correct. 
Once complete, the database was sent back to the VMD who further checked and validated the data 
and entered further data points such as duration factors and antimicrobial use metrics. Following 
discussion with various stakeholders after creation of this database, it was decided that there was a 
need for this database to be published online under a Creative Commons Licence in order to aid other 
researchers and veterinary surgeons and to try and prevent a duplication of efforts. This process is 
currently ongoing.  
In addition to this main medicine information reference database, further databases were created for 
each participating farm, which contained the VMD’s list of licensed veterinary medicines alongside 
specific columns for inputting data collected on farm during the initial inventory (Appendix 11). A 
separate sheet in each farm’s individual database contained the structured questionnaire, with limited 
response options where appropriate.  
4.3.1.2 Structured survey 
On the day of the medicine cupboard audit, a structured interview was conducted with the self-
identified “main treatment decision-maker” (hereafter called the farmer) in order to gather 
information on farm demographics, management principles, health and productivity data (Appendix 
5). This questionnaire had been designed, piloted and refined as described in Chapter 3. Stock 
numbers, production values, health and fertility data were ascertained to the best of the farmer’s 
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knowledge at the time of the visit, aided by consultation with on-farm records. This questionnaire 
took approximately 20-30 minutes to complete, with the researcher asking a series of questions and 
inputting the data directly into the pre-prepared spreadsheet.  
4.3.1.3 Medicine Inventory 
Once the structured survey had been completed, the farmer was asked to indicate all areas on the 
farm where PVM were found. The designated medicine cupboard was examined first, and certain high-
probability areas were enquired about (e.g. did the farmer store any medicines in the house or in the 
home refrigerator? Were there any medicines in any of the farm vehicles?). Farmers were also asked 
for permission to search for veterinary medicines anywhere on the farm and were then informed that 
they could continue with their work and leave the researcher to the search. The length of time taken 
to inventory PVM ranged from 45 minutes to 90 minutes and was largely dependent on the number 
of locations where medicines were present, the amount of PVM stored and the general orderliness of 
storage, which varied greatly between farms. For the purposes of this study, medicine storage was 
described as being suitable if it fit the definition given by the VMD in the Code of Practice for the 
Responsible use of animal medicines on the farms (Veterinary Medicines Directorate, 2014a). This 
states that medicines should be kept at the appropriate temperature and under the conditions stated 
by the packaging. The Code suggests that medicines should also be kept in their original packaging, be 
clean and stored where possible in a locked and secure place.  
All PVM found were entered on-location into a pre-prepared spreadsheet (Appendix 11). Location, 
drug name, pack size, number of packs, quantity remaining in each pack and expiry dates were noted. 
Where the product label was illegible it was disregarded. Where the expiry date was illegible it was 
assumed to be within date. Volume remaining was estimated by eye to the nearest 10% of pack size 
(i.e. for a 100 ml pack of liquid, volume was estimated to the nearest 10 ml and for a 50 g pack of 
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powder, quantity was estimated to the nearest 5 g). All POM-V medicines were recorded along with 
any vaccines licensed for use in cattle and all pour-on, oral and injectable endectocides 
(anthelmintics). Vaccines were recorded in number of doses rather than volume. All intramammary 
and ocular medicines were recorded as single units per tube because one tube is equivalent to one 
dose.  
 Data analysis 
Data from each farm’s individual inventory spreadsheet were then collated and analysed by retrieving 
specific datasets through R software (R Core Team 2012) and producing a database for all 27 farms to 
be compared and analysed together. The structured survey data were analysed descriptively.  
Medicine quantities were measured in total mg of active ingredient present, in mg per population 
corrected unit (PCU) in-line with nationally reported use data (Veterinary Medicines Directorate, 
2016) and in total number of “medicine units” present. Medicine units were defined as: one bottle of 
liquid, one tube of intramammary or ocular suspension, one pack of boluses or tablets, one container 
of powder or one tube of ointment. Prescription veterinary medicines were grouped according to 
therapeutic group (e.g. antimicrobial, vaccine). Antimicrobials were grouped by antimicrobial class 
(e.g. penicillin, fluoroquinolone) and according to route of administration (e.g. injectable, 
intramammary). Expired medicines were defined as those medicines with an expiry date prior to the 
day of the inventory. Milligrams of active ingredient were presented to the nearest 100 mg for the 
total weight of active ingredient, to the nearest 10 mg for mg per cow in milk and mg per 1000 litres 
of milk produced annually and to the nearest 0.01 mg for mg/PCU.  
Data was visually checked for normality. Normally distributed data were reported as a mean with 
standard deviation in brackets. Non-normally distributed data were reported as a median with range 
in brackets. Calculations were performed using a combination of Microsoft Excel (2016) and R (R Core 
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Team, 2012). Given the cross-sectional, point-prevalence nature of the dataset and the fact that the 
study farms are not intended to be a representative sample of the population, presented calculations 
were descriptive and no inferences on causality can be made.  
 Results 
 Farm Demographics 
Thirty-four dairy farms were identified as eligible for the study through self-nomination or nomination 
by veterinary practices. All were invited to enrol in the study, and 29 agreed to take part. Two farms 
dropped out of the study before the medicine inventory visit. Data for the remaining 27 farms was 
complete. These farms were located across seven counties and were under the care of nine different 
veterinary practices.  
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Table 4:1: Demographic and management characteristics of the 27 participating farms 
Definitions: Farmer = self-described main treatment decision-maker; Basic schooling = no qualifications gained; GCSE = 
General Certificate of Secondary Education; HNC = Higher National Certificate; HND = Higher National Diploma; NVQ = 
National Vocational Certificate; Blanket therapy = all dry cows treated with intramammary antimicrobial; Selective therapy 
= certain dry cows not treated with intramammary antimicrobial based on somatic cell count and mastitis risk assessment 
Farm demographic and management characteristics are described in Table 4:1. In summary, the 
median total herd size was 320 with 175 cows in milk. Most farms (59%) described the main cattle 
breed as Holstein and the majority calved year-round (81%). The median total annual milk volume per 
herd produced was 1.1 million L with annual milk sales per cow of 7500 L. Seventy-four percent of 
farmers had some formal specialised education and training in agriculture.   
  
Characteristic Response Number of farms 
(n) 












Education level of farmer 
 
Basic schooling 
O Level/GCSE/A Level 
HNC/HND/NVQ 





















Calving pattern Year-round 
Seasonal – Spring 














Waste-milk feeding Yes – all calves 





Dry cow antimicrobial therapy Blanket therapy  
Selective therapy  
18 
9 
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Table 4:2: Production, health and medicine storage characteristics of the 27 participating farms 
Property / characteristic Median or Mean* Range (Median) or SD 
(Mean)* 
Total herd size 320 119 – 1,271 
Number cows in milk 175 65 – 600 
Total annual milk volume (million L) 1.1 0.5 – 4 
Total annual milk sales per cow (L) 7500  3,600 – 11,300 
Milk price (pence per L) 22.5* 15.3* 
Somatic cell count (cells per ml) 176,407*  50,466* 
Bactoscan (1,000 bacteria per ml) 20.9* 7.5* 
Mastitis (cases per 100 cows per year) 36.7*  15.9* 
Lameness (cases per 100 cows per year) 22.2* 15.3* 
Respiratory disease (cases per 100 calves per year) 10 0 – 47 
GI disease (cases per 100 calves per year) 10 3 – 59 
Number PVM present on farm (by active ingredient) 19 9 – 35 
Number PVM present on farm (by medicine unit) 101 28 – 339 
Median = non-normally distributed data     Mean = normally distributed data 
Definitions: PVM = Prescription veterinary medicines. L = Litre. SD = Standard deviation. GI = Gastrointestinal 
 
Farm production and health characteristics are presented in Table 4:2. Two-thirds of farms used 
blanket dry cow therapy (where all cows were dried off with intramammary antimicrobial treatment). 
Twenty farms routinely fed waste milk containing antimicrobial residues to beef calves, 13 of which 
also fed waste milk to dairy replacement calves. The mean number of clinical cases of mastitis and 
lameness per 100 cows per year was 36.7 and 22.2 respectively. There were a median of 10 cases of 
respiratory disease and 10 cases of gastrointestinal disease per 100 calves per year.  
 Storage methods & labelling 
Medicines were stored in six different location types across the study farms as seen in Figure 4-1. Most 
were stored in a lockable medicine cupboard or refrigerator although 29% were stored in a non-
compliant area such as the milking parlour, the calf shed or the office. Ten farms stored 100% of their 
medicines in lockable medicine cupboards or lockable refrigerators, and two farms did not store any 
medicines in a lockable medicine cupboard or lockable refrigerator. No participating farm monitored 
the temperature of their refrigerator or medicine storage area.   
Formatted: French (France)




Figure 4-1: Medicine storage locations on the 27 participating farms 
 
Subjectively, medicines were stored in a variety of different ways, with some farms having a systematic 
and ordered storage system and others having seemingly random storage of old, new full and empty 
medicine units. Of the PVM stored, 53.6% carried the recommended prescription label from the 
prescribing veterinary practice. For antimicrobials, this figure rose to 65.1% for all antimicrobials and 
74.1% for injectable antimicrobials. At the farm-level the prevalence of labels on antimicrobials ranged 
from 6.25 - 100%. 
 Prescription Veterinary Medicines 
There were a median of 19 (9-35) different types (by active ingredient) of PVM and 101 (28-339) 
individual medicine units of PVM present on participating farms. Antimicrobials were the therapeutic 
group most commonly stored both by frequency of occurrence (median 69 (22-296) medicine units) 
and by total weight (median 182,300 (45,500 – 442,500) mg) equivalent to 1.54 mg/PCU.  




The route of administration for antimicrobials stored are presented in Table 4:3. Of the total 
antimicrobials stored across all farms 76.4% were injectable and 14.7% were intramammary. When 
units were measured, 10% were injectable (bottles) and 84.8% were intramammary tubes. 
Table 4:3: Total quantities of antimicrobial stored across all 27 participating farms, by route of administration 




All  5,127,176 (100%) 2,801 (100%) 
Injectable 3,917,116 (76.4%) 280 (10%) 
Intramammary 755,772 (14.7%) 2,374 (84.8%) 
Topical 284,348 (5.5%) 51 (1.8%) 
Oral 54,440 (1.1%) 31 (1.1%) 
Intrauterine 115,500 (2.3%) 65 (2.3%) 
 
Data on antimicrobial storage is presented in Table 4:4. Total HP-CIA storage per farm was a median 
of 10,000mg, or 0.12 mg/PCU with the majority (5000mg) being 3rd generation cephalosporin. 
Injectable antimicrobials comprised the greatest total weight with a median of 143,600mg or 1.19 
mg/PCU, compared with intramammary antimicrobials which were a median of 21,200mg or 0.21 
mg/PCU. Conversely, intramammary antimicrobials had the greatest total number of medicine units 
present, with a median of 66 units compared with 9 units of injectable antimicrobials. 
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Definitions: HP-CIA = Highest Priority Critically Important Antimicrobial; 3rd gen. cephalosporin = 3rd generation cephalosporin; 
4th gen. cephalosporin = 4th generation cephalosporin 
 
Eighty-nine percent of farms stored at least one HP-CIA. The most frequently occurring injectable 
antimicrobials were ceftiofur (a HP-CIA; n=24) and penicillin/streptomycin combination (n=24). Also 
commonly found were oxytetracycline (n=22), tylosin (n=19) and trimethoprim/sulfadiazine (n=16). 
The three lactating-cow intramammary antimicrobials most commonly identified were potentiated 
amoxycillin (n=11), the combination streptomycin/neomycin/novobiocin/penicillin (n=11) and 
cefalexin/kanamycin (n=10). The most frequently occurring dry cow intramammary antimicrobials 
were cephalonium (n=12), cefquinome (a HP-CIA; n=10) and cloxacillin (n=8).  
The total mg/PCU on each farm ranged from 0.51 - 5.08 mg/PCU (Figure 4-2). Total mg per cow in milk 
ranged from 430 – 3,430 mg (Figure 4-3). Total mg per 1000 litres of milk produced annually ranged 
from 40 – 740 mg (Figure 4-4). 








Figure 4-3: Total quantity of antimicrobial stored in mg per lactating cow on each of the 27 participating farms 
 




Figure 4-4: Total quantity of antimicrobial stored in mg per 1000 litres of milk produced annually on each of the 27 
participating farms 
4.4.3.2 Vaccines & Other PVM 
The total number of vaccine doses stored across all farms was 3,541 with a median of 0 (0-1893) doses 
per farm. Eighteen farms (66.7%) stored no vaccines at the time of the study. The most common 
diseases for which vaccines were stored were Bovine Herpes Virus-1 (866 doses; 5 farms), leptospirosis 
(835 doses; 5 farms) and bovine viral diarrhoea (BVD) (683 doses; 5 farms). Other diseases for which 
vaccines were stored were calf diarrhoea, bluetongue, clostridial diseases, lungworm, mastitis and calf 
pneumonia.   
The total number of units of NSAIDs across all farms was 75, with a median of two per farm (0-8). The 
total number of anthelmintics or anti-protozoals present across all farms was 87, also with a median 
of 2 per farm (0-14). The total number of units of hormone across all farms was 53, with a median of 
1 (0-10) unit per farm. Five farms (19%) stored prostaglandins. 
Resource availability: Investigating the contents of medicine cupboards 
97 
 
  Expired medicines 
At least one unit of expired PVM was stored on 25 farms (93%). Eighteen farms (67%) stored at least 
one expired antimicrobial and six (22%) stored at least one expired vaccine. The total number of 
expired antimicrobial units across all farms was 201, with each farm storing a median of 2 (0-58) 
expired antimicrobials. The total number of doses of expired vaccines stored across all farms was 827, 
with each farm storing a median of 0 (0-725) expired doses.  
The median length of time since expiration was 12 (1-200) months. For antimicrobials, median length 
of time since expiration was 10 (1-96) months, for anti-inflammatories 6 (2-42) months, for vaccines 
20 (2-200) and for other medicines 12 (2-120) months, with the majority of the “other” medicines 
endectocides. 
 Cascade medicines 
Medicines not licensed for use in dairy cattle were found on 16 farms (59%). A total of 30 unlicensed 
units were stored comprising 14 different medicines. Seven different unlicensed antimicrobials were 
identified totalling 709,100 mg of active ingredient. Macrolides were most common with 138,600 mg 
of erythromycin (licensed for use in poultry and pigs) found across seven farms served by two different 
veterinary practices - 2,000 mg lincomycin on one farm (licensed for use in pigs) and 200 mg 
gentamycin (licensed for use in horses not producing milk or meat for human consumption) on one 
farm. Also found were 500,000 mg of tetracyclines (licensed for use in poultry and pigs) across three 
farms served by one veterinary practice, 5,000 mg metronidazole veterinary tablets (licensed for use 
in dogs and cats but banned from use in cattle) on one farm, 18,000 mg of 1st generation 
cephalosporin of Hungarian origin and not licensed for sale in the UK on one farm and 30,000 mg of 
florfenicol of Dutch origin not licensed for sale in the UK on a different farm. There was no clustering 
of unlicensed products by farm. Other unlicensed medicines identified were: 50 ml of mepivacaine (a 
local anaesthetic agent licensed for use in horses), 1 tube of acepromazine gel and 30 ml romifidine 
Resource availability: Investigating the contents of medicine cupboards 
98 
 
(sedatives licensed for use in horses), 2 capsules of 2 mg loperamide (an antispasmodic licensed for 
human use), 200 ml sucralfate, 2 tubes of fusidic acid gel (an antibiotic topical gel licensed for use in 
cats and dogs) and one bottle of topical miconazole licensed for use in dogs. Where unlicensed 
medicines were found, farmers confirmed they were present for use in the dairy calves or adult cattle. 
 Discussion and Conclusions 
Most farms in this study stored PVM in the recommended way. However, some PVM were being 
stored in inappropriate conditions e.g. in areas at risk from heat or cold damage and exposure to 
sunlight or gross contamination. Twenty-nine percent of PVM found were not stored in a lockable 
cupboard or room. This has direct health and safety implications due to access to potentially harmful 
medicines by animals or children in addition to risks of theft. Certain medicines should be stored with 
particular care due to their potential for harm from accidental exposure (Carr and Smith, 2013). 
Prostaglandins for example, which made up a proportion of the hormone POM-V reported in the 
results section, can be absorbed transcutaneously and lead to miscarriage or serious and even fatal 
respiratory compromise in susceptible people (NOAH, 2017). 
While some farms stored a wide range of different types and quantities of PVM, others stored a limited 
number. The fact that the quantity of antimicrobials stored on farm does not appear to be linked with 
the number of animals at risk of treatment or the overall production values of the cows on the farm 
(Figures 4-2, 4-3 and 4-4) suggests that there are other reasons for the range of storage practices seen.  
As previously noted, a farmer’s treatment decisions are to some extent constrained by the PVM 
resources available to them. It follows therefore that when designing policy interventions aimed at 
reducing AMU, data on storage practices and farmers’ use of stored medicines is extremely important. 
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 Antimicrobial storage 
Antimicrobials were the PVM stored in the greatest quantity when measured by total mg of active 
ingredient as well as by individual medicine units. Twenty-four farms stored HP-CIAs indicating that 
their use is still common in UK dairy farming, however recent increased efforts to reduce their use 
mean this is likely to be a rapidly evolving picture. For example, as of June 2018 Red Tractor Farm 
Assurance require HP-CIAs only be used as a last resort, with a veterinary report outlining diagnostic 
or sensitivity testing (Red Tractor Assurance, 2018). While storage does not equate to actual use, it is 
likely that these antimicrobials are stored with the intention of use and therefore it may be that the 
use of HP-CIAs was still common practice during the period of the study. Data from the wider 
longitudinal research study is in preparation for publication and will report on actual PVM use on these 
farms including HP-CIA use over a 12-month period. 
The number of bottles of injectable antimicrobial present on farms was as high as 35 on one farm, 
with a median of 9. Keeping a store of antimicrobials like this provides a large resource for the farmer 
to use without a need to consult her/his veterinary surgeon. One of the most frequently kept 
injectable antimicrobials was ceftiofur, a HP-CIA. Given the focus on reducing the use of HP-CIAs in 
the years preceding the study, this may be indicative of a reluctance to move away from their use in 
the dairy sector. The 0-hour milk withhold carried by ceftiofur and it’s broad licensing for use in 
respiratory disease, metritis and interdigital necrobacillosis made it an attractive and cost-effective 
option for treating disease on farm, and it appears to have remained popular at least until the latter 
part of 2016. The antimicrobials most commonly used for treating mastitis in the lactation period were 
not on the current HP-CIA list although potentiated amoxycillin is not considered to be a first-line 
treatment (World Health Organisation, 2016). The most commonly stored antimicrobials for treating 
dry cows included cefquinome, a 4th generation cephalosporin and HP-CIA. 
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Many of the first-line, “responsible” antimicrobials have a relatively high total weight of active 
ingredient when compared with HP-CIAs, leading to calls for HP-CIAs to be measured and 
benchmarked separately from other antimicrobials (Mills et al., 2018, Hyde et al., 2017). This study 
provides evidence that there in an ongoing need to change behaviour and reduce the use of HP-CIAs 
on dairy farms. 
Interestingly, when measured in mg/PCU or mg/1000L milk produced annually, the data show that 
while most farms stored similar quantities of antimicrobials, a handful of farms stored up to ten times 
as much as those farms which stored the smallest amounts. This suggests other factors affect the 
storage practices of dairy farmers.  
Participating farms stored a broad range of different antimicrobials, thus increasing their options 
when making treatment decisions. This could lead to a dissonance between the intention of the 
prescribing veterinary surgeon and the actions of the farmer. Having such a large resource to draw 
upon could be seen to improve the agency and ownership of the farmer on those decisions, but 
conversely to decrease the agency and ownership of the veterinary surgeon legally responsible for 
their use. This serves to emphasise the importance of understanding the treatment decisions, given 
the relatively few resource constraints. 
 Labelling 
While there is no legal requirement for labelling of PVM provided they are supplied in their original 
packaging, both the VMD and the RCVS consider it good practice for all PVM to carry a dispensing label 
(British Small Animal Veterinary Association, 2017). These labels must not obscure the batch number 
or expiry date. The RCVS Practice Standards Scheme requires labels to contain the following 
information: name and address of the animal owner/client, name and address of the veterinary 
practice supplying the medicine, date of supply, name, strength and quantity of product, dosage and 
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directions for use, the statement ‘For animal treatment only’ and for topical preparations ‘For external 
use only’ (Royal College of Veterinary Surgeons, 2018). The lack of appropriate labels found on the 
medicines stored across the participating farms may reflect the fact that many practices are still 
labelling the external cardboard packaging (which is often discarded upon purchase) as opposed to 
the actual medicine packaging. Additionally, some farms do not store prescription intramammary 
medicines in the original boxes, and individual intramammary tubes are rarely labelled. This lack of 
labelling often means there is no indication of the dose required for injectable PVM, as only some 
PVM contain this information on the manufacturer’s label. 
 Expired medicines 
While the presence of expired medicines does not equate to their use, the fact that expired PVM were 
identified on most participating farms indicates that their use is likely to be common. Expiry dates for 
drug products are set based on real-time stability testing at appropriate storage conditions to 
determine whether the drug substance meets its individually set specification (European Medicines 
Agency, 2003). A specification “establishes the set of criteria to which a drug product should conform 
to be acceptable for its intended use” (European Medicines Agency, 1999). All but two farms stored 
at least one expired PVM with two-thirds storing at least one expired antimicrobial. This is particularly 
striking when compared with studies of household medicine storage among human health, which 
have shown a range of 3-22% of stored medicines were expired (Zargarzadeh; et al., 2005, Teni et al., 
2017). Given the average length of time passed since expiry was 12 months, with one farm storing 
medicine that was over 16 years out-of-date, their presence appears to be accepted by farmers on 
dairy farms. 
The impact of using an expired antimicrobial is ill-defined. It is assumed that the efficacy of an 
antimicrobial, or indeed any medicine, reduces with time after expiration. However, the evidence base 
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for this is small and contradictory. In one study from human health, it was shown that there was a 
decreased rate of pathogen susceptibility to expired antimicrobials (Ogunshe and Adinmonyema, 
2014). Other studies have shown that most medicines retain their efficacy for many years beyond their 
expiration date (Courtney; et al., 2009, Cantrall; et al., 2012). To the authors’ knowledge there are no 
studies on the efficacy of expired antimicrobials in veterinary medicine. 
Perhaps more important than the expiry date stated on PVM is the shelf life of the medicine once 
broached. In-use shelf life is determined for multi-use veterinary products by in-use stability testing 
of physical, chemical and microbial properties. Products approaching the end of their shelf life are 
tested, with testing designed to simulate as closely as possible real-life conditions based on likely 
usage patterns of the product under “normal environmental conditions” and stored according to the 
product literature. These drugs are measured against either their original specification or an “in-use 
shelf life” specification, as appropriate (European Medicines Agency, 2001). While this is often 28 days 
for injectable products and 24 hours for vaccines, in reality these shelf lives are rarely observed due 
to most injectable medicines being sold in multi-dose bottles and individual animals’ treatment 
courses require varying volumes of medicine. Measuring the presence and use of PVM that had passed 
its broached shelf-life was beyond the scope of this study, however future research in this area would 
be valuable.  
Expired or waste PVM should not be disposed of with normal household waste and most veterinary 
practices offer a disposal service to clients. Given the prevalence of expired PVM on the study farms, 
veterinary surgeons should determine whether the farms under their care are disposing of these 
medicines appropriately or whether they remain on farm with potential for use. Discussion of the use 
and disposal of expired PVM would make a valuable addition to herd health review meetings, 
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particularly given the veterinary surgeon’s ultimate responsibility for the safety of medicines being 
used in these food-producing animals. 
 The Cascade 
Using PVM which are not licensed for use in dairy cattle is not illegal if they are prescribed and used 
according to the Cascade and where there are established Maximum Residue Limits (Veterinary 
Medicines Directorate, 2015b). However, the use of unlicensed PVM is not currently monitored in the 
UK. Given the presence of medicines which have been prescribed via the Cascade further research is 
urgently needed in this area. In one instance, PVM were present which are explicitly banned from use 
in dairy cattle (metronidazole): administration would constitute a transgression of the law (European 
Union, 2009). 
 Study limitations 
The use of purposive sampling through veterinary practice nomination inevitably leads to the 
possibility of selection bias. The study farms were demographically reflective of the wider UK dairy 
farm population. According to the AHDB the “average number of adult dairy cows” on UK dairy farms 
in 2016 was 143 (Agriculture and Horticulture Development Board, 2016), compared to the study farm 
median of 175. The larger herd size of the study farms may influence the way in which PVM are stored. 
Larger herds are more likely to have an increased frequency of veterinary visits which may mean they 
store fewer PVM on the farm as they have additional resources available to them through the 
veterinary surgeon on a regular basis. 
Farmers were asked not to alter the medicines stored on their farms for the visit day. Given the 
prevalence of expired medicines and storage of medicines outside of designated cupboards it appears 
that farmers did not significantly improve their storage practices prior to the visit, and it is believed 
that the data described are representative of normal medicine storage on the study farms. The volume 
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of medicines in opened bottles was estimated by eye to the nearest 10 ml, which may have led to 
some over- or under-estimation of the total volume present on farm. Using reference weights for 
different medicines and a portable weighing scale to measure the weight of bottles may have 
improved the accuracy of these measurements. 
This study was cross-sectional, and the seasonal nature of dairy farming and disease prevalence should 
be noted. This study took place in the Autumn, around the time of housing for many farms, and the 
data may be different if it was to be repeated in different seasons. For example, infectious disease 
prevalence can increase during the housed winter months for certain diseases, and farmers may be 
likely to store more antimicrobials or anti-inflammatories in anticipation of an increased need for use 
at this time. This could lead the study to overestimate typical storage levels on farms, where much 
less PVM might be found in the summer months. Where mixed-enterprise farms were included, these 
stored medicines intended for use in dairy cattle and calves separately from medicines intended for 
beef or sheep. This did not allow for any measurement of the possibility of medicines stored for use 
in beef and sheep being used in the dairy cattle. It is also important to note that this study reports 
storage practices on a small number of dairy farms in South West England and South Wales and as 
such may not reflect practices found on other farms or in other regions of the UK. Further research in 
this area is needed to provide a robust evidence base for future policy decisions aimed at improving 
responsible medicine use in dairy farming. 
 Implications for medicine use 
While it has been highlighted before that veterinary surgeon must assume responsibility for providing 
advice on security, storage, hygiene, use and disposal of PVM (Carr and Smith, 2013), it would appear 
that, at least among study farms, more could be done to effect behaviour change and bring about 
responsible storage practices. As suggested, the inclusion of these important areas in the annual herd 
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health plan - comprising both a discussion of current practices and the creation of a formal Standard 
Operating Procedure for the future - seems an obvious way to begin improving matters.  
The prescribing of off-licence medicines should be an area of focus, both for the veterinary profession 
and the farming industry. Given dairy farming’s inherent reliance on public trust in food safety 
practices (a fact highlighted by 2013’s “horse-meat scandal”) it is all too easy to imagine the negative 
impact of any exposé of any “horse-drug scandal” that the press may decide to publish. While the use 
of off-licence medicines is not illegal when prescribed and used according to the Cascade and where 
there are established MRLs, the lack of record keeping suggests mandatory maximum withdrawal 
times are not being adhered to. As argued by De Rosa and Trabalzi (2016) when discussing illegality in 
the Italian food trade, legality and illegality are “social constructs which are the product of institutional 
selection”, as pithily summed up with their title: “Everybody does it”. The current climate with regards 
to off-licence medicine use certainly seems to be one of ‘don’t ask, don’t tell’, and the lack of any 
formal recognition or measurement of the practice has consequences. As such, it is vitally important 
that such grey areas are tackled head-on and that meaningful, practical policies are introduced in 
order to both clarify the legal aspects of off-licence use and to formally measure the practice.  
 Future research  
While this study highlights some important areas of interest, it is acknowledged that the sample size 
is small and was constrained by the requirements of the broader research project. This work therefore 
provides a rich source of pilot data which requires further investigation. A large, high-powered cross-
sectional study of medicines stored on randomly selected UK dairy farms in different seasons would 
be required to provide a full and valid evidence base for policy decisions based upon storage practices 
to be made. Such a study would also be valuable in order to investigate the relationship between 
veterinary medicines stored on farm and those used, including the chronology of storage and use. 
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From such as study it might be possible to estimate PVM use behaviours based on PVM storage 
practices. 
Much further research is needed on the subject of expired medicine use, in particular the effects of 
expiration on efficacy and any subsequent effects on risk of development of antimicrobial resistance. 
Equally it is important to focus on broached medicines and their use. The use of off-licence medicines 
in dairy cattle is currently very poorly measured and understood, including the adherence to extended 
Cascade withdrawal times. This seems surprising and a vital area for further work given the strict 
regulations and guidelines within which farmers and veterinary surgeon should be operating when 
treating food-producing animals, and the possible industry-wide detrimental effects of their likely 
widespread use being made public. While this area has not been ignored deliberately, continued 
inaction in the face of evidence will be difficult to justify. Equally, evidence of the extent of off-licence 
medicine use in agriculture is required urgently, and research in this area should be a focus for policy 
makers and funding bodies.  
 










Chapter 5 Measuring prescription veterinary medicine use: a 
longitudinal method comparison study 
  








Antimicrobial use on dairy farms in the UK is measured nationally to satisfy European surveillance 
reporting requirements. However, measurement of non-antimicrobial veterinary medicine use is not 
currently undertaken at a national level. National antimicrobial use surveillance has recently begun to 
use veterinary sales data as a proxy for actual use; how well these data represent actual use, however, 
has not been validated. Other methods of recording use are available, such as the use of medicine 
waste bins and data from on-farm medicine treatment records. This longitudinal method comparison 
study compares these three measures of medicine use with a pre-determined gold standard measure 
of use.  
Twenty-six dairy farms with a broad range of management systems, herd sizes and production goals 
were enrolled into the study in September 2016. A full prescription veterinary medicine (PVM) 
inventory was taken and a structured management survey was completed. Medicine waste bins were 
placed on farms and participants were asked to dispose of all used medicine packaging into these bins. 
Participants were asked to continue using and recording veterinary medicines in the usual way. PVM 
use was measured prospectively for a 12-month period through the medicine waste bins, with bins 
emptied and audited on a quarterly basis. At the end of the study, farm medicine records and 
veterinary sales data were obtained retrospectively for the study period, and medicine waste bins 
were removed. 
Veterinary sales data was shown to be the best proxy for actual use when compared with a pre-
determined ‘gold standard’. Medicine waste bins showed reasonable agreement with the gold 
standard, whereas on-farm medicine records did not show agreement with the gold standard. Using 
veterinary sales data to measure injectable and intramammary antimicrobials showed the best 
agreement, whereas all methods showed poor agreement with the gold standard when measuring 
other types of antimicrobials, vaccines or all injectable products considered together.  




Antimicrobial use (AMU) is measured at a national level in the UK for the purposes of producing an 
annual report to satisfy the requirements of the European Medicines Agency’s (EMA) European 
Surveillance of Veterinary Antimicrobial Consumption (ESVAC) project, which began in 2010. In 2018, 
the EMA launched a project to stratify sales data of veterinary antimicrobials by animal species 
(European Medicines Agency, 2018). As previously described in Chapter 2, in the UK this report is 
published annually in the form of the Veterinary Antimicrobial Resistance and Sales Surveillance 
(VARSS) report, which has recently moved away from national production and import data towards 
using veterinary practice sales data to measure species-specific antimicrobial consumption. The data 
sources in the dairy sector are currently small, making up just over 33% of UK dairy cows in 2016 and 
31% of UK dairy cows in 2017. While this move has served to increase the granularity of the data made 
available, the use of veterinary sales data as a proxy for use has never been validated in dairy cattle in 
the UK, and as such it has not been possible to estimate the representativeness of these data 
(Veterinary Medicines Directorate, 2017, Veterinary Medicines Directorate, 2018c).  
While AMU has been monitored and reported systematically for many years, prescription veterinary 
medicine (PVM) use as a whole is not currently measured or monitored on a national level. Because 
of the potential usefulness of such data, individual veterinary practices, farms, agricultural consultancy 
and data management companies are increasingly attempting to collect and analyse PVM use to 
provide information on farm and veterinary economics and animal health, for example the farm 
benchmarking service provided by Kingshay (2018). The scattered nature of this endeavour involves 
many private businesses all striving to measure the same thing without communicating or agreeing 
on a measurement standard.  
Previous research in Austria, Switzerland, Belgium and Germany have shown that veterinary sales data 
are superior to on-farm medicine records when measuring AMU (Ferner et al., 2014)(Pardon et al., 
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2012, Menendez Gonzalez et al., 2010, Merle et al., 2012). These studies did not, however, include 
other forms of PVM or compare either of these methods with a gold standard. To the author’s 
knowledge, there have been no published data on the usefulness of veterinary sales data as a proxy 
for measuring PVM use. The question of whether veterinary sales data can accurately reflect actual 
use is therefore both pertinent and largely unanswered, both specifically for measuring AMU and for 
measuring use of PVMs. 
Dairy farmers in the UK are required by farm assurance schemes such as Red Tractor to keep medicine 
records for a minimum of 5 years. These requirements state that medicine purchases, treatments and 
disposal must be recorded. Medicine purchase records must contain information on “identity of 
medicine, quantity of medicine, date of purchase, name and address of supplier, batch number(s) and 
expiry date(s)”. For medicine administration records, farmers must provide information on the 
“identity of medicine, quantity of medicine administered, batch number(s) or bottle number linked 
back to purchase records, identification of the animal or group of animals to which administered, 
number of animals treated, date of administration, date treatment finished, date when animal(s)/ milk 
becomes fit for human consumption, name of person administering medicine and reason for 
treatment.” Additionally, farmers must provide medicine disposal records including data on “identity 
of medicine, date, quantity and route of disposal” (Red Tractor Assurance, 2017). 
Given the detailed nature of the records that all Red Tractor-assured dairy farms (98% of all UK dairy 
farms are Red Tractor-assured) are required to keep, it would appear logical that to improve the 
granularity of antimicrobial and PVM use data, a move towards using on-farm records would be the 
next stage of progress (Responsible Use of Medicines in Agriculture Alliance, 2017). However, to the 
author’s knowledge, there have been no studies of the accuracy or representativeness of on-farm 
records as a proxy for use. In fact, it is known that farmers see the keeping of medicine records as a 
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“tick-box-exercise” and of low priority when compared with the many other competing daily pressures 
of farming (Escobar, 2015).  
The practicalities of using on-farm records has to date proven to be a barrier to the use of these data, 
given that farms may keep these records in multiple different formats (Mills et al., 2018). Some farms 
use computerised herd health management software with integrated medicine records, others use 
pre-prepared medicine record templates while others use less formalised systems written in day 
diaries or on scraps of paper. The Agriculture and Horticulture Development Board (AHDB) are 
currently developing and piloting a centralised, computer-based electronic medicine book system for 
collection of AMU data (eMB Cattle) with additional functionality allowing for the collection of full 
medicine records from cattle farmers. This system is based on the successful introduction of the 
electronic medicine book for the pig industry, eMB Pigs (AHDB Pork, 2018). While the successful 
introduction of eMB Cattle would greatly improve the granularity of AMU data available, and if the 
full medicine records used also include PVM use, there have not been any estimates of the validity of 
on-farm medicine records as a proxy for actual medicine use. 
By comparing veterinary practice sales data with on-farm medicine records and a longitudinal on-farm 
medicine waste study, a measurement of agreement between the recording methods can be made. 
By assuming a gold standard measurement of actual PVM use, as described below, all three individual 
methods can be compared to the gold standard and an initial estimate of the validity of each method 
can be made.  
 Methods 
 Data handling 
For each participating farm, an individual medicine workbook was created using Excel (Microsoft 
Office 365). Each workbook contained a spreadsheet listing every medicine on the VMD’s Product 
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Information Database (Veterinary Medicines Directorate, 2018b), along with columns for: the initial 
medicine cupboard inventory data, data from each quarterly medicine bin inventory, veterinary sales 
data and on-farm medicine book data. The workbooks also contained spreadsheets containing the 
structured questionnaire data, notes of any unlicensed or unlisted medicines found as well as any 
pertinent fieldnotes and reminders. Example screengrabs from these workbooks can be seen in 
Appendices 10 and 11.  
 Defining a “gold standard” 
While it is possible to determine the agreement between different methods when measuring 
outcomes, in this case comparison is somewhat meaningless without knowing how closely any of 
these methods agrees with the true value of the outcome being measured. However, as with many 
clinical outcomes in healthcare research, knowing the “true” value is often all but impossible. In this 
case, a gold standard can be defined which is the closest to the truth that can reasonably be 
determined. While many people understand the term ‘gold standard’ to mean the true value, in 
medical statistics the gold standard can be described as “the diagnostic test or benchmark that is the 
best available under reasonable conditions” (Versi, 1992, imddle of page 187).  
For this study, the gold standard was determined a priori in discussion with two veterinary 
epidemiologists (KR & FSV) and a data scientist (AD). When measuring actual medicine use on dairy 
farms, what we are ideally trying to measure is the amount of medicine administered to the cattle 
during a given time period. All the current methods for measuring this are proxies for use, that is they 
measure either what was recorded as being used, what was sold to the farm or what was discarded 
after use. These methods represent the most commonly used and logistically easy ways of estimating 
actual use. However, in order to measure actual use, it would be necessary to be present to record 
every administration of medicine for the entire study period, which is not practical. 
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From the three available methods, the potential for over- and under-estimation was discussed, and 
the possible ways of correcting these in order to approximate the ‘true’ value were explored as far as 
possible.  
Veterinary sales data:  
Overestimation – sold more during the time period than was actually used (i.e. medicines left in the 
cupboard at end of the study period). Wasted medicine not accounted for. Medicines ascribed to 
wrong species. 
Underestimation – medicines are used which were purchased before the study period, medicines 
purchased or obtained from sources other than veterinary practice. Medicine ascribed to wrong 
species. 
On farm medicine records: 
Overestimation – Farmer records more medicines being used than actually administered (e.g. records 
all dry cow treatments as x4 tubes where some cattle have three teats). 
Underestimation – Farmer forgets or neglects to record treatments. 
Medicine waste bins: 
Overestimation – Farmer discards medicines packaging into bins which were actually used before 
study period (i.e. finds a stash of empty medicine bottles and uses the bin to dispose of them). 
Underestimation – Farmer forgets to use the bin or only uses the bin for some treatments and not 
others or chooses to dispose of medicines packaging elsewhere, medicines used by the veterinary 
surgeon and not left on the farm. 
It was determined that the method best suited to determine the gold standard and where the 
potentials for over- and under-estimation could be corrected for the most easily was veterinary sales 
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data, as this did not rely on farmer compliance or memory. It was determined that the potential for a 
‘time-lag’ in veterinary sales data could be corrected by taking a full PVM inventory of the farm on the 
first and last day of the study in order to correct for the potential for use of medicines that were 
already in stock at the start of the study as well as for medicines that were not used and remained in 
stock at the end of the study.  
‘Gold Standard’ = (initial inventory + veterinary sales data) - end inventory 
This gold standard was still open to underestimation where farms sourced medicines from sources 
other than their veterinary surgeon. This was corrected for as far as practicable by enquiring whether 
medicines were ever sourced from elsewhere and checking veterinary labels during bin audits and 
medicine cupboard inventories.  
 Medicine waste bins 
The research methods for data collection using medicine waste bins are described in detail in Chapter 
3, Section 3.5.3 along with a description of piloting of the method in Section 3.5.6. To recap briefly, 
medicine waste bins  were placed on each participating farm at the initial inventory visit in the size, 
number and location of the farmers’ choice. Farmers were instructed how to use the bins and signage 
(Appendix 7) to remind them was placed strategically around the farm. All farms were then visited 
quarterly and the contents of the bins were transferred into individually labelled transport containers 
and transported back to the research area at the University of Bristol’s (UoB) Langford Campus. 
Once each farm’s quarterly bin contents were collected, these bins were individually analysed in a 
dedicated research space at UoB Langford Campus. This research space consisted of a large concrete 
feed manger where the contents of each individual bin was decanted for counting. From here, these 
contents were sorted using large plastic trays, and analysed. Information about the contents were 
entered into pre-prepared spreadsheets, one per participating farm. The data collected from the bin 
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inventories comprised of the medicine identity, pack size, quantity of packs, any waste medicine 
remaining within each pack, the expiry date and the presence of a veterinary dispensing label. These 
data were entered into a dedicated spreadsheet for each participating farm using Excel (Microsoft 
Office 365). Once the contents of the medicine waste bins had been recorded, the bins were sealed 
and disposed of as clinical waste. 
Protective equipment was necessary during these medicine bin inventories due to the presence of 
broken glass, open medicine packaging and used, unsheathed needles. The quantity of waste 
medicines present in each farm’s bins varied, with some farms providing several 120 L bins worth of 
used PVM and others providing a handful of used bottles and intramammary tubes per quarter.  
During the third quarterly bin inventory, a veterinary undergraduate who was undertaking a research 
placement within the AMR Force research group was present and conducted a second inventory of 
each bin’s contents for 15 farms. The data collected by the undergraduate was compared with the 
data collected during the study inventory in order to validate the counting method. It was found that 
the percentage difference between both counts (total number of packs present) for each of the 15 
farms’ bins was less than 3% (median number of items per bin 342, range 64 - 697) indicating that the 
inventory data collected in this project was relatively robust.   
Where medicines were found to have expired before the first day of the quarter of data collection 
being tallied, these were classified as expired medicines. Where PVM were found to have expired 
during the period for which the count was taking place, the benefit of the doubt was given that the 
medicine was used before the expiration and the medicine was not classified as having expired. Where 
medicine packages had lost all identifying feature (the label had perished completely), these were 
disregarded although such instances were rare (n=14). Any waste medicine remaining within each 
pack was estimated by eye to the nearest 10% (i.e. for a 100 ml bottle of injectable PVM, any remaining 
product was estimated to the nearest 10 ml). 
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Where possible, the final bin collection took place on the 12-month anniversary (i.e. Day 365) of the 
date the bins were first placed on each farm. However, in instances where this was not possible, bins 
were collected within 3 days of the 12-month anniversary.  
 Veterinary sales data 
Consent for the collection of veterinary sales data from each participating farm’s veterinary practice 
was obtained during the initial farm visit. Veterinary sales data for each participating farm were 
requested once from their veterinary practices’ administration team at the end of the 12-month 
medicine waste bin study. A copy of the consent form was included in the request. A research 
associate (GG) from the AMR Force research group contacted each of the nine veterinary practices 
requesting veterinary sales data for the entire time period of the study. These data were supplied by 
email in various formats, ranging from Word (Microsoft Office 365) documents, .pdf (Adobe Reader 
XI) documents, scanned practice management software printouts and Excel (Microsoft Office 365) 
spreadsheets.  
Once these data had been collected, total quantities of units sold for each different medicine were 
tallied and entered into the respective farm’s medicine spreadsheet. Veterinary sales which were 
administered by the veterinary surgeon (rather than dispensed to the farmer) were identified through 
identifying visit chronology and disregarded. Participating farmers had confirmed that those 
medicines which were administered by visiting veterinary surgeons from non-farm stock would usually 
not end up in the bin due to a dose being drawn from a multi-dose vial, and for it to be common 
practice for farm animal veterinary surgeons to dispose of their own medicine waste at the end of a 
visit. Veterinary administrations were also reported to be rarely, if ever, recorded in the on-farm 
medicine book; instead veterinary invoices were kept separately. 
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 On-farm medicine records 
On-farm medicine records were collected on or after the final day of the medicine waste bin study. 
These records took various forms ranging from dedicated computer software to farmer-created 
spreadsheets, handwritten medicine books or simply entries in the day diary. Where records were 
computerised, a copy was downloaded onto a USB stick or a print-out was made for the time-period 
required. On one occasion neither method was possible and therefore photographs of the computer 
screen were taken. Where medicine records were handwritten, photographs of each page of the 
medicine record book or day diary were taken consecutively, covering the 12-month period of 
interest. 
Computerised data were then collated, with the total volume recorded for each medicine over the 
entire 12-month period tallied and entered into the respective farm’s medicine spreadsheet. 
Photographs of hand-written medicine records were analysed temporally for the 12-month period 
and the total volume for each medicine was similarly tallied and entered into that farm’s medicine 
spreadsheet. 
 Classification of PVM 
Prescription veterinary medicines were classified according to their Veterinary Medicines Directorate 
(2018b) classification for analysis as follows: 
• Injectable antimicrobials: all antimicrobial POM-V products of injectable form. Combination 
products containing an antimicrobial as one of the active ingredients (e.g. florfenicol & 
flunixin) were classified as antimicrobials. Where an antimicrobial presented as a powder for 
reconstitution this was classified as an injectable antimicrobial and it was assumed that the 
reconstituted product would be made up to the correct volume as per the manufacturer’s 
datasheet.  
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• Intramammary antimicrobials: all antimicrobial products of intramammary form. 
• Other antimicrobials: all antimicrobials that do not fit into the above two categories. This 
included ocular preparations, tablets and boluses, powders used as footbaths but did not 
include monensin used to prevent ketosis. 
• All injectables: All PVM presented in injectable form, including antimicrobials, non-steroidal 
anti-inflammatories, hormone preparations, etc., but not including vaccines. 
• Teat sealants: all mechanical teat sealants. 
• Vaccines: all vaccine products, whether injectable or intranasal. 
 Data analysis 
Data was collated, cleaned and validated in Excel (Microsoft Office 365). Once the full 12 months of 
data had been prepared for each of the 26 participating farms, the approach to data analysis was 
decided upon after critical appraisal of the method agreement literature by the author and developed 
with the help of an experienced epidemiologist from the Bristol Veterinary School (FSV), who also 
conducted the analysis using R software (R Core Team, 2012). Four different approaches were used to 
analyse method agreement for the following combinations: 
- Vet sales vs. Gold standard 
- Medicine bin vs. Gold standard 
- Farm records vs. Gold standard 
Sample size estimation for reliability calculations was based on two observations per subject because 
all three methods of measurement were compared separately with the gold standard. An expected 
reliability value of 0.9 and an acceptable lower limit of reliability width of the 95% confidence interval 
of 0.7 was used, which gave a sample size requirement of 18 farms. This was then corrected to 23 
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farms based on an expected drop-out rate of 20% (Walter et al., 1998). This was deemed to be 
acceptable as 27 farms were enrolled onto the original project, and complete data was collected for 
26 farms.  
Analysis was conducted separately for the seven different types of PVM listed above. Initially, one-
way repeated measures ANOVAs were used to investigate whether there was a systematic difference 
between the mean medicine use measured by four different recording methods in a farm-level sample 
(Table 5:1). “Medicine use” was the dependent variable, whilst the independent variable was 
“recording method”. Prior to analysis, the normality of the dependent variable for each level of the 
independent variable was determined by visual examination of quantile–quantile plots and confirmed 
by a Shapiro–Wilk normality test (p > 0.05; results not shown). Where the normality assumption was 
not met after data transformation, a non-parametric Quade test was conducted to assess whether the 
distribution of values for each recording method were equal. The assumption of sphericity was tested 
using Mauchly’s Test of Sphericity. Where sphericity was violated, we used the Greenhouse-Geisser 
correction to make an adjustment to the degrees of freedom of the repeated-measures ANOVA. 
Where significant results were found, post-hoc tests for differences between means were adjusted 
for multiple comparisons using Tukey’s test. When a Quade test was conducted, post-hoc tests for 
differences between distribution of values were adjusted for multiple comparisons following Holm’s 
method. If the difference between means for any pair of recording methods being compared was non-
significant (i.e. there was no evidence of a systematic effect), the following two approaches were used 
to measure levels of agreement and reliability between such recording methods. 
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Table 5:1 Tests and transformations used to investigate whether there was a systematic difference between the mean 
medicine use measured by three different recording methods when compared with a gold standard measure in a farm-level 
sample. 
Medicine type Test Transformation used 
for modelling 
Injectable antimicrobial Repeated measures ANOVA  log10 (x + 100) 
Intramammary antimicrobial Repeated measures ANOVA  log (x + 10) 
Other antimicrobial Non-parametric one-way ANOVA None 
All injectables Repeated measures ANOVA log (x + 250) 
Vaccines Non-parametric one-way ANOVA None 
Teat sealant Non-parametric one-way ANOVA None 
 
The reliability between each pair of methods was measured using the intraclass correlation coefficient 
(ICC) (Watson and Petrie, 2010). The ICC takes a value from 0 (implying no agreement) to 1 (perfect 
agreement). Values less than 0.5 are indicative of poor reliability, values between 0.5 and 0.75 indicate 
moderate reliability, values between 0.75 and 0.9 indicate good reliability, and values greater than 
0.90 indicate excellent reliability. ICC estimates and their 95% confident intervals were calculated 
based on a single-rating, absolute-agreement, 2-way mixed-effects model (Koo and Li, 2016). The 
normality of the medicine use recorded by each method was determined as detailed above. Where 
the normality assumption was violated, a data transformation was applied. 
In order to measure the agreement between each pair of methods (i.e. the three recording methods 
against the gold standard), the Bland-Altman method was used (Bland and Altman, 1999). This method 
calculates the ‘bias’ and 95% limits of agreement between two methods, where the bias is the mean 
difference between the two methods. The 95% limits show the range where 95% of the differences 
between the two methods would be expected to lie. While the 95% limits show visually how well two 
methods of measurement agree, this quality judgement of this agreement depends on clinical context. 
Additionally, while the ICC shows the level of reliability between each pair of methods, this does not 
take into account the clinical context to tell us whether the level of agreement is acceptable. 
Therefore, a clinically relevant level of agreement should be used when evaluating method 
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comparison studies. In this case, it was decided a priori in discussions between GR, KR and DB in this 
study that if the 95% limits of agreement were within 30% of the mean total for the gold standard, 
this would equate to ‘reasonable agreement’; if they were within 20% of the mean total for the gold 
standard this would represent ‘good agreement’; and if they lay within 10% of the mean total for the 
gold standard, this would represent ‘excellent agreement’. This was based on the decision that a 30% 
over- or under-estimation of actual use would be acceptable as a proxy of AMU, but less than 20% 
over- or underestimation would be ideal. We used the Bland-Altman plot and Shapiro–Wilk normality 
test to check the assumptions of the method. The Bland-Altman plot was also used to detect outliers 
and the influence of large outliers was evaluated by recalculating the limits of agreement when these 
outliers were excluded (Watson and Petrie, 2010). Because for this dataset it was impossible to 
interpret whether outliers were due to data error or due to between-farm variation, data were 
analysed both including and excluding the outliers as described, and both sets of analyses presented 
in order to ensure completeness for the reader. In the analysis and interpretation of the data, only 
data including all outliers were used.  Where the agreement between recording methods varied with 
the quantity being measured, we attempted to resolve this difficulty by analysing the logarithm of the 
measurement rather than the measurement itself. For data sets for which log transformation does 
not remove the relationship between the differences and the size of the measurement, a Bland-
Altman plot was used to help in comparing the methods. 
The method agreement analyses used in this study were designed to measure the agreement between 
different methods of recording the same variable. That means that inherent within the methodology 
of the analysis is a measurement of the random or systematic measurement errors that occur. While 
the gold standard used in this chapter is related to one of the measurements (veterinary sales data), 
the analysis essentially showed that, although there is no systematic difference between the two 
results, there nevertheless exists a difference. The analysis provided a measure of the difference seen 
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between the gold standard and each method, including the method upon which the gold standard 
was based. Essentially, therefore, the analysis proved that the gold standard and the veterinary sales 
data did not produce the same result but did produce results which agreed well both statistically and 
clinically (as did the medicine waste bins in some circumstances). The Bland-Altman diagram provided 
a display of the differences between the pairs of readings. If the gold standard and the veterinary sales 
data were essentially the same measure, the Bland-Altman diagrams would show perfect agreement 
(i.e. a straight line centred at zero). In fact, they did not show that the measures obtained by veterinary 
sales data were different from those obtained by using the gold standard, although agreement was 
good. This can be explained as described in Section 5.3.2: veterinary sales data when combined with 
a pre- and post-audit inventory provided a different measure to veterinary sales data alone because 
the pre- and post-audit inventories provide additional use data not incorporated into the veterinary 
sales data alone. These measures were of course related and would be expected to exhibit correlation 
as they are different measures of the same variable (Watson and Petrie, 2010). 
 Results and discussion 
Measuring on-farm PVM use can be conducted using many different methods, as described in the 
introduction to this chapter. This study has compared the three most common methods for measuring 
PVM use against a gold standard that was agreed a priori. PVM use was subdivided into the different 
medicine types that were deemed clinically important: injectable antimicrobials, intramammary 
antimicrobials, other antimicrobials, all injectables, teat sealants and vaccines. This categorisation of 
the medicine types was agreed in discussion with clinicians and academics during farm animal clinical 
discussion meetings. Descriptive statistics for the quantities and units of measurement of these 
different medicine types recorded by the three different methods are presented in Table 5:2. As the 
distribution was not normal for any of the medicine types recorded, median values are reported along 
with the range.  
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Table 5.2: Descriptive statistics of the quantities of different medicine types recorded across all participating farms over the 
12 month period (n=26), by the three different recording methods. 
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 Type of PVM measured 
5.5.1.1 Injectable antimicrobials  
The mean quantity of injectable antimicrobials measured was significantly different between at least 
two recording methods (F3,75 = 12.91, p < 0.001, p-value after using Greenhouse-Geisser correction: 
p(GGe) < 0.001). The mean quantity of injectable antimicrobials measured by the gold standard 
method was not significantly different to the mean amount measured using veterinary sales (p = 
0.995) or waste bin (p = 0.822), whilst it was significantly different to the mean amount measured 
using the medicine book (p < 0.001).  




Figure 5-1. Bland-Altman plot comparing veterinary sales data with gold standard data for injectable antimicrobials in total 
ml1 
 
Figure 5-2. Bland-Altman plot comparing medicine waste bin data with gold standard data for injectable antimicrobials in 
total ml1.  
For 95% of farms, a measurement of injectable antimicrobials by veterinary sales data would be 
between 782.3 ml less and 546.1 ml greater than a measurement by the gold standard method (Table 
5:3). The Bland-Altman plot for veterinary sales vs. gold standard is shown in Figure 5-1. The ICC of 
                                                          
1 The y-axis represents the difference between the two named methods, and the x-axis represents the mean of 
the two methods. Dots represent the mean difference between the methods for each participating farm. The 
blue line represents the mean difference between methods across all farms and the red hashed line represents 
the 95% limits of agreement. 
Measuring prescription veterinary medicine use: a longitudinal method comparison study 
126 
 
injectable antimicrobials measured by veterinary sales compared with the gold standard is presented 
in Table 5:4 and showed excellent reliability.  
Because the limits of agreement cross zero, this means that veterinary sales data can under- or 
overestimate actual use of injectable antimicrobials. This equates to a difference of 14% 
underestimation to 10% overestimation for 95% of farms when compared with the median total per 
farm. As discussed in the Data Analysis section, the clinical interpretation of agreement is arguably the 
most important when comparing methods of measurement. Using the agreed clinical agreement 
criteria, this represents good agreement (within 20%) between veterinary sales data and actual use 
for injectable antimicrobials (Table 5:5). For injectable antimicrobials, veterinary sales data 
overestimated use by a mean of 118 ml, which is the equivalent of just over one 100 ml bottle of 
injectable antimicrobial per farm over a 12-month period.  
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Table 5:3 Bland-Altman Plot statistics for all comparison of medicine use recording methods. 
 *one outlier removed  ** two outliers removed   ***transformed   *** transformed and one outlier removed  













Vet sales vs. gold 
standard 
-118.11 338.89 -782.34 to 546.11 92.3 -255.03 to 18.80 
Waste bin vs. gold 
standard 
-999.63 3184.89 -7242.01 to 5242.75 96.1 -2286.33 to 287.06 
Waste bin vs. gold 
standard** 
-285.02 610.91 -1482.4 to 912.36 95.8 -543.15 to -26.89 
Intramammary 
antimicrobials 
Vet sales vs. gold 
standard 
-0.519 75.30 -148.10 to 147.07 92.3 -30.94 to 29.90 
Waste bin vs. gold 
standard*** 
-0.13 0.43 -0.98 to 0.72 96.2 -1.29 to 0.68 
Waste bin vs. gold 
standard**** 
0.05 0.43 0.23 to 0.14 96.2 0.09 to 0.68 
Other 
antimicrobials 
Vet sales vs. gold 
standard 
-5.38 31.20 -66.54 to 55.77 92.3 -17.99 to 7.22 
All injectable 
products 
Vet sales vs. gold 
standard 
-1090.85 3999.47 -8929.82 to 6748.12 96.2 -2706.63 to 524.94 
Waste bin vs gold 
standard 
-912.96 4059.05 -8868.69 to 7042.77 96.2 -255.81 to 726.89 
Vaccines 
Vet sales vs. gold 
standard 
-68.00 257.64 -572.98 to 436.98 92.3 -172.09 to 36.09 
Waste bin vs. gold 
standard 
53.46 723.99 -1365.57 to 1472.49 96.2 -239.03 to 345.95 
Teat sealant 
Vet sales vs gold 
standard 
8.5 97.08 -181.78 to 198.78 96.2 -30.72 to 47.72 
Vet sales vs. gold 
standard* 
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The medicine waste bin method may give values between 5242.7 ml of injectable antimicrobial above 
the gold standard method to 7242.0 ml below gold standard (Table 5:3). However, this result needs 
to be interpreted with caution because the differences between the methods were not normally 
distributed even after log transformation. In such cases, the estimated limits of agreement tended to 
be too far apart rather than too close and should not inadvertently lead to the acceptance of poor 
methods of measurement. The Bland-Altman plot revealed two large outliers (Figure 5-2). Removing 
these outliers improved the closeness of the distribution to normality but did not solve the problem. 
These two outliers also had a big impact on the limits of agreement. After excluding them, the mean 
difference became -285.0 (i.e. on average the medicine waste bin measured 285.0 ml less than the 
gold standard); the 95% limits of agreement were 912.4 ml above the gold standard and 1428.4 ml 
below it.   
Based on the ICC results as seen in Table 5:4, the reliability of injectable antimicrobials measured by 
waste bin compared with the gold standard was good to excellent. The clinical interpretation as shown 
in Table 5:5 represented moderate to good agreement. 
 
  
Measuring prescription veterinary medicine use: a longitudinal method comparison study 
129 
 
Table 5:54. Intraclass correlation coefficients and statistical interpretation of reliability comparing veterinary sales and 
medicine waste bin data with the gold standard for the different medicine types.2 Statistical interpretation is based on: 
ICC < 0.5: poor reliability 
0.5>=ICC <= 0.75: moderate reliability 
0.75>ICC <= 0.9: good reliability 
ICC > 0.9: excellent reliability 
Method 
comparison 














0.997 0.992 – 0.999 Excellent 
Intramammary 
antimicrobial 
0.991 0.981 – 0.996 Excellent 
All injectables 0.996 0.990 – 0.998 Excellent 
Other 
antimicrobials  
0.727 0.481 – 0.867 Poor to good 
Vaccines 0.878 0.749 – 0.943 Moderate to excellent 







0.926 0.843-0.966 Good to excellent 
Intramammary 
antimicrobial 
0.789 0.586 – 0.899 Moderate to good 




Vaccines 0.927 0.844 – 0.966 Good to excellent 
 Teat sealants N/A1 
 
  
                                                          
2 Medicine types and recording methods that were shown to be systematically different to the gold standard 
by repeated measures one-way ANOVA were not included for further analysis and are not presented in this 
table. 
Formatted: German (Germany)
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Table 5:5. Clinical interpretation of limits of agreement for each medicine type and recording method, when compared with 
the median total quantity for that medicine on each farm (n=27) as recorded by the gold standard.3 Based on differences of:  
>30% = poor agreement, 
 21-30% =reasonable agreement, 
11-20% = good agreement and 
0-10% = excellent agreement  
Recording 
method 
Medicine type Difference from 





Injectable antimicrobial -14 to 10 Good 
Intramammary antimicrobial -22 to 21 Moderate 
Other antimicrobial -148 to 124 Poor 
All injectables -113 to 85 Poor 
Vaccines -205 to 156 Poor 
Teat sealant -12 to 25 Moderate to good 
Medicine waste 
bins 
Injectable antimicrobial -27 to 17 Moderate to good 
Intramammary antimicrobial -63 to 106 Poor 
Other antimicrobial N/A2 
All injectables -112 to 89 Poor 
Vaccines -488 to 526 Poor 
Teat sealant N/A2 
 
5.5.1.2 Intramammary antimicrobials 
The mean quantity of intramammary antimicrobials measured was significantly different between at 
least two recording methods (F3,75 = 3.268, p < 0.03, p(GGe) < 0.0497). The mean quantity of 
intramammary antimicrobials measured by the gold standard method was not significantly different 
to the mean amount measured using veterinary sales (p = 0.999) or waste bin (p = 0.355), whilst it was 
significantly different to the mean amount measured using the medicine book (p = 0.043). 
                                                          
3   Medicine types and recording methods that were shown to be systematically different to the gold standard 
by repeated measures one-way ANOVA were not included for further analysis and are not presented in this 
table. 




Figure 5-3. Bland-Altman plot comparing veterinary sales data with gold standard data for intramammary antimicrobials in 
total number of tubes4.  
 
 
Figure 5-4: . Bland-Altman plot comparing transformed medicine waste bin data with gold standard data for intramammary 
antimicrobials in total number of tubes.4  
For 95% of farms, a measurement of intramammary antimicrobials by veterinary sales data would be 
between -148.10 tubes less and 147.07 tubes greater than a measurement by the gold standard 
                                                          
4 The y-axis represents the difference between the two named methods, and the x-axis represents the mean of 
the two methods. Dots represent the mean difference between the methods for each participating farm. The 
blue line represents the mean difference between methods across all farms and the red hashed line represents 
the 95% limits of agreement. 
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method. The Bland-Altman plot for veterinary sales vs. gold standard is shown in Figure 5-3 and 
statistics are reported in Table 5:3. The ICC of intramammary antimicrobials measured by veterinary 
sales compared with the gold standard is presented in Table 5:4 and showed excellent reliability. The 
clinical interpretation of the difference between the limits of agreement and the median gold standard 
use per farm represented moderate agreement (Table 5:5). 
The differences between waste bin measures and the gold standard were not normally distributed. A 
log transformation slightly improved the closeness of the distribution to normality. The Bland-Altman 
plot and statistics for log transformed data are shown in Figure 5-4 and Table 5:3, respectively. The 
limits of agreement derived from log-transformed data were back-transformed (antilog) to give limits 
for the ratio of the actual measurements (Bland and Altman, 1986). The antilogs of these 95% limits 
of agreement were 0.37 and 2.06. These limits indicate that for 95% of farms the quantity of 
intramammary antimicrobials recorded by the waste bin method will be between 0.37 and 2.06 times 
the quantity recorded by the gold standard. Thus, the waste bin measurement may differ from the 
gold standard measurement by 63% below to 106% above the gold standard measurement. The Bland-
Altman plot revealed a very large outlier (Figure 5-4). Removing this outlier solved the violation of 
normality and had a big impact on the limits of agreement (Table 5:3). After excluding it, the waste 
bin measurement differed from the gold standard measurement by 21% below to 15% above. As with 
injectable antimicrobials, when comparing the waste bin method to the gold standard, the differences 
were not normally distributed, which could lead to an overestimated size of the limits of agreement. 
Based on the clinical agreement measures defined in the Data Analysis section this equates to a 
moderate agreement. However, because the removal of outliers cannot be fully justified unless the 
outlier is considered to be incorrect, the data presented in Table 5:5 for clinical agreement is that of 
the full dataset, representing poor clinical agreement. Based on the ICC results presented in Table 5:4, 
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the reliability of intramammary antimicrobials measured by waste bins compared with the gold 
standard was moderate to good (0.789, 95% CI = 0.586 – 0.899, p < 0 .01).  
For intramammary antimicrobials, veterinary sales data estimated use to within one tube of the gold 
standard. The 95% limits of agreement again crossed zero (-148.1 to 147.07); as above, this illustrates 
that veterinary sales have the potential to over- or underestimate actual use of intramammary 
antimicrobials.  
Injectable and intramammary antimicrobials may be considered the most important PVM from a use 
surveillance point of view due to the current ESVAC requirements to collate and publish annual data 
on AMU (European Medicines Agency, 2017), and indeed these are the antimicrobials most commonly 
used (Veterinary Medicines Directorate, 2018c). In this study, the results for these two types of PVM 
were relatively straightforward and suggest that using veterinary sales data is a reliable way of 
estimating use, although sales data tends to underestimate use and can both under- or overestimate 
use. With an increasing number of years of data from veterinary sales, it is likely that the degree of 
over- or underestimation would decrease, and veterinary sales data would more closely approximate 
actual use over a longer time period. For example, medicines being used from or stored in the 
medicine cupboard would be more likely to be used over a longer time period. Medicine waste bins 
showed poor clinical agreement, although removal of the one outlier did improve this to reasonable 
agreement. Further studies with a greater sample size may help to show whether this outlier was 
incorrect or not.  
5.5.1.3 Other antimicrobials 
‘Other’ antimicrobials are also an important component of AMU surveillance, but the picture is 
complicated by the various different units of measurements, depending on what form the ‘other’ 
antimicrobial took. For ophthalmic ointments, measurement was on a per tube basis. Antimicrobials 
in powder form were measured per sachet, and in tablet or bolus form were measured per packet. 
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This makes it inherently difficult to compare the figures for ‘other antimicrobials’ with those for 
injectable or intramammary antimicrobials as the potential for over- or underestimation is likely to 
vary between these different presentations. However, it was decided that measuring for each 
different formulation was not possible owing to the sheer volume of data analysis required. 
Additionally, ‘other antimicrobials’ make up a small proportion of overall antimicrobial use, with 
injectable and intramammary antimicrobials known to be the most commonly used antimicrobials 
(Veterinary Medicines Directorate, 2018c, Hyde et al., 2017). Despite this, as it is valuable to be aware 
of the likely degree of over- or underestimation of these particular antimicrobials when measuring on-
farm AMU, their inclusion as a group is justified. 
There was a significant difference in the measurement of other antimicrobials across recording 
methods (F3,75 = 16.22, p = < 0.001). The quantities of other antimicrobials measured by the gold 
standard method were not significantly different to the quantities measured using veterinary sales (p 
= 0.467), whilst these quantities were significantly different to the quantities measured using the 
waste bin (p < 0.001) and the medicine book (p < 0.001). 
Veterinary sales data may give values between -66.54 units fewer to 55.77 units greater of ‘other’ 
antimicrobial than the gold standard method (Table 5:3). However, this result needs to be interpreted 
with caution because the differences between both methods were not normally distributed even after 
log transformation. As previously stated, the estimated limits of agreement tend to be too far apart 
rather than too close and should not inadvertently lead to the acceptance of poor methods of 
measurement. Based on the ICC results shown in Table 5:4, the reliability of other antimicrobials 
measured by veterinary sales compared with the gold standard was poor to good (0.727, 95% CI = 
0.481 – 0.867, p < 0 .01). Based on the clinical interpretation as shown in Table 5:5, agreement was 
poor. 
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5.5.1.4 All injectables 
The mean quantity of all injectable antimicrobials measured was significantly different between at 
least two recording methods (F3,75 = 15.41, p < 0.001, p(GGe) < 0.01). The mean amount of injectable 
product measured by the gold standard method was not significantly different from the mean amount 
measured using veterinary sales (p = 0.995) or waste bins (p = 0.829), whilst it was significantly 
different to the mean amount measured using the medicine book (p < 0.001). 
 
Figure 5-5. Bland-Altman plot comparing veterinary sales data with gold standard data for all injectable prescription 
veterinary medicines in total ml5.  
                                                          
5 The y-axis represents the difference between the two named methods, and the x-axis represents the mean of 
the two methods. Dots represent the mean difference between the methods for each participating farm. The 
blue line represents the mean difference between methods across all farms and the red hashed line represents 
the 95% limits of agreement. 




Figure 5-6. Bland-Altman plot comparing medicine waste bin data with gold standard data for all injectable prescription 
veterinary medicines in total ml.6 
 
For 95% of farms, a measurement of injectable antimicrobials by veterinary sales data would be 
between -8929.82 ml less and 6748.12 ml greater than a measurement by the gold standard method 
(Table 5:3). The Bland-Altman plot for veterinary sales vs. gold standard is shown in Figure 5-5. The 
ICC of all injectable products measured by veterinary sales compared with the gold standard is 
reported in Table 5:4 and showed excellent reliability. However, the clinical interpretation, as 
presented in Table 5:5, represented poor agreement. 
For medicine waste bins, 95% of farms would have a measure of all injectables between 8868.69 ml 
less and 7042.77 ml greater than a measurement by the gold standard method (Table 5:3). The ICC of 
all injectable products measured by medicine waste bins compared with the gold standard is reported 
in Table 5:4 and showed good to excellent reliability. However, the clinical interpretation as seen in 
Table 5:5 showed poor agreement.  
                                                          
6 The y-axis represents the difference between the two named methods, and the x-axis represents the mean of 
the two methods. Dots represent the mean difference between the methods for each participating farm. The 
blue line represents the mean difference between methods across all farms and the red hashed line represents 
the 95% limits of agreement. 




There was a significant difference in vaccines measured among recording methods (F3,75 = 17.43, p = 
< 0.001). The quantities of vaccines measured by the gold standard method were not significantly 
different to the quantities measured using veterinary sales (p = 0.590), or the quantities measured 
using the medicine waste bins (p = 0.170) whilst these quantities were significantly different to the 
quantities measured using the medicine book (p < 0.001). 
 
Figure 5-7. Bland-Altman plot comparing veterinary sales data with gold standard data for vaccines in total number of 
doses.7.. 
                                                          
7 The y-axis represents the difference between the two named methods, and the x-axis represents the mean of 
the two methods. Dots represent the mean difference between the methods for each participating farm. The 
blue line represents the mean difference between methods across all farms and the red hashed line represents 
the 95% limits of agreement 




Figure 5-8. Bland-Altman plot comparing medicine waste bin data with gold standard data for vaccines in total number of 
doses. 8.  
The Bland-Altman plot for veterinary sales vs. gold standard is shown in Figure 5-7 and for waste bin 
vs. gold standard is shown in Figure 5-8; statistics are reported in Table 5:3.  
Veterinary sales data may give values between 572.98 doses of vaccine below the gold standard 
method to 436.98 doses above it. Medicine waste bins may give values 1365.57 doses below the gold 
standard method to 1472.49 doses above it (Table 5:3). However, these results need to be interpreted 
with caution because the differences between both methods were not normally distributed even after 
log transformation. In such cases, the estimated limits of agreement tend to be too far apart rather 
than too close, and should not inadvertently lead to the acceptance of poor methods of measurement.  
The ICC of vaccines measured by veterinary sales data compared with the gold standard is presented 
in Table 5:4 and showed moderate to excellent reliability. The ICC of vaccines measured by medicine 
waste bins compared with the gold standard is also presented in Table 5:5 and showed good to 
excellent reliability. The clinical interpretation of both veterinary sales data and medicine waste bins’ 
                                                          
8 The y-axis represents the difference between the two named methods, and the x-axis represents the mean of 
the two methods. Dots represent the mean difference between the methods for each participating farm. The 
blue line represents the mean difference between methods across all farms and the red hashed line represents 
the 95% limits of agreement 
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agreement with the median gold standard measurement of use on each farm represented poor 
reliability (Table 5:5).  
When measuring vaccine use, there is currently no national recording or surveillance system, 
therefore data on use of these veterinary medicines is largely unavailable. In addition, not all vaccines 
are POM-V. Private veterinary practices have created their own PVM recording and benchmarking 
systems, although the ownership and sharing of this data is often contentious and validation of the 
data is difficult. However, RUMA’s approach to encouraging the responsible use of medicines includes 
the promotion of preventive medicine and alternatives to antimicrobials (Responsible Use of 
Medicines in Agriculture Alliance, 2017). An increasing use of vaccines should lower disease burden 
and reduce the need for antimicrobials. The inclusion of these other veterinary medicines in this 
analysis provides a basis for stakeholders when deciding whether to begin surveillance of vaccine use 
in the future. 
5.5.1.6 Teat sealants 
There was a significant difference in teat sealants measured among recording methods (F3,75 = 9.25, p 
= < 0.001). The quantities of teat sealants measured by the gold standard method were not 
significantly different to the quantities measured using veterinary sales (p = 0.193), whilst they were 
significantly different to the quantities measured using the waste bins (p < 0.05) and the medicine 
books (p < 0.05). 




Figure 5-9. Bland-Altman plot comparing veterinary sales data with gold standard data for teat sealants in total number of 
tubes.9  
Veterinary sales data may give values between 181.78 tubes of teat sealant below the gold standard 
method to 198.78 tubes above it (Table 5:3). However, this result needs to be interpreted with caution 
because the differences between both methods were not normally distributed even after log 
transformation. In such cases, the estimated limits of agreement tend to be too far apart rather than 
too close and should not inadvertently lead to the acceptance of poor methods of measurement. The 
Bland-Altman plot revealed one large outlier (Fig 5-9). Removing this outlier improved the closeness 
of the distribution to normality but did not solve the problem. However, this outlier had a big impact 
on the limits of agreement. After excluding this outlier, the mean difference became 26.04 (i.e. on 
average the veterinary sales data measures 26 tubes less than the gold standard) and the 95% limits 
of agreement were 49.50 tubes below the gold standard and 101.58 tubes above it. The ICC of teat 
                                                          
9 The y-axis represents the difference between the two named methods, and the x-axis represents the mean of 
the two methods. Dots represent the mean difference between the methods for each participating farm. The 
blue line represents the mean difference between methods across all farms and the red hashed line represents 
the 95% limits of agreement 
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sealants is presented in Table 5:4 and showed excellent reliability. However, the clinical interpretation 
of agreement showed poor agreement (Table 5:5). 
Teat sealant use is not currently a requirement of the VARSS report, although the new RUMA Targets 
Task Force AMU targets include a target to increase the use of mechanical teat sealants in dairy cattle 
(Responsible Use of Medicines in Agriculture Alliance, 2017). It is therefore likely that teat sealant use 
will be measured in a similar way to AMU in the UK dairy herd, and data on the best way to measure 
use is valuable. As shown in this study, veterinary sales data is again the best proxy for actual use when 
measuring teat sealants, although data in this study were very skewed by one farm. While it could be 
argued that removing this one farm with outlying data does not give a true picture, considering both 
the complete dataset and the dataset without this farm provides a more complete picture than either 
result alone. It is possible that this farm already had 12 months of teat sealant in stock at the beginning 
of the study, thus skewing the data by underestimating use for the period. Skewing of PVM use data 
in this way may be the norm on some farms and therefore should be taken into account and not 
omitted from the analysis, but only through a study with a larger dataset across a greater number of 
farms can this be known.  
 Differences in agreement by medicine type 
The type of medicine being measured had an effect on the reliability and agreement for both measures 
where ICC were calculated: veterinary sales data and medicine waste bins. As can be seen in Table 5:4, 
for veterinary sales data, injectable antimicrobials, intramammary antimicrobials all injectables, and 
teat sealants showed excellent reliability with ICC and 95% confidence intervals >0.9. However, when 
measuring vaccines, veterinary sales data showed moderate to excellent reliability with ICC 0.878 and 
95% confidence intervals 0.749 to 0.943; other forms of antimicrobial showed only poor to good 
reliability with ICC of 0.727 and 95% confidence intervals ranging from 0.481 to 0.867. When using the 
clinical interpretation seen in Table 5:5, the differences were more stark. Injectable antimicrobials 
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showed good clinical agreement, intramammary antimicrobials showed moderate agreement, teat 
sealants showed moderate to good agreement and the medicine types ‘other’ antimicrobials, all 
injectables and vaccines showed poor agreement.  
For medicine waste bins, the differences in statistical reliability between different medicine types are 
also shown. Injectable antimicrobials, all injectables and vaccines all showed good to excellent 
reliability with ICCs ≥ 0.9 and 95% confidence intervals between 0.790 and 0.966. Intramammary 
antimicrobials showed moderate to good agreement with an ICC of 0.789 and 95% confidence 
intervals of 0.586 to 0.899. ‘Other’ antimicrobials and teat sealants were shown to be systematically 
different and therefore showed no statistical reliability. For clinical agreement, as shown in Table 5:5, 
only injectable antimicrobials showed moderate to good agreement, while intramammary 
antimicrobials, all injectables and vaccines showed poor agreement, ‘other’ antimicrobials and teat 
sealants showed systematic differences and therefore no agreement.  
The differences seen between the measurement of different types of PVM are an interesting result. 
These differences may lie in a number of physical and social factors. Some of these differences may 
be explained by their different physical characteristics of the medicines (i.e. throwing away an 
intramammary tube or 100ml bottle of injectable product is easy and likely to be remembered, 
whereas throwing away a torn sachet of powder may be forgotten), the relative importance a 
farmer places on that medicine (antimicrobials may be seen as of greater importance than anti-
inflammatories and therefore recorded and disposed of more accurately), geographical location of 
use (intramammary antimicrobials are likely to be administered in the milking parlour and therefore 
near a bin and a whiteboard for record keeping whereas an eye ointment might be administered in 
the field, without ready access to a medicine bin or recording book). These differences between 
recording methods for different types of medicine require further work to investigate the factors at 
play.  
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 Method of measurement 
When compared against the gold standard, the three different methods of measurement showed 
varying levels of agreement. Each method of measurement was subject to a repeated measured on-
way ANOVA initially in order to determine whether any methods showed a systematic difference to 
the gold standard.  For all types of medicine measured, farm medicine records showed a systematic 
difference to the gold standard. As such, farm medicine record data could not be included in any 
further analysis beyond this initial stage, and for this reason results for this method is not reported 
alongside the other methods of measurement beyond the results of the ANOVA. 
The reliability between  methods was measured using the ICC which reflects the degree of correlation 
and agreement between measurements. This method has been used previously when comparing 
medicine waste bin use with farmer recall in a small study of Peruvian farms (Redding et al., 2014) and 
is advocated in Watson and Petrie’s 2010 review of the correct methodology for method agreement 
analysis (Watson and Petrie, 2010). However, as previously described in the Data Analysis section, the 
ICC shows statistical reliability but does not relate agreement to the clinical context. As such, it is 
important to pre-define acceptable clinical limits of agreement (Watson and Petrie, 2010), as was 
done in this study.  
5.5.3.1 Veterinary Sales Data  
Veterinary sales data showed the best levels of agreement with the gold standard when measuring all 
six different medicine types. Agreement was best - excellent reliability (ICC > 0.9) - when measuring 
all injectable PVM (ICC = 0.999), injectable antimicrobials (ICC = 0.998), intramammary antimicrobials 
(ICC = 0.995) and teat sealants (ICC = 0.976).  
Clinically, veterinary sales data also showed the best levels of agreement, with good agreement for 
injectable antimicrobials, moderate to good agreement for teat sealants and moderate agreement for 
intramammary antimicrobials. It showed clinically poor agreement with vaccines, all injectables 
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considered together and other antimicrobials, although still proved to be superior to the agreement 
for the other two methods for these medicine types. 
While veterinary sales data shows the best agreement with the gold standard, this does not mean it 
exactly represented the gold standard. While the fact that the limits of agreement cross zero in almost 
all instances means that veterinary sales data has the potential to exactly reflect the gold standard, 
this also means that in some other cases veterinary sales data can over- or underestimate actual use 
as measured by the gold standard. In general, the Bland-Altman plots showed an overestimation of 
use when measured by veterinary sales data, although the degree of overestimation varied between 
medicine type being measured.  
5.5.3.2 Medicine waste bins 
Medicine waste bins have been used in academic research to measure antimicrobial use on dairy 
farms (Redding et al., 2014, Nobrega et al., 2017, Saini et al., 2012). However, as presented in Chapter 
2, there has not been any validation of the levels of agreement between the data provided by medicine 
waste bins and the actual use of medicines on farms.  
The results of this study indicate that medicine waste bins show good to excellent reliability when 
measuring injectable antimicrobials, all injectables and vaccines, and moderate reliability when 
measuring intramammary antimicrobials; however, there was a statistically significant bias when 
measuring other antimicrobials and vaccines and therefore agreement could not be measured.  
Clinically, medicine waste bins showed moderate to good agreement for injectable antimicrobials and 
poor agreement for intramammary antimicrobials, all injectables and vaccines.  
This study is the first to show that while medicine waste bins do show moderate to good agreement 
with actual on-farm use for injectable antimicrobials, they are less accurate for the other types of 
medicines. This study has also demonstrated that the data provided by medicine waste bins was 
inferior to that provided by veterinary sales data when compared with the gold standard. Medicine 
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waste bin audits were also more time-consuming, labour-intensive, and required greater farmer 
acceptance and compliance. Their use may be justified and potentially preferable in cases where 
obtaining veterinary sales data is difficult due to its non-existence or data protection issues, but, in 
most instances using veterinary sales data in the UK context would be the superior method of 
estimating use.  
5.5.3.3 On-farm medicine records 
The results of this study show that on-farm records are not currently a good proxy for on-farm PVM 
use because their measures have been shown to be statistically different to the gold standard for all 
medicine types studied. This may initially appear counter-intuitive, as farm assurance requirements 
for on-farm medicine records should mean they provide detailed and accurate data that is temporally 
correct and therefore superior to other sources of use data. However, as shown by previous literature 
and known anecdotally by many veterinary surgeons and farmers, on-farm medicine records are often 
seen as an unnecessary bureaucratic burden and of little value to farmers (Escobar, 2016). The 
variability and inaccuracy of the on-farm medicine records in this study may be attributed to the lack 
of value that farmers place on medicine records, as shown by Escobar and others (Escobar, 2015). 
Where farmers do not believe in the intrinsic value of record-keeping, they are unlikely to prioritise 
maintaining those records.  
Given the results of this study, it is suggested that work needs to be done to improve the quality of 
farm medicine records before such data can be relied upon to measure antimicrobial or PVM use; for 
instance, providing farmers with easy-to-use data entry platforms that are integrated with veterinary 
sales and cattle movement records. There are published studies which have relied solely on farm-
based records for quantifying antimicrobial use in countries other than the UK (Stevens et al., 2016, 
Gonzalez Pereyra et al., 2015), and further research is necessary to ensure the validity of these data. 
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Farmers are now required to submit antibiotic usage data annually for farm assurance purposes (Red 
Tractor Assurance, 2017) and AHDB are currently piloting eMB Cattle (personal communication) which 
will include the ability to submit antibiotic usage data online. If these data are to be used in the future 
for AMU surveillance, it is important to acknowledge and attempt to mitigate the current poor quality 
of farmer-recorded data. However, it is possible that simply through providing a streamlined, uniform 
data submission process, data quality may improve. It is also possible that data quality would 
deteriorate through false recording, particularly if the record kept were to be used for benchmarking 
and target-driven bonuses or penalties. It is therefore essential that the quality of the data being 
entered into any potentially mandatory new recording system be fully measured and validated.  
 Limitations 
The relatively small number of farms involved in this study mean that there is a risk of bias from 
outliers and the potential that these farms do not represent the wider sample population. Despite 
this, the number of farms was in excess of that required by the sample size calculation in order to 
show an expected excellent reliability. While it has been suggested that, as a rule of thumb, 30 
heterogeneous samples should be taken in order to calculate ICC (Koo and Li, 2016), it has elsewhere 
been suggested that sample size can be calculated based on the expected ICC and the lower 
acceptable limit of the 95% confidence interval (Walter et al., 1998) which was used in this study and 
the minimum sample size surpassed. The limitations of non-normal data, the removal of outliers and 
data transformation have been discussed individually as they occur in this section. 
With the different recording methods, there were several areas for potential discrepancies. Bin use is 
farmer-dependent and relies on the farmer remembering to use the bins and using them correctly. 
This means that there is a chance that some conscientious farmers were more likely to use the bins 
regularly and accurately. Conversely, a farmer forgetting to (or choosing not to) use the bins would 
have affected the results. It is difficult to say whether farmers who used the bins less well also 
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maintained less accurate on-farm medicine records due to the small sample size of this study, although 
this is a possibility and could have introduced bias into the study.   
Another limitation of this study, it could be argued, was the number of different formats in which the 
on-farm medicine records were presented. Farmers were asked to provide “their normal medicine 
records, in the way they would normally record them”. This ranged from detailed computerised 
records linked to individual cow identification and tag numbers through to pencil marks written on 
the side of a bottle. While these different formats mean data were recorded with varying degrees of 
detail, this was a true reflection of the real “on-farm” data present and, as such, it was part of the 
study design to accept on-farm records in all forms. The alternative would have been to provide a 
standardised medicine record format; however, this would have the potential to change the recording 
behaviour and would not have reflected true practice.  
Similarly, veterinary practice data was made available in various formats. These were all computerised 
records, with some practices sending through Excel (Microsoft Office 365) spreadsheets and others 
sending through scanned print-outs of invoice data. Although these differing formats made data 
assimilation more time-consuming and painstaking, it was not believed that this had an effect on the 
quality of the data collected.  
Developing a “gold standard” for PVM use was necessary for this study in order to have a comparator 
for the three methods of recording, none of which had previously been validated. The definition of 
gold standard used for this study was: “a benchmark that is the best available under reasonable 
conditions. Indeed, is not the perfect test, but merely the best available one that has a standard with 
known results. This is especially important when faced with the impossibility of direct measurements.” 
(Cardoso et al., 2014). The actual “ground truth” use of PVM on farms is almost impossible to directly 
measure over a 12-month period without direct observation. Through discussion with a data scientist 
and epidemiologists, the gold standard used in this study was agreed to be the best available measure 
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under reasonable circumstances. This gold standard is itself open to bias, given that it is based on 
veterinary sales data combined with on-farm inventories. If a farm were to source PVM elsewhere, or 
PVM were somehow omitted from the initial or final inventory, this would affect the gold standard 
use value. Sourcing PVM elsewhere appeared not to be a major factor on participating farms; farmers 
were asked whether they used more than one veterinary practice or procured PVM from other sources 
- PVM on farms were generally labelled by the prescribing practice and there was only one instance 
of a foreign PVM being found on a participating farm. PVM inventories were carried out diligently, and 
as set out in Chapter 4 Section 3, therefore the risk of omitting PVM was kept to a minimum. 
Several assumptions were made when collecting and analysing the data, as laid out in Chapter 5 
Section 3. Where labels had perished on PVM items found in waste bins and the type of medicine was 
unidentifiable, these PVM were disregarded. Although the number of medicines this applied to was 
small (n=14), this would still lead to an underestimation of PVM use based on medicine waste bin data. 
Where PVM items in the inventories or in the medicine waste bin were opened and contained some 
remaining medicine, the quantity remaining was estimated to the nearest 10% by eye. Ideally, it would 
have been possible to obtain reference weights for each PVM type and use a portable weigh scale to 
more accurately estimate the quantity of PVM remaining. Estimation by eye was used due to the 
speed and simplicity of these estimations, although over- and underestimation of actual medicine 
remaining was possible. Final inventory visits and bin collections were carried out on the 12-month 
anniversary of the study +/- 3 days. This led to a potential 6-day difference in the length of time some 
farms were studied, although it was assumed that this would be unlikely to significantly affect the 
farm’s medicine recording given that for each farm the veterinary sales data and on-farm medicine 
records were measured for the same time period as the bins were present. 




The use of veterinary sales data as a proxy for actual on-farm use of PVM is justified based on the 
results of this study. While there were some limitations to the study, these were largely mitigated 
against and, given its exploratory and original nature, these results could be used as evidence to 
inform policy decisions until further research can validate the findings.  
The acceptable limits of agreement between different recording methods when measuring medicines 
are a clinical, not statistical, decision. This explains the occasional disparity between the statistical 
determination of agreement as shown by the ICC, and the clinical interpretation of agreement when 
measuring different types of medicine. Whether a method agrees with the gold standard is important. 
However, whether the level of agreement represents what would be clinically acceptable when 
measuring veterinary use is more important. 
Since the gold standard is not currently a feasible way of measuring actual use of veterinary medicines 
on farms, veterinary sales data provides the best available proxy for use, with the best available levels 
of statistical and clinical agreement. Medicine waste bins provide acceptable levels of agreement with 
the gold standard when considering injectable and intramammary antimicrobials. On-farm medicine 
records do not provide acceptable levels of agreement with gold standard measures of use for any 
medicine type. 
 Future work 
The results of this study should be seen as “pilot data” to inform further research designed to validate 
veterinary sales data and on-farm medicine records as proxies for actual PVM use. Further research 
should include a larger study with a greater number of farms, distributed across the UK in order to 
assess the generalisability of the results. It would also be useful to repeat this study on different types 
of farms where data on medicine records and PVM use is even less available, namely beef farms, sheep 
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farms, mixed holdings and small-holdings. It would also be useful to conduct similar research in other 
countries, in order to assess the similarities or differences between recording methodologies 
internationally. Previous published research quantifying AMU on farms have relied on farm-based 
medicine records (Stevens et al., 2016, Hyde et al., 2017, Gonzalez Pereyra et al., 2015), and it is vital 
that more research is undertaken to assess the validity of these data internationally. 
If and when a new computerised medicine book is introduced for use in UK cattle farming, it would be 
very useful to conduct similar research in order to evaluate the potential impact of a nationally 
coordinated online recording method for farmer-inputted data. The results of this study do not 
support the use of on-farm records in their current form due to the fact that they do not agree with 
the gold standard for use. There is, however, much potential for improved quality of data with an 
improved data collection system.  
 Policy implications 
The current move towards using veterinary sales data as a proxy for on-farm medicines use appears 
to be justified based on the results of this study. Further work to validate these results and the ongoing 
implications for national recording is required. The use of medicine waste bins in academic studies 
appears to be justified when measuring injectable and intramammary antimicrobials. The use of 
medicine waste bins also represents the best alternative method of recording use when veterinary 
sales data are not available.  
Despite the potential for more temporally accurate and granular data to be available through the use 
of on-farm medicine records, the results of this study indicate that these data are not currently of 
good enough quality to be used as a proxy for actual use on dairy farms. It is important that before 
any decisions are made to move towards using this form of data collection, efforts are invested in 
improving the quality of these records and validating the data. 












Chapter 6 Towards understanding the values of dairy farmers that 
influence treatment decisions and medicine-use practices 
 
  











The use of prescription veterinary medicines (PVM) on UK dairy farms is complex. Understanding the 
way in which PVM are used through quantitative means alone is limited. By using qualitative research 
methodologies, it is possible to begin exploring the context and meaning behind treatment decisions, 
in addition to the beliefs and motivations driving those treatment practices.  
In this study, three North Somerset dairy farms were enrolled to a 12-month participant observation. 
Additionally, 20 semi-structured in-depth interviews were conducted with dairy farmers from South 
West England and South Wales. Qualitative data were collected in the form of interview transcripts 
and ethnographic fieldnotes. These data were analysed qualitatively, using iterative-inductive 
thematic analysis.  
Four key themes were identified that had a direct or indirect relevance to medicine use and treatment 
decisions: knowledge, trust, autonomy of treatment practices and a duty of care. These themes 
contain several sub-themes which relate to specific values and practices observed or discussed on the 
participating farms. The study highlights important areas for focus when aiming to influence or 
improve medicine use on dairy farms, both for policy makers and the veterinary profession.  
  





Veterinary medicine use on UK dairy farms is complex and can only be partly understood through 
quantitative means. Improving our measurement of the medicines prescribed by veterinary surgeons, 
while crucial, is only one piece of the jigsaw. In order to create as complete a picture as possible, the 
subject must be explored through multiple methodological lenses (Buller et al., 2015).  
For example, consider a single antimicrobial: oxytetracycline. Knowing that a farmer purchases 15 
bottles of oxytetracycline injectable solution in a year, when previously he or she had purchased 2-3 
bottles per year is important. However, simply measuring the quantity purchased does not explain to 
us why this farm’s need for this antimicrobial has increased so dramatically. While the veterinary 
surgeon may, and indeed should, have some insight into the reasons for such an increase, these 
reasons are usually only superficially measurable in a quantitative way. Only by speaking to the farmer 
and being present to observe the daily use of this antimicrobial can the picture be informed with the 
richness and detail required to understand the reasons and drivers of actual antibiotic use. Many 
veterinary surgeons are perhaps lay-ethnographers in this respect; they gain their in-depth 
understanding of a farm through multiple interactions with the farmer. By questioning, participating 
in and observing the operation of the farm, the veterinary surgeon builds a picture of the context and 
the culture of the farm and thus begins to understand the complexity of medicine use practice. 
However, because most veterinary treatments on dairy farms are administered in the absence of the 
prescribing veterinary surgeon, the current study has focussed instead on the treatment decisions and 
medicine use practices of farmers in order to build a picture of the on-farm cultures and practices 
when the farm veterinary surgeon was not present.  
This thesis argues that these on-farm cultural practices and the contexts within which treatment 
decisions are made by individual farmers are of equal significance to quantitative epidemiological data 




relied upon so heavily by veterinary research and government policy, as discussed in Chapter 2 (2.4.1). 
Management practices on farms depend on the unique circumstances experienced by different 
farmers, along with their goals and values (Ritter et al., 2017).  Indeed, there may be no obvious logical 
reason for management decisions made by farmers when viewed by the outside observer (Kristensen 
and Jakobsen, 2011). As such, in order to develop effective policy interventions and knowledge 
exchange programmes, and promote productive communication, it is necessary to improve our 
understanding of how treatment decisions are made, how practices of medicine use are engaged 
across the unique circumstances on individual farms, and to explore farmers’ goals and values.   
The Health Belief Model (Janz and Becker, 1984) and Theory of Planned Behaviour (Ajzen, 1991) - 
discussed previously in Chapter 2 - are certainly over-represented in qualitative enquiry of farmer 
behaviour (Buller et al., 2015, Ritter et al., 2017). This thesis posits, as others have, that the limitations 
of those constructs can lead to an incomplete understanding of the situational contexts and cultural 
practices that determine medicine use (Buller et al., 2015).  
The government regulations, the economic pressures, and the farm assurance and disease 
surveillance programmes to which a farm is subject - which can be described as the wider farming 
context - are constantly changing. In addition, the narrower context of staffing, weather, animal health 
and the personal lives of farmers, along with numerous other factors, are in continuous flux. Since the 
farmer’s context can affect their decision making (Ritter et al., 2017), it is therefore vitally important 
that research into decision making on farms is capable of including and reflecting upon the impacts of 
these contextual variations. 
By using an ethnographic approach, this research observed and analysed farmer behaviour as it 
occurred. Ethnography has been described as being able to examine “social life as it unfolds, including 




looking at how people feel, in the context of their communities” and provides an understanding of 
“social life as the outcome of the interaction of structure and agency through the practice of everyday 
life” (O'Reilly, 2012, top of page 1). Ethnography has the advantage of the researcher being present 
and asking questions for a prolonged period of time, believing that “relevant and interesting 
information is more likely to surface in informal context than in formal interview settings” (Pool and 
Geissler, 2005, top of page 16). There is a difference between what people say, what they think, and 
what they do, and it has been argued that ethnographic research is best placed to understand these 
differences (O'Reilly, 2012, Lambert and McKevitt, 2002).  
The aim of the study presented in this chapter was to improve understanding of the practice of 
veterinary medicine use, by exploring the values, motivations, culture and practices of UK dairy 
farmers when using PVM. Ethnographic in nature, the study involved 20 UK dairy farmers taking part 
in semi-structured qualitative interviews (n=20) along with a 12-month participant observation study 
conducted across three UK dairy farms (n=3).  
This chapter will describe the research methods used, outline the four key themes which have 
emerged from the data and discuss their relevance to the current literature, their implications for 
policy and the areas where further research may be required.  
 Materials and Methods 
As discussed in detail in Chapter 3, ethnography as a methodology can take many forms through the 
use of different research methods. The most common and fundamental research method used in 
ethnographic research is that of ‘participant observation’, while semi-structured in-depth interviews, 
focus groups and other qualitative research methods can all contribute to the overall methodological 
approach. 




In the study described in this chapter, participant observation and semi-structured in-depth interviews 
were performed concurrently rather than sequentially. That is, while they occurred at different times 
and on different farms, participant observation visits took place on three farms over the course of 12 
months and were interspersed with visits to collect semi-structured in-depth interviews from other 
farms, in order that through reflexivity the participant observation could inform the interviews and 
vice versa. Recruitment of farms, ethical approval and participant consent for the research are 
described in detail in Chapter 3 and, where necessary, are expanded upon below.  
The positionality of the researcher is of great importance when conducting ethnographic research.  In 
this instance, the researcher and author (GR) was a veterinary surgeon with a background in farm 
animal and equine practice, although she was no longer in clinical practice. However, the researcher’s 
veterinary qualifications were not volunteered to participants; instead she introduced herself as a 
research student from the University of Bristol. Where participants enquired further, her veterinary 
qualifications were not concealed.  
 Semi-structured in-depth interviews 
Participants for this study were recruited as described in Chapter 3. Briefly, veterinary practices in the 
study area (South West England and South Wales) were approached and asked to nominate dairy 
farmers to take part in a 12-month mixed-methods study investigating PVM use. Twenty-seven 
farmers were recruited to the wider study using maximum-variation purposive sampling, along with 
two farmers who were recruited to the pilot study (n=29). All 29 farmers were invited to participate 
in a semi-structured in-depth interview exploring their beliefs, values and motivations about 
veterinary medicine use. Of these 29 farmers recruited to the wider study, 27 agreed to take part in 
the interviews. For those who declined to be interviewed (n=2) the reasons given were a “lack of time” 




(n=1) and being “too shy to be recorded” (n=1). From the pool of remaining participants, 20 farmers 
were interviewed once by the author (GR) over the course of 24 months. 
Interviews began with the two participants involved in the pilot study. After this, interviews took place 
in clusters of three to five interviews at a time according to the schedules of both the participants and 
the researcher (GR). Participants were not interviewed in any predetermined order other than 
occasionally being arranged according to geographical location where the researcher was likely to be 
at the opportune time. As described in Chapter 3, interviews were conducted on the participants’ 
respective farms. Interviews were usually conducted at the kitchen table or farm office with a cup of 
tea: however five interviews were collected out on the farm, either in the dairy, on the farmyard or in 
the cow shed. Participants were reminded at the commencement of the interview that it was to be 
recorded and their permission for this was requested at each and every interview. The interview was 
presented as a relaxed and far-ranging chat about their opinions and thoughts on various aspects of 
medicine use. It was stressed at this point that there were no right or wrong answers and that 
participants should feel free to ask questions for clarification at any point, as well as suggest other 
areas for discussion. The researcher (GR) introduced herself as a researcher from the University of 
Bristol and did not disclose unless asked that she was a veterinary professional.  
Interviews broadly followed the topic guide in Appendix 9; after the initial 3-4 interviews, however, 
the guide was only referred to towards the end of the interview to ensure all areas of interest to the 
researcher had been covered. Participants were found to be very forthcoming in the main, and often 
the topic guide was not necessary as the interview would naturally cover the areas of interest 
following a few introductory questions. Interview participants were in general very open to discussing 
the topics covered and seemed to enjoy the process. Indeed, several remarked on how pleasurable 
they had found being interviewed.   




Following each interview, fieldnotes taken at the time were expanded upon to include reflective 
descriptions of the interview location, any additional persons present or interruptions to the 
interview, the researcher’s overall perception of the openness, tone and attitude of the participant 
during the interview and any relevant themes or ideas from the interview that warranted further 
exploration.  
All interviews were sent for “intelligent verbatim” transcription by the University’s recommended 
transcription services (Bristol Transcription Services Ltd.). This form of transcription edits out 
repetitions and fillers such as ‘ummm’ or ‘aaahh’ while transcribing all of the interview content. Once 
received as Word documents (Microsoft Office 365), the researcher (GR) read through the transcripts 
while simultaneously listening to the audio recordings in order to detect and correct any inaccuracies 
or misunderstandings. This was especially important and took a considerable length of time given the 
technical nature of the conversations about medicines and disease, and due to the pronounced and 
varied regional accents presented. Transcripts were cleaned and anonymised at this stage (i.e. where 
names or identifiers were used during the interview, these were replaced with generic descriptors, 
e.g. the veterinary surgeon’s name was replaced as [main vet]). 
As discussed in Chapter 3, the qualitative analysis within this thesis was iterative-inductive, drawing 
on Braun & Clarke’s Thematic Analysis (Braun and Clarke, 2006) and Glaser & Strauss’ Grounded 
Theory (Glaser and Strauss, 1999). As such, no formal framework or initial hypothesis was set at the 
outset, although certain questions and areas of interest were outlined and a level of a priori knowledge 
and set of assumptions were present. The resulting themes are therefore largely grounded in, and 
have emerged from, the data itself. This approach, commonly used in the qualitative social sciences, 
has the benefit of allowing for exploration of previously unknown areas without the constraints of an 
a priori hypothesis. While grounded theory advocates a complete lack of prior knowledge or reading 




around a subject and has a pre-determined model for how data collection and analysis should occur, 
in reality this is very difficult (Timonen et al., 2018). Additionally, grounded theory is a ‘theory-
generating’ research methodology whereas this study does not seek to generate theory specifically 
but rather to describe the values and cultures present amongst dairy farmers as a basis for further 
research. Here, a more pragmatic approach was taken and, while the results are very much emergent 
from, and grounded in, the data, the analysis itself broadly followed the description of thematic 
analysis put forward by Braun & Clarke (Braun and Clarke, 2006) while aligning with the epistemology 
of ethnographic research as laid out in Chapter 3.  This provides a more flexible approach to analysing 
qualitative data and seeks to identify and describe patterns and themes across an entire dataset. 
Once the first ten interviews had been collected, transcribed and anonymised, transcripts were 
imported into a computerised qualitative data analysis software (QSR Software, NViVo 10) for data 
analysis to begin. Interviews were individually assessed, and the content was coded whereupon 
sections of text which referred to a certain topic or thought were tagged with a code representing that 
topic or thought. Sections could be tagged multiple times where it was felt that the key content 
covered more than one topic of interest. These codes were inductive, with a coding framework being 
developed from the initial five interviews and then refined over the course of analysis of the remaining 
data. Interviews continued, and data collection and analysis occurred concomitantly and iteratively 
with the emerging themes from the initial interviews being further explored and examined as 
interviewing progressed and as the researcher’s insight evolved.  
Interviews were analysed in groups of two to three from this point, as and when they were conducted. 
Once 20 interviews had been collected and analysed, it was determined that “data saturation” had 
been achieved and interviews ceased. Data saturation is defined as the point in qualitative research 
where the collection of further data contributes no further trends or themes than those already 




apparent from previous data analysis (Kuper et al., 2008). In reality, data saturation is more of a 
conceptual notion than an absolute reality. With every interview something novel will emerge, and it 
is likely that there is never a point where nothing new can be learned. It is however possible to reach 
a point where the key themes are largely unchanged with each progressive interview, at which time 
data saturation can be said to be achieved.  
All interviews were coded by the researcher who had conducted them (GR). Initially, open coding was 
conducted of the transcripts. During this process, memos were kept of interesting themes that 
appeared to emerge and areas to explore further. Once the initial open coding of interviews had taken 
place, axial coding was performed to identify relationships between codes (Corbin and Strauss, 2015). 
Codes were placed into sub-themes where the researcher felt they were on a related topic. From 
further analysis of these sub-themes, five main themes emerged which are discussed in the Results 
section of this chapter.  
To ensure rigour, 10% (n=2) of interview transcripts were coded independently by a second 
postgraduate research student (LM) familiar with the process of thematic analysis. Both researchers 
then compared and contrasted the coding labels that had been developed to establish whether they 
captured the data in a comparable way. Although the specific names of codes differed between 
researchers (as is inevitable when coding independently), it was agreed that codes were broadly 
comparable and captured the same essence of the meanings of the data. Additionally, once axial 
coding and an initial template for emergent themes was reached, the researcher (GR) used member 
checking (Kuper et al., 2008), discussing these findings with the key informants involved in the 
participant observation to assess whether the results reflected their experiences. Participants agreed 
that the themes did accurately reflect their own experiences of medicine use and treatment decisions. 




A total of 20 interviews were collected, with a mean length of 49 minutes and 59 seconds (Range 26:20 
– 77:32). A summary of the participant characteristics can be seen in Table 6.1. Briefly the participants 
farmed in 7 different counties in England and Wales. The majority farmed Holstein-type dairy cows. 
The median age bracket of participants was 41-50 years of age; 17 participants were male and three 
were female. The participants farmed a median of 230 (Range 80 - 490) adult dairy cows and produced 
a median of 1,900,000 (Range 550,000 – 3,600,000) litres of milk annually.  
  




















1 18-30 M Somerset 230 2,000,000 Holstein N/A 
2 18-30 M Somerset 230 2,000,000 Holstein N/A 
3 51-60 M Somerset 180 2,100,000 Holstein Good 
4 18-30 M Swansea 100 650,000 Holstein Poor 
5 51-60 M Dorset 80 550,000 Mixed Good 
6 41-50 M Wiltshire 320 1,900,000 Holstein Good 
7 41-50 M Somerset 220 1,900,000 Holstein Poor 
8 >60 M Somerset 180 630,000 Jersey Good 
9 31-40 M Carmarthenshire 80 650,000 Holstein Variable 
10 41-50 M Wiltshire 470 3,600,000 Holstein Good 
11 41-50 M Dorset 490 3,500,000 Holstein Good 
12 51-60 M Somerset 150 1,500,000 Holstein Poor 
13 41-50 F Carmarthenshire 110 500,000 Jersey Variable 
14 31-40 M Carmarthenshire 280 1,500,000 Friesian Poor 
15 51-60 M Somerset 340 3,000,000 Holstein Poor 
16 18-30 F Somerset 360 2,100,000 Holstein Poor 
17 51-60 M Hampshire 180 1,300,000 Ayrshire Good 
18 41-50 F Somerset 280 1,700,000 Guernsey Good 
19 51-60 M Pembrokeshire 220 1,800,000 Holstein Poor 
20 >60 M Somerset 80 900,000 Friesian Poor 
                                                          
10 Medicine records were rated Good/Variable/Poor by the researcher depending on availability of complete 
records throughout the study and presence of records for all PVM. Where N/A, this farm was not a part of the 
wider medicine audit and medicine record quality could not be ascertained. 





 Participant observation  
As described in Chapter 3, participant observation is “the process enabling researchers to learn about 
the activities of the people under study in the natural setting through observing and participating in 
those activities” (Kawulich, 2005, Section 2: Definitions). Three farms from the 27 initially recruited to 
the project were selected for the more intensive year-long participant observation. These farms were 
purposively selected based on location (within 30 minutes of Bristol Veterinary School), size and 
management type. It was also decided that all three farms would ideally be under the care of one 
veterinary practice in order to minimise the differences in veterinary advice and veterinary medicines 
available to the farmers. To reflect as broad a range of dairy farming practices as possible, it was 
decided a priori that farms would be recruited for participant observation through maximum variation 
sampling to include one relatively small family farm, one average-sized farm and one larger farm which 
employed a herd manager.  
Once these farms had been identified, a request was made during the initial recruitment visit for 
consent to allow the researcher (GR) to visit the farm regularly over a 12-month period for participant 
observation. A key informant was identified on each of the three participating farms and was the main 
point of contact with the researcher to arrange field visits. All three identified farms consented to this 
additional involvement and specific Participant Information Sheets and Consent Forms (Appendices 2 
& 3) were left at each farm for a cooling off period of 14 days before being returned to the researcher.  
  













Total annual milk 
production (litres) 









A 360 140 2,100,000 3 1 1 
B 600 210 4,000,000 4 7 3 
C 75 6 613,000 4 0 0 
 
Visits were arranged by telephone call or text message between the researcher and the key informant. 
This communication was mostly informal, and key informants would send the researcher a message if 
they thought an event of interest was taking place on the farm. Similarly, the researcher would 
maintain regular contact by telephone between visits to discuss any important changes or news to do 
with the farm, to arrange subsequent visits and generally keep up-to-date. The key informant was not 
necessarily the person that the researcher would spend time observing during the visits, and this 
depended on the number of staff, the duties being carried out and the time of day the visit occurred. 
Across all farms the researcher spent time with every member of family or staff who played a regular 
role in animal health and treatment decisions.  
It had been decided between the researcher (GR) and the PhD supervisory team (KR, DB, HB, HL) that 
initial participant observation visits would be undertaken during morning milking, as discussed in 
Chapter 3. Morning milking was identified by each key informant on each participating farm as being 
the time of day where disease was most likely to be identified and diagnosed, and where treatment 
decisions were most likely to be made. Morning milking occurred at 4am, 5am and 7.30am across the 
three participating farms. Calf management and feeding took place on all three farms after morning 




milking had finished, and therefore the majority of participant observation visits took place for the 
entire morning milking period plus calf management and feeding, usually finishing around midday. On 
occasion, visits were targeted at afternoon milking or specific days and times where the researcher 
had been notified of an event of interest (e.g. a tuberculosis test, vaccination of youngstock, a busy 
calving period, etc.).  
Visits lasted a mean of seven hours and occurred approximately once a month, although this was 
tailored to the particular circumstances of the farm. For example, one of the farms had a seasonal 
calving herd, where the farm aimed to calve around 400 of the cows and heifers in a 6-week period in 
the spring. During this period, the researcher increased the visit frequency to every three weeks in 
order to capture the predicted increase in treatment decisions during the calving and immediate post-
calving periods. At other times during the year visits were less frequent, occurring once every six to 
eight weeks.  
Upon the researcher’s return to the office following a field visit, ethnographic fieldnotes were 
expanded upon and written up in a narrative fashion. A personal observation journal was also kept, 
and these narrative fieldnotes and personal logs were often referred to and re-read during the course 
of the 12-month study. In this way, analysis of the participant observation was iterative and cyclical in 
nature. Areas of interest from previous visits could be identified and highlighted for further 
exploration at subsequent visits, informal interviews could explore possible themes and questions 
emerging from the data, and theories could be tested. Fieldnotes were coded in a similar way to that 
described for the semi-structured in-depth interviews above, however fieldnotes were kept in a 
written not computerised form and codes were applied to the notes in situ in the dedicated 
notebooks.  




 Data Analysis 
Although data analysis has been described separately in the above sections on the semi-structured in-
depth interviews and the participant observation, in reality analysis occurred concurrently and was 
inextricably linked. Analysis and data collection for both methodologies occurred iteratively and 
inductively. Themes which emerged from the earlier interviews were explored and tested during 
participant observation, and themes which emerged during the participant observation were explored 
and tested during later semi-structured in-depth interviews. The analysis presented therefore draws 
upon the material generated from both methods. As distinctive themes emerged from both interviews 
and participant observation, these were explored further during subsequent visits and refined during 
the analysis. Certain themes proved insufficiently substantial for further consideration while others 
formed the basis of the following analysis. 
 Results and Discussion 
Over the course of this research, drawing upon the interviews, the participant observation and the 
subsequent data analysis of both, four key themes appear to strongly account for the practices of 
treatment decision making and PVM use on the farms investigated. These were the farmers’: 
• knowledge and understanding of the treatment of disease,  
• conditional trust in the actors involved in the treatment process,  
• treatment practices and the frameworks within which they occur, and  
• sense of duty to the care and wellbeing of their animals.   
Each of these were seen to directly or indirectly affect the observed treatment decisions and practices 
being carried out over the year-long participant observation.  Each will now be discussed in turn. 





“Father's said many a time you're never too old to learn if you're not too stubborn to listen.” – 
Farmer 5 
Knowledge has become a value-laden term in epistemology, however in this context the knowledge 
that farmers speak of refers to what they see as the positivistic “truths” about the physiology and 
pathology of disease processes, medical pharmacology and the management of animal health. 
Farmers have an acute awareness of the limitations of their ‘formal’ knowledge yet rely strongly on 
experiential and experimental knowledge that can, on occasion, put them at odds with the more 
‘evidence-based’ medical knowledge of their veterinary surgeons.  
Within the overall theme of knowledge, four clear dimensions are discernible as presented in the four 
sub-sections below. Here the four dimensions of knowledge are teased out: experiential, 
experimental, uncertainty and conceptualisation. 
6.4.1.1 Experiential knowledge 
Experiential knowledge describes the impact of past experience on farmers’ current knowledge about 
farming, disease and treatment. The majority of farmers interviewed had many years of experience in 
dairy farming, and in agriculture more generally, and would regularly refer to their previous 
experiences when discussing treatment or management choices. This experiential knowledge was 
used in many contexts to justify treatment decisions, in particular where those decisions may be 
considered contentious or going against their perception of the social norm.  
Experiential knowledge was most commonly articulated in the form of anecdotal evidence of previous 
treatment successes or failures, as has been described in other work (Hektoen, 2004). The outcomes 
of previous treatment decisions proved to be a key factor in the decision to treat, which medicine to 




use, and in what quantity. This can be described as a degree of ‘path dependency’, where decisions 
follow a pathway laid down by the perceived success or failure of previous decisions. As one farmer 
succinctly put it: 
“It's worked in the past so why shouldn't it work in the future?” - Farmer 5 
Equally, where a treatment has failed to ‘work’ (i.e. has failed to result in recovery from disease) it is 
written off as ineffective and a farmer would not consider using it again under normal circumstances. 
Interestingly, one farmer did reflect on this practice and appeared to accept that the medicine may be 
effective despite the treatment failure: 
“No, never found it worked but it probably does and it just could be just that I’ve tried it, didn’t work 
on one animal and I’ve just kind of thought, this doesn’t work. You kind of get used to certain tubes 
and how easy they are to apply sometimes as well.” - Farmer 17 
This quote also demonstrates that experiential knowledge is not only rationalised, it is also embodied. 
For example, how ‘easy to apply’ a medicine may be is learned from past experience and can also 
contribute to the perception of prior successful use, rather than simply the effectiveness of the 
treatment in inducing recovery from disease.  
There is a well-known phenomenon of confirmation bias whereby new evidence tends to be used to 
confirm one’s existing beliefs (Nickerson, 1998); it is known to affect the treatment decisions of human 
medical clinicians (Saposnik et al., 2016) as well as veterinary surgeons (McKenzie, 2014). In dairy 
farming, there is little published specifically on the influence of anecdotal evidence on treatment 
decisions, however Swinkels’ (2015) work on mastitis treatment touches on the subject. Equally, in 
medical anthropology the distinctions between the experience-based knowledge of healthcare 




professionals and those of non-professionals are well-documented, with both ‘formal’ and ‘informal’ 
knowledge playing an important role (Pool and Geissler, 2005).  
More generally, farmers believed their own experiences of dairy farming to be of great value to 
themselves, their animals and their farms (Buller and Roe, 2016). It is important to note that 
experiential knowledge was not always limited to that individual’s experiences, but also the 
experiences of generations that had farmed before. Given the generational nature of family farms, 
this experiential knowledge is a commodity passed from parents to their children. In this way, while 
scientific understanding of disease processes evolves, and the medicines used to treat disease 
advance, the science may be of lesser value to a farmer than the understanding of disease gained 
through personal and familial experience.  
Under certain circumstances farmers believed experiential knowledge to be superior to knowledge 
acquired from veterinary surgeons or from other “expert” sources (in this case knowledge exchange 
meetings organised by the national dairy levy board, AHDB): 
“Yes, I think I know how to look after a cow now. I don’t think I need to go to a meeting unless – I 
don’t want to be blasé mind you, but I think I know that my cows all look well and I don’t need to go 
to a meeting. It’s all repetitive stuff that I basically know already.” – Farmer 20 
In one example from the ethnographic fieldnotes, a farmer described the tensions between, on the 
one hand,  the advice and “scientific knowledge” being given by their veterinary surgeon about the 
best way to manage a recent outbreak of pneumonia in their calves; on the other hand, the advice 
and “experiential knowledge” of their grandfather. Here, the farmer’s veterinary surgeon had advised 
vaccinating the calves against certain respiratory diseases in combination with investment in 
individual calf hutches to reduce the disease burden. The farmer’s grandfather on the other hand 




disagreed and advocated placing heaters in the calf shed while treating all of the calves with a dose of 
long-acting antimicrobial because “this has always sorted the problem in the past”.  
In this example, the confrontation of modern scientific understanding and experiential knowledge 
caused obvious tensions between the farmer, his veterinary surgeon and his family. In negotiating a 
resolution, a ‘compromise’ of sorts was reached whereby the farmer treated all of the calves with an 
antimicrobial while also beginning to research the purchase of individual calf hutches for the next 
season. This example illustrates the tensions between these two forms of knowledge, and the impact 
that they can have on medicine use. 
6.4.1.2 Experimental knowledge 
In addition to experiential knowledge, which can perhaps be described as passive knowledge 
acquisition, farmers use experimental knowledge when making treatment decisions (Farrington and 
Martin, 1988). Here, they actively test and trial different medicines, treatment and management 
practices in order to find which work best.  
“It’s just something that we’ve tried over the years and it works, so that’s what we do. When they 
calve, they have one of those five-in-one tubes. It’s just got egg stuff in it and it’s just protein and 
egg, but we find... we’ve done our own little experiment here on calves that have had newborn tubes 
and calves that haven’t had newborn tubes, and the calves that have newborn tubes will be far 
thriftier than the calves that don’t. So it’s something that we’ve done here ourselves...” – Farmer 13 
Often, this knowledge is experimental and acquired by design. Occasionally, such knowledge may be 
gained accidentally: 




YG [young female staff member carrying out morning milking], on finding a cow that needs 
treatment fetches a Mastiplan intramammary tube from the medicine cupboard. She pulls the lid 
away from the tube in such a way that the infusion tip becomes bent at an approximately 45° angle 
from straight. She then proceeds to swiftly wipe the udder, fore-strip some milk and infuse the 
contents of the tube before noting the treatment on the whiteboard behind her. I ask if she bent the 
tip on purpose, because I hadn’t seen that before. “Yeah, I always do it like that”. I ask if someone 
showed her the technique or where she learned to do it. “I guess I just accidentally did it once and 
realised it made it so much easier to do.” – excerpt from fieldnotes, Farm B 
It has been stated that “experimenting is part of farming as much as tilling the soil, planting seeds and 
caring for animals” (Haverkort, 1991, top of page 3) and the development of context-specific farming 
practices worldwide has been attributed to the experimental activities of farmers (Hoffman et al., 
2007). There is a wealth of literature describing the various ways in which farmers use autonomous 
experimentation, particularly in Asia, Africa and South America (Vogl et al., 2017). Indeed, the idea of 
“farmer innovators” (Critchley, 2000, Reij and Waters-Bayer, 2014) and “research-minded farmers” 
(Biggs, 1990) is well known, and a recent Austrian study showed 90% of farmers reported 
experimenting in an autonomous way (Vogl et al., 2017). Farmers have also been shown to be more 
willing to experiment with alternatives to antimicrobial treatment for treating mastitis than veterinary 
surgeons (Poizat et al., 2017). The emergence of experimental knowledge as a factor in treatment 
decision-making and veterinary medicine use in this study should therefore be unsurprising, however 
it has rarely been examined in this context.  
6.4.1.3 Uncertainty 
While experiential and experimental knowledge both act to improve a farmer’s understanding of 
disease and treatment, uncertainty remains a key feature of treatment decision-making. Uncertainty 




in this context can take the form of being unsure of a diagnosis, being unsure of which medicine to 
use to best treat the disease or being unsure about what dose is required. Uncertainty may also 
manifest as risk-averse behaviour: where there is uncertainty over the presence or severity of disease, 
antimicrobial treatments are used ‘just in case’, or as one farmer put it: 
“It’s cheaper than a dead cow”  – Farmer 2 
Indeed, in human health it has been shown repeatedly that uncertainty over the presence of 
pathological bacterial infection is positively associated with prescribing antimicrobials (Horwood et 
al., 2016, Whaley et al., 2013). Similarly, farmers have been shown to be uncertain about how to treat 
mastitis effectively in the Netherlands and Germany, leading to extended courses of antimicrobial 
treatment (Swinkels et al., 2015). 
Uncertainty can arise from scenarios where determining the correct course of action is either difficult 
or impossible in the circumstances (e.g. whether a calf is coughing due to viral or bacterial disease). It 
is therefore easy to understand the rationale of making a risk-averse decision, where treating with an 
antimicrobial is considered low risk for the animal and not treating is considered high risk. 
Uncertainty can also present as a self-identified knowledge gap. This is where the farmer knows there 
is a correct answer (e.g. a certain antimicrobial is clinically proven to be most effective to treat a given 
disease), but s/he does not have the knowledge to make an informed decision. This study has shown 
that farmers believe they are ill-informed about the medicines they use:  
“I think medicine, the problem is there’s no knowledge. I’ve seen my dad in the medicine cupboard 
literally picking up different bottles of antibiotic and thinking “hmmm, which one today?” You can go 




to ag [agricultural] college or uni and they don’t teach you a thing about medicines.” – excerpt from 
fieldnotes, Farm A 
Interestingly, when questioned further, farmers believed their veterinary surgeon should be the 
source of this information but were dissatisfied with the current provision of knowledge about 
medicine use. They believed their vets were often too busy to explain the correct use of medicines in 
enough detail, or in some instances that they did not have sufficient knowledge in this area to advise 
appropriately. There was even uncertainty about how to get the information and uncertainty about 
whether there was additional information to be had: 
“Yeah, I tend to stick to the medicines that I know. That’s what I was about to say. There’s probably 
other drugs out there that I don’t know about because I’ve always stuck to the ones that I know – the 
Tylan, the... it’s quite boring. The Metacam, the Cronyxin; I use a bit of steroid, there’s the Tylan and 
there’s the Marbox jabs, a bit of Norodine on the calves. There’s probably other stuff out there, but I 
think probably farmers’ll stick to what they know. There could be a cheaper drug, there could be a 
cheaper drug – how do we find out? How do we get that information?” – Farmer 13 
6.4.1.4 Knowledge conceptualisation 
“Some people say you should be using more mammary tubes and less injection but I don’t know. I 
just feel like with tubes there’s a load of antibiotic just going in and sitting there at the bottom of the 
udder not really doing much. With an injection you feel more that it’s getting at things from 
everywhere you know? I don’t know if that’s right through mind.” – excerpt from fieldnotes Farm B 
It became obvious from the interviews and field research that dairy farmers created their own 
understanding of disease, negotiating experiential knowledge, experimental knowledge, “expert” 
advice and their own internal logic. A narrative was needed for each treatment or medicine, and in 




the absence of the scientific and veterinary training required to explain the processes of disease and 
healing farmers would develop their own understanding of disease.  
An example of such a narrative, taken from the ethnographic fieldnotes, illustrates this point:  
Cows from the farm start acting strangely, become very lethargic, lose weight and have reduced milk 
yields and at a certain period every year. The farmer believes it coincides with a time period when the 
milking cows are moved to a different field, near a coastal path, and associates it with a higher salt 
intake. In order to counteract this, he will drench each cow with warm water after morning milking 
every day for the 1-2 weeks that they remain on this land, “so that I can dilute the salt”. The farmer 
says he has asked his vet about the problem, which he calls “seawall syndrome”, and the vet just 
shrugged and said they didn’t know what it might be. - Excerpt from fieldnotes, Farm C 
In this example, knowledge about disease and treatment has been constructed through a combination 
of learned experience (the cows become unwell when on that pasture), situational knowledge (that 
field is near the sea and therefore salty) and pre-existing knowledge (water dilutes salt). Most notable 
is the absence of any input from the veterinary surgeon despite their opinion being sought.  
These narratives - while powerful and with a significant influence on the diagnosis and treatment of 
disease - are uncertain. Farmers were aware of the limitations of their understanding: that a farmer’s 
understanding of disease may differ from what can be considered the scientific knowledge of disease. 
However, in the absence of any other way of explaining their experiences with disease and treatment, 
this negotiated understanding was used to inform treatment decisions on a daily basis. Indeed, it has 
been shown that farmers who score highly in ‘knowledge’ during exploratory factor analysis tend to 
be the lowest overall users of antimicrobials (Kramer et al., 2017). In human medicine, patient literacy 
and understanding of disease is known to affect treatment compliance and disease management 




(Gazmararian et al., 2003) and to be influenced by patients’ experience of disease and the 
communication style of their healthcare professional (Weiss, 2007) among other factors. 
 Trust 
The second major theme to emerge from the ethnographic data was trust. Trust can be described as 
a sociological construct referring to people’s expectations (Goold, 2002). It is also an active component 
of agency: it underwrites social order (Lewis and Wieigart, 1985) and to a greater or lesser extent, 
underwrites the critical relationships on the farm. These include the relationships between keeper 
and kept animal, between producer and consumer and between human endeavour and natural 
process. In sociological terms, trust is often seen as essentially conditional; it can be earned or lost in 
a continuously re-negotiated relationship. In human medicine, there is an increasing focus on the 
value and nature of trust (Goold, 2002). A 2017 meta-analysis found a small-to-moderate correlation 
between trust in healthcare professionals and treatment outcomes (Birkhauer et al., 2017).  
 In this study, trust was interpreted as a relationship between the farmer and the different ‘actors’ 
seen by the farmers as being involved in the treatment process. These ‘actors’ were not always people; 
indeed, farmers developed conditional and relational trust in their animals, in the medicine and in the 
data as described below. Through interviews and observation, five aspects of trust were identified; 
these will now be explored in detail.   
6.4.2.1 Trust in the veterinary surgeon 
“Yeah I guess it varies a bit and you know, the advice. You know, where are the vets getting their 
advice? That changes doesn’t it. Either they’re newly graduated and they’re using what they learnt 
when they studied, which is changing all the time, or they’re using their, you know they’re going to 
other sort of training courses which is off the back of new research and their advice is changing all 
the time isn’t it? So – You know they’re all generally on the same page, but obviously they’re not all 




going to be all clones of each other. They’re going to have opinions and different experiences and 
stuff but then that’s also useful, so… Yeah you do develop a relationship with certain ones that you 
sort of trust or with, what’s the word, you sort of value their opinion more than others maybe.” – 
Farmer 1 
The relationship between a veterinary surgeon and a farmer is important to dairy farmers (Hall and 
Wapenaar, 2012) and depends to a large degree on trust (Richens et al., 2015). Increased frequency 
of veterinary contact has been shown to improve responsible use of antimicrobials (Higham et al., 
2018). The enactment of veterinary surgeons’ advice on farm is influenced by a combination of the 
farmer’s trust in the veterinary surgeon’s ability, integrity, benevolence and predictability (Bard, 
2018), as confirmed by the above quote. Trust between farmers and external advisors is a critical 
component in building the social capital required to enact advice (Fisher, 2013). Bard and others 
(2017) have shown that, when communicating with farmers, veterinary surgeons tend to have a 
paternalistic and directive style. It was hypothesised that this style of communication was one of the 
reasons why the uptake of veterinary advice in animal health planning was low and there have been 
calls for a ‘paradigm shift’ in veterinary communication towards a more mutualistic and collaborative 
approach (Shaw et al., 2006, Vet Futures Project Board, 2015).  
Farmers emphasised the value they placed on trust when discussing the veterinary surgeon-farmer 
relationship. Once trust has been earned, it is seen as stable and difficult to lose. However, before it 
is earned, the initial interactions between a farmer and a new or unfamiliar veterinary surgeon are 
critical and likely to set the course for the relationship in the long-term: 




“First impressions make a massive difference for quite a long time. Male vets, especially new ones, 
sometimes they’re too cocky. That’s why we always sway towards the women” – excerpt from 
fieldnotes, Farm C 
The importance of the first impression made by the veterinary surgeon appeared frequently in farmer 
interviews and was deemed as difficult to re-negotiate once the assessment had been made. However, 
there was also an acknowledgement of the veterinary surgeon’s ability to redeem themselves and 
‘earn’ the trust of a farmer through an act of unexpected successful veterinary intervention: 
“Farmers are pretty typical like they have their favourite vet on the farm and it’s always guilty until 
proven innocent. ‘That new vet’s bloody useless rah rah rah,’ but then they turn up one morning and 
save a cow and all of a sudden they’re the best thing ever.” – Farmer 1 
The veterinary surgeon was viewed as an important source of information on disease control, due to 
their knowledge of on-farm animal health and the local disease epidemiology (Gunn et al., 2008). 
However, there were reported discrepancies between the veterinary surgeon’s perceived role and the 
preferences reported by farmers (Hall and Wapenaar, 2012). This discrepancy may lead to a 
breakdown in communication, advice uptake and, ultimately, trust. Where advice is sought or given 
on medicine use or treatment decisions, integrity is particularly highly valued: 
“I also think the drug companies have got quite a big lean on quite how they push certain ways of 
doing things. Because they tend to lead the vets into saying, “Right, this is the way to do it.” Because 
that’s how they get told it. I am not saying the vets are misleading or doing anything deliberately, I 
just think the industry has a nasty habit of being led...” – Farmer 6 




In the above example, the farmer was explaining why he would deliberately choose to ignore the 
advice of his veterinary surgeon about which medicines to use, and instead do his own research. This 
suggests that a lack of trust in the vet and their advice, or indeed the manner in which this advice is 
given as shown by Bard and others (2017) can directly impact treatment decisions. This may, in turn - 
and depending on where alternative advice or knowledge is sourced - lead to inappropriate or 
irresponsible medicine use.  
6.4.2.2 Trust in the staff 
While trust in the veterinary surgeon influenced the uptake of advice, this was often only the first step 
in the decision-making process. In order to enact this advice, there must also be trust in the person 
delivering the action. In this case, this action is the diagnosis and treatment of disease. The majority 
of farms employ some staff, either unofficially (where a farm is run by various family members who 
all have a stake in the business) or officially (where external employees are hired to carry out work). 
The roles of staff members can vary significantly between farms, but in most cases staff will be 
interacting directly with the cattle and will have some responsibility for animal health. Animal care is 
seen as physically demanding, containing elements of care work and emotional work (Brandth, 2006). 
Dairy farmers in the US have been shown to underestimate the satisfaction of their staff, and also the 
willingness of staff to learn animal management and dairying skills (Durst et al., 2018). On the other 
hand, dairy farmers place great value in capable staff, which impacts on their decisions to treat 
diseased animals (Horseman et al., 2014): 
“My attitude is a good herdsman deserves double, a bad one deserves to pay you really” – Farmer 3 
“To build a team of three people has taken me – a team as good as this has probably taken me six or 
seven years. To find three people that will work together, fit together” – Farmer 6 




The four aspects of trust, and the concept of a “shared understanding” described by Bard (2018) when 
discussing the veterinary surgeon-farmer relationship can also be seen to fit the trust relationship 
between farmers and their staff. This trust relationship is reliant on the farmer’s perception of the 
staff members’ ability, integrity, benevolence and predictability (Bard, 2018). Where one of these four 
areas are seen to be lacking, overall trust is lost.  
A lack of trust in staff was seen in this study to lead to closer control over animal health decisions and 
a lack of delegation of the work of disease monitoring, diagnosis and treatment. In one case, a farmer 
describes not being able to leave the farm to join a family holiday due to a lack of trusted staff: 
“And know that I’m not gonna come back to anything dead – well, not dead through incompetence – 
but I’ve been away... it does happen when I go away, so I don’t go away any more. I didn’t go away 
on our family hol... My husband and the kids went on our family holiday this year. I stayed home. 
Yeah, I just can’t do it. It’s not in my nature. If I’m coming home and finding dead things because they 
haven’t been looked after properly, it’s not…” – Farmer 1 
Trust has been identified as an important component of the management-staff relationship in other 
healthcare settings (Mullarkey et al., 2011). Trust influences staff morale, the delegation of tasks and 
improves the uptake of advice and delivery of care (Firth-Cozens, 2004). This trust is reciprocal in 
nature, where increased trust by a manager results in enhanced reciprocal trust by their subordinates 
(Seppälä et al., 2011), although it has been shown that bosses trust subordinates more than the 
subordinates trust their bosses (Butler, 1986). This reciprocal trust was observed in this study to be 
recognised by farmers in a management position:  
“To be honest there’s a cow that [herdsman] just treated, she only had one clot and I don’t think she 
really needed a treatment, but you can’t really criticise them for treating you know. There’s a few 




here being treated that don’t really need it I think but what can I say? If I criticise their decision then 
next time there’s a really sick cow and it doesn’t get treated because they’re afraid I’ll have a go then 
I’m not really doing my job properly, so it’s “Well done. Good spot Thank you””  – excerpt from 
fieldnotes, Farm B 
6.4.2.3 Trust in the medicine 
The perception of a medicine’s “power” has been described by Nichter’s work (1980) studying 
perceptions of medicines in southern India. This power (relating to its perceived potency and ability 
to heal) influences the decision to treat, choice of medicine and the perception of a treatment’s 
success or failure (Relun et al., 2013). Indeed, as Pool and Geissler (2005, top of page 88) put it 
“Western pharmaceuticals are not only chemical substances but also social and cultural objects with 
diverse and often contradictory meanings and uses”. 
Trust in a medicine can depend on the branding and cost of purchase, with known brands increasing 
trust and cost being directly correlated with quality (Aivalli et al., 2018, Dunne and Dunne, 2015). Even 
the colour of a medicine has been shown to influence perceptions of its potency (de Craen et al., 
1996). When treating mastitis, antimicrobials are regarded by dairy farmers as the treatment with the 
best possibility of a positive prognosis (Vaarst et al., 2003).  
Treatment outcomes (or perceptions of treatment outcomes) on farms can reinforce or negate initial 
trust in a medicine:  
“I’ve actually gone back to Naxcel [an injectable HP-CIA] in cows because nothing else was working… 
won’t work, we can’t get it to work.” – Farmer 11 




Treatment outcomes can lead to changing the medicine being used, or changing the dosage until a 
perceived positive outcome is reached: 
We used to use Cobactan but we found it wasn’t working that well. We started Mastiplan, 4 tubes 
but that wasn’t really working either so now they get 8 tubes over four days and that seems to be 
working. They get a Finadyne jab and three days of 33ml Duphatrim too.” 
 – excerpt from fieldnotes, Farm B 
Where trust in a medicine has been gained or lost, this will have long-term consequences on the future 
use of that medicine on that particular farm. These consequences may not be seen on any other farm 
and are specific to the perceived performance and ‘power’ of each medicine on each farm. In this way, 
it can become difficult to predict the treatment decisions and behaviours of farmers without first 
understanding their particular relationships with the medicines they have available to them. Trust in 
medicine had different components for a farmer. Firstly, a medicine’s reputation amongst peers can 
be an important motivator when choosing a treatment. Secondly, treatment decisions were 
influenced by the farmer’s own experiences of the medicine: whether it was easy to use and whether 
it led to a positive outcome for the animal. Thirdly, trust in the medicine was linked to trusted advice: 
here the veterinary surgeon’s recommendations for treatment can be pivotal, depending on the trust 
relationship that exists with the farmer.  
6.4.2.4 Trust in the animal 
The perception of an animal’s inherent susceptibility to - or ability to recover from - disease was 
manifest as a trust in the animal. This trust was placed in the animal’s biological processes (Bergea et 
al., 2016), their genetic make-up and their anthropomorphised personality traits. In one instance, a 
cow was recumbent in the cubicle shed following a difficult calving the previous day: 




A cow has been down in the cubicles overnight. She’d been treated with Naxcel and Ketofen and is 
brought into the large straw pen using a JCB bucket. They work to get a hip hoist around her pelvis 
and lift her onto her feet, placing three calves onto her udder to suck while she stands. “We’ll do this 
for a few days and see how she does. She’s got daft cow disease, that’s what’s wrong with her” says 
the farm manager. - Excerpt from fieldnotes, Farm B 
The development of a trusting relationship between people and animals is rooted in the process of 
caring for animals (Knight, 2005). Trust in the animal has been described in the context of farmer 
safety and farmer-animal communication (Buller and Roe, 2016). While Ingold (2000) theorised that 
the process of farming an animal moved the relationship between animal and human from one of 
trust to one of domination, it has also been argued that this explanation is oversimplified and there 
exists a social contract between animals and those who farm them (Oma, 2010). In the context of 
medicine use and treatment decisions, this trust in the animal’s ability to heal can affect the energies 
expended in achieving that outcome. Where an animal is not trusted to recover, the decision to cull 
rather than treat may require a lower threshold: 
“That one’s knackered. Foot swelled up, treated her, she got better but now it’s even worse. We just 
need to shoot some of them” – excerpt from fieldnotes; herdsman, Farm B 
A lack of trust in an animal to recover may decrease the overall investment that a farmer is willing to 
make, limiting their motivation to treat. This investment refers not only to the monetary expense of 
the medicine, but also to the time investment required by a particular course of treatment. Animals 
are identified as being ‘useless’ or ‘stubborn’ where they are chronically diseased or refractory to 
treatment. This is despite the possibility of mis-diagnosis or inappropriate treatment and irrespective 
of what may be an incurable condition or guarded prognosis: 




“This red heifer here” points at a calf recumbent flat on its side, breathing heavily “She’s a princess 
you know. She’s had everything right, but she’s doing everything she can to die. Typical red heifer.”  – 
excerpt from fieldnotes, Farm A 
In human health it has been shown that low trust in the patient negatively affects the quality of 
healthcare provided (Gilson, 2003) and a scale has been developed to measure trust in the patient by 
their clinician (Thom et al., 2011). Despite this, this area of patient and clinician trust has been 
identified as a neglected area of research (Brennan et al., 2013). Although the farmer-cow relationship 
may mirror the clinician-patient relationship in many ways, it is not directly comparable due to the 
inability on the animal’s part to participate consciously in the trust relationship. The paediatric 
clinician’s relationship with their patient may reflect more accurately the imbalance of agency, 
however there are no reported studies of trust between clinicians and their paediatric patients.  
6.4.2.5 Trust in the data 
The final aspect of trust that emerged from this study was that of trust in the data available to the 
farmer which may be used to guide treatment decisions. This data may take the form of medicine 
treatment records hastily scribbled on scraps of paper, or well-organised computerised records of 
production data inputted by external milk recorders. Farmers recognise the variable quality of the 
data available to them, and their reliance on that data varies accordingly.  
“They were only milk-recording every three months so I refused to do it [selective dry cow therapy] 
because if you have a cell count that’s two months old you just have no idea what’s going on in that 
udder in front of you”  – excerpt from fieldnotes, Farm B 
The value of maintaining good quality records was recognised but was often accepted to be sub-
optimal due to time constraints, multiple people being responsible for inputting data and a relatively 




low prioritisation of data collection when compared to other work. Poor data quality can lead to a 
mistrust in the data and present as a barrier to data-driven decision-making (Haug et al., 2013). 
Indeed, farmers have been shown to have a different understanding of the purpose of record-keeping 
to regulators. Farmers often keep the required records for the purpose of external accountability, 
while maintaining separate, self-designed records for their own use (although there may also be 
significant heterogeneity in the quality and use of these records) (Escobar, 2015). Farmers regard 
paperwork as enforced and unnecessary burden and often fail to comply with the requirements placed 
upon them by various external regulators (Escobar, 2016). 
 Autonomy of treatment practice  
The third major theme identified was that of autonomy in treatment practice. This refers to farmers’ 
perceptions of their own autonomy with respect to treatment practices, which are focussed on the 
endogenous and exogenous frameworks they operate within. That is, the practical, physical and 
resource-specific frameworks that were in place on any farm (e.g. whether the medicine was available 
in the cupboard, whether staff and facilities were available in order to treat) and the legislative and 
regulatory frameworks that are imposed on a farm (e.g. milk withdrawal periods, farm assurance 
requirements).  Other research has found a lack of belief in self-efficacy among farmers to be 
associated with lowered intent to implement disease control programs (Ellis-Iversen et al., 2010). The 
participants in this study expressed an acute awareness of their feelings of impotence with regard to 
treatment decisions and veterinary medicine use. These factors took the form of external forces, of 
their place within the decision hierarchy of the farm and of the physical resources available to them 
(Alarcon et al., 2014), each of which is discussed in turn below.  




6.4.3.1 Regulatory frameworks 
External factors create a framework - both legal and practical - within which the UK dairy farmer must 
work. These can take many forms: from government-mandated bovine tuberculosis (bTB) testing and 
control measures to farm assurance schemes, milk-buyer enforced herd health management and 
veterinary treatment protocols.  
Farmers often related their treatment decisions directly to the limits that external forces placed on 
their options. An important and regularly identified constraint on farmers’ decision-making regarding 
treatment was the issue of bTB control measures. The study areas were all in regions with a high 
prevalence of bovine tuberculosis; consequently farms underwent regular bTB testing of their cattle. 
Farmers have been shown to believe they are unable to do anything and have no control over bTB 
(Enticott et al., 2015). Many of the farms were under bTB restrictions where they were unable to sell 
young animals into the beef sector, creating issues of insufficient housing and feed. Where farms had 
lost a significant number of cattle to slaughter from bTB testing, they were unable to make voluntary 
culling decisions in order to maintain a herd size large enough to produce the volume of milk required. 
This inability to cull animals on a voluntary basis (i.e. where the animal is not culled due to bTB or dies) 
led to an increased number of chronically diseased animals on farm. Animals with long-standing issues 
of lameness or mastitis were being maintained within the herd, despite there often being no prospect 
of cure.  
“I think it’s getting harder and harder to be a farmer. More and more I feel like I’m just carrying out 
the instructions of the vet, or the Ministry [DEFRA]. Or bloody Arla [milk buyer]. Take TB for example. 
I can’t make culling decisions can I, if they’re telling me I have to get rid of 30 odd of my best cows 
every year? Means I have to keep the shit ones just to stay in milk. Or antibiotics. I can’t use certain 




ones, I can’t dry them off with Cephaguard, can’t do this, can’t do that. It gets right on my nerves.”  – 
Farmer 19 
Dairy farming is an industry particularly vulnerable to market forces, and there have been well-
publicised recent periods where farmers are being paid below the cost of production for their milk. 
This study occurred towards the tail-end of one of those periods, and these economic constraints had 
a pronounced effect on treatment decisions. As one farmer put it:  
“We just keep our heads down. The milk price is up but we’re just paying off what we owe from when 
it was low. Sod’s law as soon as we pay off it’ll crash again. You just can’t win” – excerpt from 
fieldnotes, Farm C 
By “keeping their heads down”, farmers mean that they are unable to invest in their farm. This 
investment may be the purchase of land, new housing, new stock or just improvements to current 
structures. An inability to invest can have negative consequences on animal health, welfare and 
production (Jarvis and Valdes-Donoso, 2015). Paradoxically, this may then lead to an increased need 
for veterinary treatment and medicines. However, during periods of economic stress, farmers often 
reduce their use of veterinary services in a bid to minimise costs.  
Given that 98% of UK dairy farms are members of a farm assurance scheme, it follows that farm 
assurance places an additional framework within which decisions about treatments are being made 
(Responsible Use of Medicines in Agriculture Alliance, 2017). As described in Chapter 2, the Red 
Tractor farm assurance scheme publishes a list of standards that must be maintained by farms, as 
assessed during regular farm audits. Notably in June 2018, Red Tractor announced new measures to 
reduce the use of HP-CIAs: veterinary surgeons could only prescribe these medicines to assured farms 
as a last resort where there was evidence of diagnostic or sensitivity testing that made it necessary to 




use these medicines. While this new standard was not in force at the time of data collection for this 
study, it illustrates the power that farm assurance has to drive prescription veterinary medicine use 
at the farm level. 
Farm assurance schemes have been recognised as being of limited practical value to farmers (Escobar, 
2015), however given the very high uptake of such schemes in the dairy industry some value is placed 
on membership. While farmers recognise the necessity of being a member of a farm assurance 
scheme, the actual practice of enacting the standards is frequently seen as a ‘tick-box exercise’ that 
does not improve the health or welfare of the animals on the farm.   
“It’s a bit of a strange one, because the organic certificate, when they ask you on your annual 
questionnaire what drugs you’ve used, they only count tubes. So therefore, I will use three tubes of 
Tetra Delta and half a bottle of Penstrep, because it doesn’t count. Which seems a bit cynical, but it 
works.”  – Farmer 6 
On the surface, the introduction of treatment protocols on a farm reduces the autonomy of the farmer 
with regards to treatment decisions. Despite this, treatment protocols were overwhelmingly viewed 
by interviewees for this study as being a positive component of practice, with farmers finding having 
a protocol empowering. This can in part be explained by the feeling that a treatment protocol 
eliminates the uncertainty felt when diagnosing and treating disease. In this way, treatments were 
always able to be justified and there was no sense of needing to defend their decisions. In human 
medicine it has been shown that prognostic uncertainty drives antibiotic prescribing in children 
(Horwood et al., 2016) and the introduction of clinical decision support tools reduces inappropriate 
antimicrobial prescribing (Samore et al., 2005, Jenkins et al., 2013).  




Treatment protocols were not commonplace on the participating farms. Those that did use them, 
however, found them very valuable in aiding decision-making and improving the relationship with 
their veterinary surgeon. Farms that did not use protocols expressed a desire for their veterinary 
surgeon to design treatment protocols which could be used on their farm. The key factor with the 
development of protocols appeared to be that they were designed collaboratively, and not written by 
the veterinary surgeon in isolation and handed to the farmer in a paternalistic fashion: 
“What I’m finding with our vet is that they do respect our opinion and I think that in turn means 
we’re ready to listen to theirs. I mean you say about herd health plan we have been doing specific 
plans for specific problems, so we had a bit of a niggling issue with VLD [abnormal vulval discharge] 
and we now have a very nicely written up protocol”  – Farmer 18 
Improving responsible use of antimicrobials was seen as a benefit of introducing treatment protocols: 
“It’s always been a challenge, mastitis, so we have come up with a protocol which fits our system 
really. We have reduced antibiotic usage massively in mastitis cows. We have used a lot of anti-
inflammatories purely to help the cow through the first stages of the process of mastitis, a lot of self-
cure…” – Farmer 8 
Protocols were also viewed as enabling farmers to ensure that, where multiple members of staff might 
be responsible for treatments, treatments were standardised: 
“We established a way of working and a sort of protocol, which established exactly how we should be 
doing things with the calves and so with new people coming along I can make sure they do exactly 
what we want them to do all the time in a way that we know works. We’re constantly developing 
that, trying to make things better all the time, and that’s an ongoing process. In fact, over the last 




few months we’ve cut our antibiotic use down still further, we were fairly in control of it before.”  – 
Farmer 13 
6.4.3.2 Farming this farm  
“I mean we … because we’re farmers we spend most of our day whinging about things going wrong. 
That’s what we do … moaning. But in reality, it’s bloody good.”  – Farmer 1 
Social identity theory is based on the idea that a person’s sense of who they are rests on their 
perceived membership of a particular social group (Turner and Reynolds, 2010). A farmer’s identity is 
based on his or her being a farmer, and all farmers have an idea of what it means to be a “good farmer” 
(Burton, 2004). Farmers’ social identities are dependent on context and are dynamic and complex 
(McGuire et al., 2013). While the idea of the good farmer has most often been explored in the context 
of environmental impacts and ‘productivist’ behaviour amongst farmers, this idea’s core message was 
reflected in this study as was its potential to impact upon behaviour. 
While the farmer’s own personal identity as a farmer is clearly important to treatment decisions and 
medicine use behaviours, the farm itself also has an identity in the mind of the farmer. Farmers see 
their farms as being unique and out of the ordinary (Kaler and Green, 2013). What works on most 
farms does not work on others and vice versa. A farmer will use a certain veterinary surgeon or a 
certain medicine or dose because that is what works on ‘this farm’.  This sense of uniqueness is 
intimately linked with the farmer as an experimenter, developing their own knowledge of the 
treatments that work on their farm, with their cows. Some of this reasoning is based on scientific 
understanding – each farm environment will have its own microbiome, and the microbiome of each 
herd will be unique and different to that of the next herd. Similarly, the disease prevalence, bovine 
genetics and antimicrobial resistance patterns will be unique to each farm. While this is unlikely in 
many situations to require a different clinical approach to treatment (antimicrobial resistance is rarely 




of clinical relevance in cattle and biosecurity and good management practices are the same across 
most dairy farms) the farmer needs to feel that advice and treatment decisions are being made with 
the uniqueness and idiosyncrasies of their farm in mind.  
"The dairy industry in West Wales is different to the dairy industry in Scotland – there’s regional 
differences in this country, let alone a different country…West Wales, with two different languages 
spoken, is different to being down in Kent or wherever, isn’t it?”   - Farmer 7 
Farmers viewed their particular farm context to be important with regards to medicine use. It can be 
seen from the difference in medicine record quality between farms of different sizes in Table 6:1 that 
variation in medicine records could not be easily explained by simple demographic data, and there 
was no obvious correlation between size of farm, age of farmer or production levels and the quality 
of records kept. When looking at the interview data, farmers’ views on medicine use did not appear 
to differ widely between farms with good medicine records and those with poor quality medicine 
records. This may be an example of the disconnect between intention and behaviour, and something 
about the context on that farm that affects the medicine record quality is missing from the data 
available about those farms. This is where participant observation can help, with the particular context 
only truly becoming visible when an observer is present on farms for a prolonged period. For example, 
when farmers are under-staffed and time-poor, this may lead to medicine record keeping being a low 
priority when compared with other more pressing tasks, despite intentions to the contrary (Escobar, 
2016). 
The nature of the farm’s identity was seen to be heavily influenced by the farmer’s potential for future 
investment and the situation regarding succession planning. Where farms’ futures were deemed 
secure - perhaps where younger generations showed a committed interest in continuing to run the 




farm - investment was likely to occur. However, where a farm’s future was less certain, investment in 
infrastructure and new stock was less important. While this situation is understandable, it is likely to 
have negative consequences on animal health and the potential for increasing use of veterinary 
medicines in order to compensate for a lack of up-to-date infrastructure and an ageing population of 
cattle. The farm’s future appeared to represent an attitudinal difference between farms with a secure 
mid-to-long term plan and those without. 
“No, I’m not spending money willy-nilly. We should be re-seeding forty-odd acres, but we’re just 
gonna manage it a bit better. I’m not spending that much money on re-seeding forty acres, especially 
if we decide to get out [of farming] in two or three years.” – Farmer 16 
6.4.3.3 Physical resources 
As illustrated in Chapter 4, the physical resources available to a farmer will have an effect on the 
treatment decisions that farmer is able to make (Hektoen, 2004). Put simply, if the farmer wished to 
treat an animal with an antibiotic, s/he was usually limited by what was in stock on the farm. If the 
farmer wished to use a medicine that was not in stock, treatment was delayed while the veterinary 
surgeon was called out or the farmer drove to the veterinary practice to collect the medicine.  
“Come to think in terms of the specific how to choose which antibiotic to use in a case of mastitis, the 
short answer is it depends whether it’s first case, whether it’s a repeat and, you know, what we’ve 
got in stock.” – Farmer 18 
Other physical resources were also important in influencing animal health and therefore treatment of 
disease. Where farm buildings were suboptimal, farmers might have been required to rely on the use 
of veterinary medicines to maintain animal health that was compromised by poor housing. Where 
cattle must walk a considerable distance over stony ground to reach their daily grazing, farmers may 




need to increase the use of anti-inflammatory painkillers to treat lameness. In one case, cattle were 
being dried off at the end of their lactation and transported by trailer to their grazing, far away from 
the main farm. This situation meant that the farmer was unwilling to use selective dry cow therapy, 
or even to move away from the HP-CIA that they considered the most likely to reduce the risk of 
mastitis: 
“I’d like to not use antibiotics in some cows, but because of how they get dried up here, they go in the 
trailer, they go to the other farm. It’s just so risky, so they’ve recently tried to move me onto that 
[selective dry cow therapy] but we’re about the health and we’re still using Cephaguard”  – Farmer 
17 
6.4.3.4 Decision hierarchy 
Within any organisation, there is a structural hierarchy (Diefenbach, 2013). On dairy farms, this 
hierarchy can come in various guises. A family farm is often run by multiple generations at once, 
however it is recognised that there is either implicit or explicit hierarchical structure when it comes to 
key decision-making (Headlee, 1991). Indeed, issues surrounding succession on UK farms are a 
recognised area of tension on family farms.  
“It’s so frustrating that I want things done my way but my dad actually makes the decisions so I don’t 
have the authority to do any managing” – excerpt from fieldnotes, Farm A 
Conversely, on farms that employ many staff who are not immediate relations, or farms that are run 
by an employed farm manager, the hierarchy is far more explicit and structured. 
Where a person lies within the hierarchical structure affects the treatment decisions they are able to 
make. Tensions emerge where a farmer feels disempowered and unable to make treatment decisions. 




In this instance, subversive behaviour in order to achieve the desired treatment option in spite of a 
superior’s decision was observed.  
“What will eventually happen, like it has many times in the past, is that I’ll go so far, and then I just 
lose it. Then I go off on one, and then it will get done. Or something will get done… Yeah, big time, 
which is annoying because that proves to me that he knew all along that it needed doing. But why 
wait when it’s things that are affecting your cows’ health? … It is really, because if he would give me 
a bit more power to say, “Get on and do some of it.” I wouldn’t mind, but I can’t at all. I know what 
needs doing, but he has to have the final say and he’s a tight old thing, well all farmers are, aren’t 
they? We’ll get there in the end.” – Farmer 8 
These tensions were expressed as a  source of stress to farmers. While farm managers or farmers 
employing staff had to navigate the trust relationship between themselves and those they managed 
(as described in 1.3.2.2), unless they were at the top of the hierarchical tree, they were also subject 
to the loss of autonomy prescribed by their superiors. These restrictions (or barriers) to treatment 
took many forms but most commonly were economic in nature. 
“There was this cow who had E. coli. I’d been off for the weekend, came back and spotted it straight 
away. I asked him “why haven’t you tubed her?” “We’re not allowed to tube anything” he said. He 
wouldn’t let me treat her! It’s common sense, if they’re that sick. You might at least get some money 
back if you can send them down the road [to slaughter]. If they’re going to shoot her anyway may as 
well try to save her” – excerpt from fieldnotes: herdsman, Farm B 
Here, one farm worker was chastising a fellow farm worker who was - on paper - employed at the 
same level. Both were acting within the same restricted structure where they had been told by their 
superiors not to treat animals with new cases of mastitis, but one felt greater autonomy to override 




that decision than the other. This illustrates the importance of the individual’s subjective 
interpretation of decision-making power and authority as well as the differences in behaviour that 
these subjectivities can induce.  
 A duty of care 
The fourth and final major theme identified in this study was that of a duty of care that the farmer 
feels towards the animals s/he farms. This can be conceptualised across two key areas: the bovine 
patient and treatment as action, as outlined below. As Buller and Roe (2016, bottom of page 54) argue, 
animal stockpersons should be reconsidered as animal care persons. Care is inherently complex, with 
the care of another an “achievement alongside other demands which may be in tension with care 
delivery – minimising costs, personal challenges, competitive advantage – each being well-recognised 
characteristics of the commercial industrialised, food animal production environment.” 
Here this argument is furthered by suggesting that, where treatment decisions are concerned, a key 
motivator is a sense of duty to the wellbeing of the animals for which the participants are responsible. 
While care can be described as an achievement in spite of other pressures, it is also a raison d'être in 
and of itself. This ‘duty of care’ was at the heart of medicine use and the treatment of disease on UK 
dairy farms.  Dairy farmer empathy is associated with animal welfare (Kielland et al., 2010) and the 
emergence of duty of care as one of the five key values of dairy farmers when making treatment 
decisions is therefore reassuring. 
The value that the dairy farmer placed on the care of their animals can be examined in two key areas: 
the bovine patient and treatment as action. Of course, both are inextricably linked and resist 
separation, however, by discussing them separately it is somewhat easier to illustrate the main points 
of this argument.  




6.4.4.1 The bovine patient 
Dairy cattle (and indeed all farmed species to a greater or lesser extent) are almost entirely reliant on 
farmers to provide them with the basic necessities of life. Feed, water and shelter are key components 
of the “five freedoms” of animal welfare (Farm Animal Welfare Council, 2009); however, the most 
pertinent to this study is that of freedom from pain, injury or disease. Dairy cattle rely on the farmer 
for their physical health and wellbeing. This places the dairy cow in the position of ward, or patient, 
while simultaneously placing the farmer in the position of care-giver.  
This sense of the ‘bovine patient’ underlies many management and husbandry practices, not least 
veterinary treatment decisions. While always needing to operate within the constraints of the 
economic, societal and political context of dairy farming, farmers see their cattle as dependents. They 
value the “work” that these animals do, and the income and career that they are provided by these 
animals’ existences and milk production.  
“They've done us alright, you've got to look out for them. I'm probably just too sentimental for being 
a dairy farmer…”  – Farmer 5 
This two-way relationship between the farmer as a provider of care for the cow, and the animal as the 
provider of an entire way of life is appreciated in various ways. One farmer acknowledged the 
pleasurable lifestyle and work being afforded as attractive, while simultaneously declaring their love 
for the animals they work with: 
“There’s a lot of benefits. You look at you’re your own boss living in a lovely area with animals that 
you love. It’s your own boss syndrome really. No regrets, no. I wouldn’t change it for the world.”   – 
Farmer 3 




“Yeah we’re very much independent agents … and I would like to think that we do our best to treat 
our animals well.” – Farmer 18 
This mutually beneficial relationship between farmer and animal drives many treatment decisions on 
farms. A cow relies on their farmer to treat them appropriately when they are diseased. The farmer’s 
willingness to do this might be driven in some cases by a feeling of reciprocity. There is a sense that 
the farmer “owes” their animals a good life as a reward for the provision of a rewarding career and 
lifestyle. Indeed, for some farmers, this sense of reciprocity may lower treatment thresholds to the 
point that animals are treated unnecessarily, or even overdosed with PVM as a means of reward.  
6.4.4.2 Treatment as action 
As discussed, the health and wellbeing of the animals under the care of the farmer is extremely 
important to the farmer’s sense of identity as a “good farmer” and is driven by his or her duty of care 
to the animal. Indeed, Buller and Roe discuss the elements of self-care and maintenance of a farmer’s 
own wellbeing as being inextricably linked with the health and welfare of their animals.  
During the participant observation fieldwork, there were examples of animals being perceived to be 
diseased or suffering,  leading to farmers expressing  feelings of distress and a desire to take action to 
relieve the suffering and treat the disease. Farmers have been shown to extend the duration of 
antimicrobial treatments because doing so made them feel like “good farmers” (Swinkels et al., 2015). 
This sense of treatment representing a positive action is not only serving to maintain animal health 
and welfare but is also self-serving in nature.  
Where treatment is seen as action, veterinary medicines can be viewed as the tools for positive action 
in the face of disease. This can lead to over-treatment and over-medicalisation of both self-limiting 
disease and mis-diagnosed disease where symptoms actually lie within the ‘normal’ range for that 




animal or herd. The concepts of overdiagnosis and medicalisation are well recognised in human 
medicine (van Dijk et al., 2016), and the overuse or irresponsible use of pharmaceuticals is often 
attributed to these phenomena (Welch et al., 2012). 
In the context of veterinary medicine use on dairy farms, this concept of treatment as action can 
manifest in many ways. From the risk-averse behaviour inherent in the overuse of antimicrobials to 
the blanket use of veterinary medicines in animals that are believed to be weak unless treated: 
“Every Guernsey calf has to have steroids to get it going.” – Farmer 13 
While it is true that many farmers identify Guernsey calves as being smaller and less vigorous that 
their Friesian or Jersey counterparts at birth, this farmer had equated that with a need for 
corticosteroids in order to give them a ’helping hand’ during the neonatal period. This was despite the 
likely negative health effects of a neonatal animal receiving corticosteroids without proven clinical 
need, which may or may not have been known to the farmer.  
While treatment is seen as a positive action in most cases and can serve to relieve the distress 
associated with caring for diseased animals, the need to treat can also represent failure to some 
farmers: 
“Well obviously I’d love a day without having to treat sick animals, a lot of people would. The thing I 
hate is the sick cows and having to tube cows, that is when you feel failure. But then I try to compare 
it by 250 humans there would be one or two going into the doctors every day wouldn’t there?” – 
Farmer 3 




Several farmers expressed pride when a treatment had succeeded, for example in an animal who had 
recovered from lameness following multiple time-consuming interventions trimming her feet to 
improve hoof conformation. Some also expressed frustration and shame when treatment failed to 
correct chronic disease and they were unable to cull, for example an animal remaining in the herd 
despite chronic foot problems and severe lameness. One farmer attributed a spate of healthy calves 
with no pneumonia or diarrhoea to luck, despite management interventions which had led to the 
improvement. Conversely a period of increased disease in calves was blamed on the weather, 
overcrowding, or other more tangible reasons on many occasions.  
Worry and frustration were words that emerged frequently during this study, particularly where 
autonomy or knowledge were felt to be restricted. This perhaps indicates the pressure and stress that 
can be caused when farmers, driven by their sense of identity and a duty of care, are unable to do 
what they consider to be the best by their animals. If a farmer feels duty-bound to protect the health 
and welfare of their cows, and their entire sense of identity depends on the ability to enact this duty, 
it is little wonder that feelings of distress occur where a farmer does not believe they have sufficient 
knowledge or where they are limited in their ability to treat as they see fit.  
Where antimicrobial use is concerned, farmers again expressed feelings of shame or defiance: 
“Antibiotics is a dirty word isn’t it?”  – Farmer 20 
While often acutely aware of the drive for reduced use, these emotional factors were perceived as 
limiting farmers’ treatment practice and ability to do the best by their animals. The concept of “this 
farm” being special was again very present. There was a perception that while reducing antimicrobials 
in agriculture overall was conceptually beneficial, measures to improve responsible use did not 
necessarily apply in the context of “this farm”.  





The themes that emerged during the analysis of the substantial body of data gathered during this 
study provide some original, empirical, qualitative evidence that significantly extends what is already 
known and moves it into a new domain; that of medicine use and treatment decision making. They 
agree with and greatly extend some of the themes reported in the existing literature and are situated 
within the context of medicine use. The idea of a farmer’s identity influencing management decisions 
has been described widely in the literature on the “good farmer”. When framed according to 
medicine-use behaviours, a farmer’s belief in the uniqueness of their own farm, coupled with their 
professional and personal identities, form the foundation upon which treatment decisions are made.  
Upon this foundation of identity lies the concept of trust. As has been described in this chapter, this 
trust is a liminal and relational concept that is continually renegotiated between the farmer and the 
‘key actors’ (the veterinary surgeon, staff, animals, medicine and data). Given the continuous and 
reactive nature of trust, the context and culture of an individual farm is inherently unstable and 
vulnerable to change as the nature of these trust-relationships change. This presents a  ‘moving target’ 
for industry and policy makers when trying to create any model for behaviour, even a farm-specific 
rather a one-size-fits-all model.   
Knowledge, however, may seem a more straightforward concept in some respects. Farmers develop 
their own understanding of treatment and disease based on their innate knowledge and the 
knowledge they have acquired through experiential and experimental means. However, they are 
bound by the knowledge they do not have. Farmers express a frustration with these self-identified 
knowledge gaps and a desire to be provided with more information, specifically information about 
medicines. They believe that veterinary surgeons should be providing this knowledge but are currently 
unsatisfied with the provision of information by their veterinary surgeons. A lack of communication 




between the veterinary profession and the farming community may explain some of this disparity and 
a focus on this area by both parties should be a priority in the future.  
While treatment decisions are a product of the identity, trust and knowledge of the farmer, they also 
depend upon the farmer’s autonomy, whether real or perceived. Where tensions are created between 
the farmer’s own experience-based judgements and the ability to implement these judgements, these 
tensions lead to stress and worry. Conversely, where treatment autonomy is aligned with 
collaboratively developed protocols, the outcome is a reduction in uncertainty and, accordingly, the 
stress that accompanies such uncertainty. 
One of the key drivers behind the treatment decisions made by the farmers in this study was their 
sense of having a duty of care over their animals. The cows and calves on the farm constitute 
domesticated dependents who rely entirely on the farmer to provide the means for their health and 
welfare. By using this inherent drive to care for their animals effectively, veterinary surgeons and 
policy makers may be able to improve animal health and welfare dramatically.  
 Study limitations 
One of the most frequent criticisms of ethnography - and of qualitative social science in general - is 
that the data produced may be biased. The researcher (by the very nature of their presence) may 
influence what people say or how they act. Hence, data must be analysed and discussed reflexively, 
acknowledging these influences (Kuper et al., 2008). Additionally, the researcher cannot entirely 
exclude their own preconceptions or ideas which may influence the way they analyse the data. In the 
case of this study, the researcher’s positionality as a veterinary surgeon may have influenced the 
behaviour and responses of the participants and also the analysis of the data. While the researcher 
(GR) did not volunteer her background as a veterinary surgeon, it would have been obvious that she 
had some experience in and understanding of normal dairy farming practices. Additionally, the 




researcher’s experiences working as a dairy veterinary surgeon will have inevitably coloured the 
analysis of the data.  
While these criticisms make an important and valid point, as Pool and Geissler (2005) argue, social 
knowledge is always positional. There is no way of observing a society without having a position within 
it, and as such, influencing it. The authors posit that this influence is “not a methodological flaw that 
must be hidden, but an integral aspect of this kind of research that we should accept and make explicit 
in the presentation of results” (Pool and Geissler, 2005, bottom of page 17). The strength of qualitative 
research lies in the richness and depth of data, and the reflexivity of the researcher. This tacit 
knowledge can serve as a source of data, and a powerful tool for interpretation and analysis in 
qualitative research (Giacomini, 2001). The ethnographer’s goal is not to establish “the truth”, but 
rather to explore the multiple contextual truths that are experienced by the people being studied 
(Emerson et al., 2011). The positivistic view of quantitative science cannot be appropriately applied to 
qualitative research, and its experiential, reflective and critical nature are to its credit, not detriment 
(May, 2002). 
During the 12-month period when research visits were taking place, participants became accustomed 
to the researcher’s presence and the writing of fieldnotes. A friendly working relationship developed 
between the researcher and the participants, and in one case a key informant requested social media 
contact and invited the researcher to join a family dinner. In all interactions with all of the participants, 
the relationship was friendly, cordial and somewhat inquisitive. Although it was anticipated before the 
commencement of fieldwork that gaining a level of trust and respect would take time and initially 
responses and behaviours might have been guarded and artificial, this did not appear to be the case 
in practice. The researcher was welcomed very quickly on all three farms, seen as a useful addition to 
the working team and given some roles to carry out while undertaking the research. On more than 




one occasion participants requested to see the ethnographic fieldnotes that were being written and 
expressed surprise at their boring nature and the interest in what they perceived to be the mundane 
and uninteresting day-to-day occurrences on their farms. 
This research relied upon 20 semi-structured in-depth interviews and three 12-month focussed 
ethnographies analysed together. While this may appear to be a small sample, the selection of the 
farms and the study area was intended to reflect an intentionally restricted geographical and cultural 
area where dairy farming constituted a distinctive and coherent social and economic practice and the 
use of antimicrobial medicines emerged as a key component of contemporary husbandry. Twenty 
interviews may not represent the views of all dairy farmers, and indeed they are not intended to do 
so. This study aimed to describe and investigate the daily practices and values of these farmers to 
provide an in-depth understanding of how medicines and medicine use has become part of the 
infrastructure of livestock farming while reflecting what may be true for the wider population. Many 
qualitative studies in veterinary medicine have used fewer interviews (Vaarst et al., 2002) or very short 
interviews conducted by telephone (Richens et al., 2015) without the benefit of in-depth participant 
observation to explore farmer attitudes and perceptions. In combining a highly focused case study 
employing both qualitative and quantitative data, this research therefore represents a robust study 
within the veterinary literature.  
The three farms where participant observation occurred were as unique as any farm in the UK, with 
their own specific contexts and cultures. This being said, each of these farms sits within the wider dairy 
farming context and culture of UK agriculture. The three farms on which this research focussed shared 
as many differences as they did similarities, and the insights gained bring a new understanding of 
antimicrobial use. These farms were all run by farmers who were engaged and interested in treatment 
outcomes and the health of their animals, while also being driven by a need to be productive and 




profitable. This manifested in different ways depending on the particular farm context. For example, 
the small, family run farm based treatment decisions on their in-depth knowledge of each particular 
cow’s history, temperament and subjective value to the farm, whereas the large farm with 700 dairy 
cows based their treatment decisions more at the herd level, and when considering individual animals 
would assess their value in terms of production and data analysis. These differences in the way the 
particular farm context affected the way in which treatment decisions were made - while still being 
driven by the same motivations and values as described in this chapter - present a fascinating 
confirmation of the importance of farm-specific context to the decision making process.  
An additional challenge in this thesis has been the focus on animal patients and the treatment 
decisions that affect them and their welfare as well as their value. This research has drawn attention 
to the duty of care farmers have towards their animals as an important consideration in making 
treatment decisions. While it is recognised that treatment decisions for dependent domesticated 
animal patients are likely to draw in part upon similar concerns for health, welfare and comfort that 
would apply to human patients, including the participant farmers themselves, the research 
undertaken here did not seek to specifically explore the epistemological and methodological 
challenges of understanding the differences between animal and human treatment decision making. 
Similarly, while it is accepted that decisions relating to preventative use of medicines are likely to be 
driven by different considerations than those relating specifically to therapeutic uses, the empirical 
work in this thesis intentionally focused on treatment decision making.  
 Policy implications & future research 
It became clear during the course of this research that dairy farmers in the UK do not use prescription 
veterinary medicines exactly as prescribed by their veterinary surgeon. Doses are increased or 
decreased, course lengths are altered, and medicine-choice is based on multiple factors of which 




veterinary advice is but one. A US study showed that 77% of surveyed veterinary surgeons believed 
that dairy farmers followed protocols for antimicrobial use (Cattaneo et al., 2009) while a different 
study also based in the US showed that 21% of farmers had written treatment plans and less than a 
third consulted their veterinary surgeon prior to treating sick animals (Sawant et al., 2005). In Sweden 
dairy farmers’ treatment decisions often differ from normal veterinary recommendations (Vaarst et 
al., 2002) and in the Netherlands and Germany it has become a social norm to extend antimicrobial 
treatment duration for mastitis (Swinkels et al., 2015). Given this dichotomy and the results of the 
research presented here, it follows that veterinary surgeons need to be made more aware of the 
actual practices occurring on farms under their care, especially given the veterinary surgeon’s ultimate 
responsibility for the health and welfare of the animals. 
There proved to be an appetite by participating farmers for more veterinary input, especially in the 
form of knowledge exchange, development of treatment protocols and practical, applicable herd 
health plans. For farmers to be able to value any treatment protocols it was necessary for them to be 
farm-specific and delivered in a collaborative rather than paternalistic way. While herd health planning 
is already a mandatory part of farm assurance schemes, policy-makers should consider improving the 
practical applicability of these herd health plans and encouraging collaborative development. 
The development of a trusting relationship between the dairy farmer and their veterinary surgeon 
should be an area of focus for the veterinary profession in the UK. While other research has shown 
that veterinary surgeons’ prescribing habits are not driven by income or profit (De Briyne et al., 2013, 
Gibbons et al., 2013), some farmers in this study perceived this to be the case and were consequently 
less likely to trust in their veterinary surgeon’s advice. Future research focussing on interventions 
aimed at improving farmer-veterinary surgeon trust and communication as a way of improving 
responsible medicine use would be beneficial. 




National control programmes have been shown to influence farmers’ attitudes, knowledge and 
behaviour with regards to mastitis (Jansen et al., 2010); such programmes could also be useful tools 
for encouraging behaviour change aimed at reducing antimicrobials. Further research is needed to 
evaluate the impact of treatment protocols on reducing treatment uncertainty and thereby improving 
responsible medicine use.  
More work should also be done to further investigate farmers’ sense of duty of care to their animals. 
The effectiveness of policy interventions aimed at improving farmers’ awareness of pain, disease and 
animal welfare indicators should be measured to determine whether, by improving recognition of 
poor health and welfare, farmers will alter their behaviour leading to lower treatment thresholds 
driven by this duty of care. Because treatments are often given by farmers, they represent positive 
action in the face of suffering, and therefore searching for alternative actions to that of antimicrobial 
use is a vital tool in the fight against AMR. It would be valuable to research whether farmers who use 
a more holistic approach to herd health (those who practice homeopathy or other alternative 
therapies, for example) have improved treatment practices purely due to the fact that they can use 
alternative remedies. Although scientific consensus reveals many of these therapies to be ineffective, 
the fact that farmers could take a positive action, allowing a disease process that would have always 
self-cured the time to do so and avoiding the need for antimicrobials, may be seen as a step forward. 
This approach, however, results in a risk of not treating animals who would require medical 
intervention. Seeking alternative actions and therapies where there is an evidence-base suggesting 
that pharmaceuticals are not required may indeed help to reduce the over-use of antimicrobials and 
other PVM. 
Finally, there is a need for greater emphasis on participatory policy development coupled with 
participatory action research (using ground-up rather than top-down approaches to behaviour 




change) amongst UK dairy farmers. This type of activity takes advantage of farmers’ desire to see the 
value in policy and research outputs, to tailor these appropriately to their own needs and, 
consequently, to increase their impact. As Ritter and others (2017, top of page 1) state “providing 
them (farmers) with rational but universal arguments might not always be sufficient to motivate on-
farm change”. A participatory approach, however, may be more effective at inducing genuine and 





























This thesis has explored and assessed the way that prescription veterinary medicines (PVM) are used 
on UK dairy farms through a mixed-methods approach. The work has considered the existing literature 
relating to PVM legislation, antimicrobial use and farmer behaviour, both nationally and 
internationally. This review of the literature identified several key knowledge gaps, which were used 
to formulate the research questions posed. Specifically, these knowledge gaps were the lack of quality 
and granularity of data available on antimicrobial use in the UK, the need for data on non-antimicrobial 
PVM use and the need for ethnographic study of medicine use behaviours.  
The research questions developed were: 
i. How are prescription veterinary medicines being stored on UK dairy farms? 
ii.  Can veterinary medicines sales data, on-farm medicine records or medicine waste bins be 
used to accurately estimate on-farm medicines use on study farms? 
iii. What are the values and practices of dairy farmers and what are the on-farm contexts 
affecting medicine use practice on UK dairy farms? 
From these research questions, three key studies were designed, each using a different research 
methodology. The first examined the PVM storage practices on the participating farms using a cross-
sectional study. The second was a method comparison study determining the levels of agreement 
between three different methods of recording PVM and a ‘gold standard’ measure. The third major 
study was ethnographic in nature, utilising 12 months of participant observation work on three dairy 
farms and combining these data with that of 20 semi-structured in-depth interviews with dairy 
farmers aimed at studying the values, beliefs and on-farm culture influencing PVM use.  
For each of these three studies, the results are discussed in detail in their respective chapters, and 
specific conclusions drawn from the work are presented. In this conclusion, the results of the different 





studies together, and to consider the broader narrative and contribution this work makes to the study 
of PVM and antimicrobial use in the UK.  
 Summary of findings 
i. How are prescription veterinary medicines being stored on UK dairy farms?  
UK dairy farmers were seen to store PVM in a broadly ‘correct’ way, although in varying quantities. 
Storage of expired and unlicensed medicines was common, and occasionally inappropriate medicines 
were present on farms.  
ii.  Can veterinary medicines sales data, on-farm medicine records or medicine waste bins be 
used to accurately estimate on-farm medicines use on study farms?  
Veterinary sales data showed the best levels of both clinical agreement and reliability of the three 
medicine use measuring methods. It showed moderate or good clinical agreement and good or 
excellent reliability with the pre-determined gold standard for injectable and intramammary 
antimicrobials. Medicine waste bins showed moderate clinical agreement with the gold standard 
when measuring injectable antimicrobials. On-farm medicine records did not agree with the gold 
standard for use, and, as such, are not an effective way of reliably measuring actual PVM use.  
iii. What are the values and practices of dairy farmers and the on-farm contexts affecting 
medicine use practice on UK dairy farms? 
The answers to this research question are complex, but the study described in Chapter 6 shows that 
the attitudes, values and contexts most relevant to medicine use practice can be broadly divided into 
four dominant themes: knowledge, trust, autonomy of treatment practice and a duty of care. The way 





contradictory. It is important, however, to realise that changing medicine use practices requires an 
understanding of all factors involved in treatment decisions.  
The overall narrative of this thesis shows that dairy farmers store, record and use PVM in varied ways 
that have previously been unrecorded in the literature.  While this  variation did not seem to be 
explained by herd size, productivity or management type when visually examined, studies with greater 
power would be required to prove this. However, there are likely to be cultural and social reasons for 
the differences in medicine use practices described. The values and beliefs of dairy farmers which 
were manifest in this research may go some way to explaining the variations in practice observed. The 
on-farm context within which treatment decisions were made was also evident as a factor influencing 
medicine use practices, for example which member of staff was responsible for the decision and which 
particular animal required treatment. 
These values, practices and contexts are important to inform our understanding not only of PVM 
treatment decisions but also to the way in which PVM are stored and the accuracy of different 
methods of recording use. An example of this is the low value farmers placed on the regulatory 
frameworks within which they must operate and the effect of these frameworks on the quality of farm 
medicine records being maintained. Equally, this thesis has argued that the way in which PVM are 
stored and recorded influences the treatment practices observed, for example resource availability 
having a direct impact upon treatment choice: if a medicine is not present in the medicine cupboard 
it is unlikely to be considered for use. The inextricable links between storage, recording and use of 
PVM are a key finding that has been demonstrated in this thesis. 
 Contribution to scientific knowledge 
This thesis provides an original and necessary contribution to scientific knowledge and the body of 





• By demonstrating original findings which have been published in a peer-reviewed journal 
describing the storage of expired and unlicensed medicines on UK dairy farms, the variation 
in the quantities of medicines stored and the storage methods, 
• By determining the levels of agreement between different veterinary medicine recording 
methods and a ‘gold standard’ for use, 
• Through establishing the values, beliefs and on farm contexts influencing veterinary medicine 
treatment practices. 
The strengths of this thesis lie in the study design – through using different methodological approaches 
it has been possible to examine the topic of medicines use through different lenses. Using this mixed-
methods approach, it has been possible to build a rich picture of PVM use on UK dairy farms.  
The three farms where participant observation was conducted can be viewed as case studies. It is not 
claimed that these farms are representative of all farms, however some particular insights and lessons 
from observation of these three farms can be taken forward. What this research is providing is 
threefold: 
1. The development of a triangular methodology that has been tested in this particular context 
and can be used elsewhere, in other contexts, 
2. A demonstration of how medicine use is strongly influenced by context, hence highlighting 
that it is critical to understand the context and the specificity of such use. This also highlights the fact 
that context is social, technical, economic and geographical, amongst other factors. Only by 
investigating and understanding the importance of this contextual variation do we come close to a 
genuine understanding of how medicines are used and how the different approaches to 





3. An illustration of how different ways of understanding medicine use do not always fit together 
nicely, and that policies and strategies based upon one particular sense of use may well fail in a 
different context if those designing the policies or strategies do not understand what else is going on 
in practice.  
This being said, these case study farms are real farms using real medicines to treat real disease. They 
are not hypothetical or ’model’ farms which represent all of dairy farming, although some of these 
insights can be used towards future models of treatment decision across the wider dairy farming 
sector. While the results derived from this study are not, and were never intended to be, generalisable 
across the entire industry, they can be used to develop models of behaviour and treatment decision 
making - including behavioural intervention work - which could be tested across the different contexts 
of the broader dairy farming population 
The use of medicine, particularly antimicrobial treatments, being seen as almost a signalment of the 
“good farmer” across these three farms was, while expressed in different ways, a strong emergent 
narrative which was further substantiated by some of the semi-structured in-depth interviews. 
Similarly, during the course of the data collection it became apparent that some farms could be 
described as tidier than others, and that there appeared to be some form of correlation between the 
presentation of a farm and their use of antimicrobials. The four themes that emerged in this research 
can help to explain this point, and to understand how this work fits within the wider thesis when taken 
together with the quantitative work presented in Chapters 4 and 5. 
For example, during the course of the data collection it became apparent to the researcher that some 
farms could be described as taking greater care in their presentation than others. When driving onto 
a farm for the first time, it was possible to place farms on a scale ranging  from “tidy farm” to “untidy 
farm” based on the upkeep of the farm track (potholes/mud/cracked concrete), the organisation and 





and other such markers. While this was not objectively measured in this project as it had not formed 
part of the initial research questions, what appeared to emerge during data collection and subsequent 
analysis was that perhaps those farms which could be classed as “tidy” were more likely to have good 
quality medicine records, have greater compliance with medicine bin use, store their medicines in a 
more orderly way and have different motivations and values regarding treatment decisions than those 
farms which could be classed as “untidy”. Although it was not possible with the data in this thesis to 
directly compare the subjective “tidiness” of farms with their medicine use or farmers’ values as 
elicited from interview and participant observation, it is an interesting observation that warrants 
further research. The four themes emergent from the data in this chapter may go some way to explain 
this relationship: a “tidy farm” may be more engaged with external advisors and peers, gaining greater 
knowledge about medicine use and developing trusting relationships with veterinary surgeons and 
other sources of knowledge. These farms may feel they have greater autonomy of treatment practice, 
perhaps they are more financially secure or have more fixed succession planning in place. Additionally, 
there may be a link between the inherent drive to present a tidy farm to the world, and to present 
healthy animals to the world, as described in “a duty of care”. While this explanation is clearly 
speculative in nature, given the constraints of the data and the subsequent inability to fully analyse it 
through this lens, it does present an interesting, original research question and a rich area for future 
work. 
The implications of the research are far-ranging, as discussed later in this chapter. The contribution 
this thesis makes to knowledge has been original and important, in an area of intense political and 
scientific focus. The knowledge gaps identified in the literature review and outlined above were used 
to design and implement the studies detailed in Chapters 4 – 6, which have yielded interesting and 
valuable results. Given the pioneering nature of this work, the results of this study can be used as an 





knowledge gaps and research questions which can be pursued in future work. These policy 
implications, practical applications and areas for further research are discussed below.  
 Strengths and limitations of the Thesis 
The strengths and limitations of each individual study are discussed in their respective chapters; 
however, it is important to note some of the strengths and limitations of the thesis as a whole. Some 
of the key strengths can be summarised as: 
• The study used mixed methodologies, combining quantitative, qualitative and ethnographic 
approaches, in order to establish a deep and insightful understanding of the practices of medicine use 
within livestock farms. 
• The study enabled the identification and analysis of the values, beliefs and on-farm contexts 
that differentially influenced - in complex and multiple ways - the veterinary medicine treatment 
practices and provided insights into the potential impact of these influences. 
• The positionality of the researcher as a veterinary surgeon with extensive experience of dairy 
cattle practice provided excellent access, compliance and easy communication between the 
researcher and the participants. The development of a trusting relationship was made possible in part 
by the researcher being able to demonstrate and aptitude for and ease with working on a dairy farm, 
along with technical knowledge of dairy farming and medicine treatments.  
• The study provided the ability to triangulate some data between the different research studies 
in order to gain a further depth of understanding. 
 The limitations of this research can be summarised as: 
• The use of purposive sampling of dairy farm participants in this thesis may introduce the 





valid method, and the demographic data of the recruited farms did broadly reflect those of the UK 
dairy farming population. 
• The positionality of the researcher as a veterinary surgeon may have influenced the behaviour 
and responses of the participants and also the analysis of the data. This was mitigated in so far as 
possible in the quantitative research by analysing the data in a positivistic way, with data validation 
being done by other researchers. For the qualitative data, this was achieved by adopting an informed 
but neutral approach, with the researcher presenting herself as a university research student without 
an agenda and analysing the data reflexively, accounting for the effects of positionality as described 
in Chapters 3 and 6. 
• Prescription veterinary medicine storage practices and recording may have been influenced 
by the research being undertaken. Beginning the research with a PVM inventory may have had 
subsequent consequences on the way PVM were being used for the 12 months studied, due to the 
on-farm resources being an important part of treatment decision making, as described in Chapter 6. 
In this study, farmers were asked not to change PVM storage prior to the first visit and it was 
emphasised that the researcher was not there to audit their practices and report back to any 
legislative body but was simply interested in the real practices found on farms. Similarly, with medicine 
records it was emphasised that the work was designed to show what happens on real farms, not to 
demonstrate perfect practice. The presence of expired and unlicensed medicines across many of the 
study farms in Chapter 4 indicated that storage practices were unlikely to have been significantly 
improved as a consequence of this approach. 
• It was not possible to triangulate all data across all three studies. For example, not all of the 
farmers who participated in the semi-structured in-depth interviews were from farms who 
participated in the cross-sectional study of the medicine cupboards, and not all farms that participated 





• The research took place between September 2016 and April 2018. During this time, milk prices 
were initially very low (below the cost of production) and then improved progressively, while the 
political environment was changing rapidly following the Brexit vote and the development of a post-
Brexit agriculture bill. The outcomes of this research therefore may not reflect PVM use during more 
stable markets or during different political and cultural climates. 
The nature of mixed-methods research is such that it always requires some compromise between the 
demands of quantitative methodologies and those of qualitative methodologies. These limitations 
include questions of sample size, sampling method, scientific rigour and epistemological approach. 
These compromises - and the justifications and precedents for the use of mixed methods - have been 
discussed at length in Chapter 3. Essentially, the added value of methodological pluralism through 
data triangulation and combined interpretation can lead to an outcome far greater than the sum of 
its parts.  
The opportunities for further work validating and exploring that which is laid out in this thesis are 
discussed in the next section. 
 Further work 
There are multiple opportunities for further work to continue to explore and evaluate the outcomes 
communicated in this thesis. The exploratory nature means that the results of this original work would 
benefit from further research in order to validate the findings. 
By repeating the cross-sectional study of veterinary medicine cupboards on dairy farms in successive 
years, trends in medicine storage and use could be identified. Increasing the number of farms studied 
would be beneficial, as would sampling farms from a wider geographical area than that included in 
this thesis. By using repeated measures of medicine storage over successive years, changes in storage 





particularly important given recent changes to restrict the use of HP-CIAs across the agricultural sector 
in the UK as outlined in Chapter 2. 
Repeating the PVM measurement method comparison study across a greater number of farms 
distributed across the whole of the UK would help to show whether these findings are repeatable and 
representative of UK dairy farms. With the introduction of several new electronic medicine recording 
tools for farmers on the market likely in the coming years, it is important to investigate whether these 
new recording systems have a positive or negative effect on the reliability of the data collected. If the 
industry is considering moving away from the current veterinary sales data model for antimicrobial 
use recording towards using farm-based records - as is indicated by the piloting of a national electronic 
cattle medicine book - the validity of this recording method must be elucidated.  
Further ethnographic work with veterinary surgeons and dairy farmers would add to the foundation 
developed in this thesis. For example, by conducting interviews with other key actors in the treatment 
decision paradigm (e.g. employed farm workers or family members with less overall decision-making 
authority) it would be possible to further explore the subversive treatment behaviours and 
organisational hierarchy identified in the participant observation work presented in Chapter 6. In 
addition, participant observation with prescribing veterinary surgeons and veterinary practice staff 
involved in dispensing  these medicines and providing treatment advice to dairy farmers would yield 
a wealth of data that would help to further colour the picture.  
In addition to furthering the work presented in this thesis, there is a need to repeat this research in 
different contexts and locations. The knowledge gaps identified about the use of PVM on UK dairy 
farms are arguably larger for smallholdings, and for beef and sheep farming. By examining the 
contents of medicine cupboards on these farms, exploring medicine use measures and conducting 
ethnographic work, it would be possible to align the knowledge base with that now available for dairy 





use on UK dairy farms with those in other settings. The legislative, cultural and systematic differences 
between dairy farms in these countries would likely yield results that differ from those presented here. 
It is, however, possible that some universal truths about medicine use on farms remain, and it would 
be very valuable to explore this further.  
 Policy implications and practical impact 
The results presented in this thesis have many implications for policy makers, industry stakeholders 
and the veterinary profession. As it is an under-researched area (as outlined in Chapter 2), adopting 
evidence-based policy is difficult with regards to PVM use. The prescription, dispensing, use and 
recording of PVM is a highly regulated area (again, as described in Chapter 2), however the impact of 
this regulation, the adherence of veterinary surgeons and dairy farmers to current legislation and the 
potential for targeted and meaningful behaviour change to improve responsible medicine use has 
been largely unknown.  
The way in which PVM are being stored on dairy farms is an entirely new area of research in the UK 
and there has been a significant level of interest in the results of this work when disseminated to the 
veterinary profession and key stakeholders. The results of this work have been published in a peer-
reviewed publication aimed at UK practising veterinary surgeons (Rees et al., 2018). The conclusions 
of this paper called for veterinary surgeons to include a medicine cupboard ‘health check’ in their 
annual herd health planning. This publication has had a direct impact on the veterinary profession: 
upon its publication during World Antibiotic Awareness Week 2018, the University of Bristol, the 
British Veterinary Association, the British Cattle Veterinary Association and the Responsible Use of 
Medicines in Agriculture Alliance issued press releases calling for veterinary surgeons to work with 
their farmers to ensure that expired and inappropriate medicines were disposed of correctly and did 





veterinary profession and the agricultural sector, leading to more responsible use of veterinary 
medicines. 
The differences shown between the methods of measuring PVM use also have important ramifications 
for the agricultural industry, milk buyers and government policy advisors. The results presented in 
Chapter 5 support the Veterinary Medicines Directorate’s current move towards using veterinary sales 
data to improve data granularity with regards to antimicrobial use monitoring and provide a much-
needed evidence base for this method of surveillance. Academics who use medicine waste bins now 
have some validation of this research method, particularly in instances where veterinary sales data is 
not available. Policy decisions regarding the use of on-farm medicine records for medicine use 
monitoring should bear in mind the results of this research which show that they do not currently 
reflect actual medicine use. 
Given that knowledge about the way in which a medicine should be used is only part of the overall 
context within which a treatment decision is made, policy that focusses on knowledge transfer alone 
is unlikely to make a significant difference to on farm treatment practices. In fact, it seems likely that 
only through a combination of many different strategies aimed at different areas affecting medicine 
use is real and impactful change likely to be brought about. In this work, farmers expressed a desire 
for more formal training in responsible medicine use, and in July 2018 the Animal Medicines Best 
Practice programme was launched by the National Office for Animal Health in collaboration with 
Lantra, a provider of training and qualifications in land-based skills. This initiative aims to provide the 
resources for training in responsible medicines use and appears to directly answer this identified 
industry need. The impact of this new initiative has yet to be seen, and private veterinary practices 
have also begun to offer training in medicine use to farmers. Hence, this evolving picture will be in 





This thesis has shown that farmers desire a sense of autonomy; as such, using participatory 
approaches that empower farmers may be useful. Farmers need to trust their advisors and their staff, 
which may indicate a need for human resources and management skills training to be provided to 
them. The duty of care that dairy farmers feel towards their animals – which, in turn, drives the use of 
‘treatment as action’ - suggests that the veterinary profession and policy makers may need to provide 
alternatives to antimicrobials so that farmers can still feel as if they are taking positive steps to 
improve the health and welfare of their animals in the face of uncertainty. Lastly, the development of 
treatment protocols - in collaboration with veterinary surgeons and specifically designed for their 
particular farm - is likely to be positively received and lead to less uncertainty and more responsible 
medicine use practice.  
This work also shows that the experiential and experimental knowledge acquired by dairy farmers 
strongly affects their understanding of disease, their trust in medicine and, subsequently, their 
treatment decisions. While the tenets of evidence-based veterinary medicine may abhor the design 
of these pseudo-scientific evidence sources, rather than dismiss this as ‘bad science’, it is very 
important that veterinary surgeons and academia engage fully with this driver of knowledge and 
practice. By encouraging on-farm experimentation and drawing on the considerable practical 
experience of dairy farmers, it should be possible to utilise a rich source of information that can be 
used to improve medicine use practices. It is important to encourage ‘good science’ and critical 
thinking amongst farmers while also appreciating and working with the evidence that farmers hold 
valuable. 
There are also practical implications to the research presented in this thesis. For veterinary surgeons 
who work with dairy farmers, key recommendations include the need to discuss PVM storage and the 
disposal of expired and unlicensed medicines. By utilising proactive and practical herd health planning, 





help to increase trust and therefore make veterinary advice uptake more likely. The incorporation of 
a medicine cupboard ‘health check’ into the annual herd health plan could be very powerful, 
particularly if physically standing in front of the medicine cupboard and discussing the contents leads 
to more impactful and practical change. This would enable veterinary surgeons to identify and offer 
to dispose of expired medicines, discuss off-licence medicine use via the Cascade system, ensure 
farmers are confident knowing which medicines to use and when, and communicate any new 
developments or possible improvements to the current medicine use practices on the farm. The 
benefits of this approach would apply to the farmer - who has the opportunity and time for open 
communication about medicines with their veterinary surgeon – as well as be of benefit to the 
veterinary surgeon by increasing engagement, providing an opportunity to discuss and prescribe new 
medicines as appropriate, identifying any particular concerns with herd health or medicine use in 
general and to replacing expired medicines with newer ones.  
The practical implications of these results for dairy farmers should not be understated. While 
influencing policy decisions, academic research and veterinary advice are key goals, the people using 
these medicines (the farmers themselves) are the ones ultimately affected by any recommendations 
made. Investing in staff management strategies to improve trust between the various actors on farm 
in combination with formal training in responsible medicine use and the collaborative development 
and use of treatment protocols are likely to have the greatest positive impact on treatment practices. 
Additionally, emphasising the value of accurate medicine records and practical applications of herd 
health advice - in combination with improved understanding of the need to remove expired and 
inappropriate medicines - should be the message communicated to the farming community. 
With this new understanding of prescription veterinary medicine use on UK dairy farms, we can hope 
to collaboratively move toward a future where evidence-based, good quality data and anthropological 





objective, while ambitious, could benefit not only dairy farmers and the cows they care for but also 
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Appendix 1: Participant information leaflet for medicine audit farms 
 
      
 
Participant Information Sheet 
 
Study title: Understanding on-farm medicine use in dairy cattle: Addressing 
the knowledge gap 
We would like to invite you to participate in our research study. Before you decide, we would like 
you to understand why the research is being done and what it would involve for you. Talk to others 
about the study if you wish, and please do ask us if there is anything that is not clear. 
What is the purpose of this study? 
This study aims to bring about a greater understanding of the way medicines are used in dairy cattle. 
Currently little is known about what happens to prescribed medicines after they are sold by the 
veterinary practice. The focus of the study is to try and understand how medicines are used, the 
reasons why they are used as they are and whether this use is reflected by the veterinary sales data 
from your veterinary surgeon.  
Why have I been invited? 
You have been invited to participate in this study for one of the following reasons: 
a) You have been suggested as a suitable participant for this study by your veterinary practice 
b) You have been approached by the researchers directly because you fit the criteria for the 
study  
There will be around 20-30 dairy farms in total recruited to this study. 
Do I have to take part? 
It is up to you to decide to join the study. We will describe the study and go through this information 
sheet with you. If you agree to take part, we will then ask you to sign a consent form. You are free to 
withdraw from the study at any time, without giving a reason.  
What will happen if I take part and what will I have to do? 
Involvement in this study will be over a period of 12 months, from September 2016 – August 2017, 
during which time the researcher is likely to visit 4-6 times.  




• Complete a participant information questionnaire gathering data about your farming 
enterprise 
• Participate in an in-depth interview with the researcher. This interview will last 
approximately 60-90 minutes. This interview will be audio-recorded using an encrypted 
dictaphone and transcribed for analysis. All data used from these interviews will be made 
anonymous and may include the use of anonymised quotes.  
• Allow veterinary prescription data from your veterinary surgeon to be viewed. The 
researcher will collect data of all of the medicines prescribed to your farm over the course of 
a year, from September 2016-August 2017. No financial records or drug costs will be sought, 
the data used will include the name of the drug, formulation, volume sold and dates. 
• Allow the contents of the medicine cabinet and any other areas where medicines are stored 
on the farm to be examined at intervals throughout the year. Photographs may be taken of 
relevant areas of medicine storage and use and other areas of the farm to help illustrate the 
research, where appropriate. These photographs will be anonymised. 
• You will be asked to throw away all empty medicine packaging/bottles etc. into the bins 
provided for the course of the whole year. The researcher will examine the content of these 
bins every 2-3 months after which they can be emptied. 
• Provide access to your medicine records and herd health plan for analysis 
All of the data collected on the farm will be stored securely at the University of Bristol and will be 
completely confidential. Any names or identifying features will be removed from the data collected 
from this farm before is it made public. 
The study is about gathering data about what happens on a day-to-day basis on your farm. This 
study will not provide guidance about medicine use, aim to reduce, influence or in any way change 
medicine use on your farm. 
Will I be paid to take part in this study? 
There is no payment for participation, however following participation in this study a small token of 
gratitude will be offered. This might be tickets to a national diary show, a conference or gift tokens 
with a value in the region of £30-50 
What are the possible disadvantages and risks of taking part? 
There are no foreseen disadvantages or risks of taking part in this study. However suspected 
notifiable diseases, illegal practices or mistreatment of animals would require reporting to the 
relevant authority by the researcher, as they would by any other visitor to the farm.  
What are the possible benefits of taking part? 
We cannot promise that this study will provide any immediate benefits to you, however the 
information we get from this study will help to inform the agricultural community, veterinarians, 
those in research development and policy-makers about how veterinary medicines are being used 
across the dairy industry. Many people enjoy participation in research, particularly expressing their 
views during in-depth interviews. 




All information gathered about you and the farm will be handled in confidence by us. All data will be 
stored on encrypted computers or in locked cabinets at the University of Bristol. Audio-recordings of 
the interview will be made using an encrypted dictaphone. These interviews will be transcribed, 
coded and the results anonymised. Quotes from interviews may be used, but these will also be 
anonymous, any names or identifying features will be removed.  
Data from this study will be available to genuine researchers upon request, and will be stored for 20 
years. After this point it will be disposed of securely. 
What will happen if I don’t want to carry on with the study? 
You can withdraw from this study at any time without giving a reason. The data collected up until 
the date of withdrawal will still be included in the study. 
 
What will happen to the results of the research study? 
It is intended that the results of this study will be published in the scientific literature, and presented 
at national and international conferences. Results may also be publicised through the agricultural 
press. A ‘newsletter’ giving an overview of the study results will be sent to you and all other 
participants once the study and analysis have been completed. You will also be invited to a meeting 
where the results will be presented. Your individual results will not be available. 
Who is organising and funding the research? 
This research forms the basis of a PhD project by Gwen Rees through the University of Bristol. The 
study has been funded by the Langford Trust, a charity promoting the practice, advancement and 
teaching of veterinary science.  
Who has reviewed the study? 
The University of Bristol Research Ethics Committee has reviewed this study 
Where can I find out further information? 
For any further information, please contact the lead researcher: 
Gwen Rees 




+44 7855 804270 gwen.rees@bristol.ac.uk 
 
If you have any concerns related to your participation in this study please contact the Research Support Officer: 





Appendix 2: Participant information sheet for farms undergoing 
participant observation 
 
      
Participant Information Sheet  
(Participant Observation Farms) 
Study title: Understanding on-farm medicine use in dairy cattle: Addressing 
the knowledge gap 
We would like to invite you to participate in our research study. Before you decide, we would like 
you to understand why the research is being done and what it would involve for you. Talk to others 
about the study if you wish, and please do ask us if there is anything that is not clear. 
What is the purpose of this study? 
This study aims to bring about a greater understanding of the way medicines are used in dairy cattle. 
Currently little is known about what happens to prescribed medicines after they are sold by the 
veterinary practice. The focus of the study is to try and understand how medicines are used, the 
reasons why they are used as they are and whether this use is reflected by the veterinary sales data 
from your veterinary surgeon.  
Why have I been invited? 
You have been invited to participate in this study for one of the following reasons: 
c) You have been suggested as a suitable participant for this study by your veterinary practice 
d) You have been approached by the researchers directly because you fit the criteria for the 
study  
There will be around 20-30 dairy farms in total recruited to this study, of which 3-5 will include year-
long observation. 
Do I have to take part? 
It is up to you to decide to join the study. We will describe the study and go through this information 
sheet with you. If you agree to take part, we will then ask you to sign a consent form. You are free to 
withdraw from the study at any time, without giving a reason.  




Involvement in this study will be over a period of 12 months, from September 2016 – August 2017, 
during which time the researcher is likely to visit often and spend time on the farm observing normal 
daily routines.  
During the study you will be asked to: 
• Complete a participant information questionnaire gathering data about your farming 
enterprise 
• Participate in an in-depth interview with the researcher. This interview will last 
approximately 60-90 minutes. This interview will be audio-recorded using an encrypted 
dictaphone and transcribed for analysis. All data used from these interviews will be made 
anonymous and may include the use of anonymised quotes.  
• Allow the researcher to visit regularly to observe the normal routine administration of 
veterinary medicines and other daily work. This may include visiting during TB testing, while 
worming or vaccinating animals, foot trimming, during milking and at other periods. 
• The researcher will be in regular telephone contact, in order to discuss any ongoing 
medicine and health issues and to arrange times and days to visit. 
• Allow veterinary prescription data from your veterinary surgeon to be viewed. The 
researcher will collect data of all of the medicines prescribed to your farm over the course of 
a year, from September 2016-August 2017. No financial records or drug costs will be sought; 
the data used will include the name of the drug, formulation, volume sold and dates. 
• Allow the contents of the medicine cabinet and any other areas where medicines are stored 
on the farm to be examined at intervals throughout the year. Photographs may be taken of 
relevant areas of medicine storage and use and other areas of the farm to help illustrate the 
research, where appropriate. These photographs will be anonymised.  
• You will be asked to throw away all empty medicine packaging, bottles, etc. into the bins 
provided for the course of the whole year. The researcher will examine the content of these 
bins every 2-3 months, after which they can be emptied. 
• Provide access to your medicine records and herd health plan for analysis 
All of the data collected on the farm will be stored securely at the University of Bristol and will be 
completely confidential. Any names or identifying features will be removed from the data collected 
from this farm before is it made public. 
The study is about gathering data about what happens on a day-to-day basis on your farm. This 
study will not provide guidance about medicine use, aim to reduce, influence or in any way change 
medicine use on your farm. 
Will I be paid to take part in this study? 
There is no payment for participation, however following participation in this study a small token of 
gratitude will be offered. This might be tickets to a national diary show, a conference or gift tokens 
with a value in the region of £50-100 
What are the possible disadvantages and risks of taking part? 
There are no foreseen disadvantages or risks of taking part in this study. However suspected 
notifiable diseases, illegal practices or mistreatment of animals would require reporting to the 




What are the possible benefits of taking part? 
We cannot promise that this study will provide any immediate benefits to you, however the 
information we get from this study will help to inform the agricultural community, veterinarians, 
those in research development and policy-makers about how veterinary medicines are being used 
across the dairy industry. Many people enjoy participation in research, particularly expressing their 
views during in-depth interviews. 
Will my taking part in the study be kept confidential? 
All information gathered about you and the farm will be handled in confidence by us. All data will be 
stored on encrypted computers or in locked cabinets at the University of Bristol. Audio-recordings of 
the interview will be made using an encrypted dictaphone. These interviews will be transcribed, 
coded and the results anonymised. Quotes from interviews may be used, but these will also be 
anonymous, any names or identifying features will be removed.  
Data from this study will be available to genuine researchers upon request and will be stored for 20 
years. After this point it will be disposed of securely 
What will happen if I don’t want to carry on with the study? 
You can withdraw from this study at any time without giving a reason.  
What will happen to the results of the research study? 
It is intended that the results of this study will be published in the scientific literature and presented 
at national and international conferences. Results may also be publicised through the agricultural 
press. A ‘newsletter’ giving an overview of the study results will be sent to you and all other 
participants once the study and analysis have been completed. You will also be invited to a meeting 
where the results will be presented. Your individual results will not be available. 
Who is organising and funding the research? 
This research forms the basis of a PhD project by Gwen Rees through the University of Bristol. The 
study has been funded by the Langford Trust, a charity promoting the practice, advancement and 
teaching of veterinary science.  
Who has reviewed the study? 
The University of Bristol Research Ethics Committee has reviewed this study 
Where can I find out further information? 
For any further information, please contact the lead researcher: 
Gwen Rees 
+44 7855 804270 gwen.rees@bristol.ac.uk 
 
If you have any concerns related to your participation in this study please contact the Research Support Officer: 





Appendix 3: Consent form  
 
       
CONSENT FORM 
Title of project: Understanding on-farm medicine use in dairy cattle: 
Addressing the knowledge gap 
Name of Researcher: Gwen Rees 
 
1. I confirm that I have read and understand the information sheet dated 
[09.05.2016] [Version number 1.2] for the above study. I have had the 
opportunity to consider the information, ask questions and have had those 
answered satisfactorily.   
 
2.  I understand that my participation is voluntary and that I am free to withdraw 
at any time without giving any reason 
 
3.  I understand that relevant veterinary and farm data, as described in the 
information sheet, which is collected during the study may be made available, 
in anonymised form, to genuine researchers upon request 
 
4.  I agree to the use of audio-recording equipment in this study and the possible 
use of anonymised quotes and photographs in any future publications 
 
5.  I agree to my veterinary surgeon being informed of my participation in this 
study 
 
6.  I agree to my veterinary medicine prescription data (excluding financial data) 
being made available by my veterinary surgeons for the purposes of this study 
 
7.  I agree to take part in the above study 
 
________________________            ______________________           _________________________ 
Name of Participant   Date    Signature 
________________________             ______________________          ________________________ 































The following data will be used as part of the study “Understanding on-farm medicine use in dairy 
cattle: Addressing the knowledge gap” 
This questionnaire is to be asked verbally and completed by the researcher during the first visit to 
the farm.  
NAME………………………………………………………………………   DATE……………………………………………… 




NAME OF VETERINARY PRACTICE………………………………………………………………………………………………………. 
NAME OF VETERINARY SURGEON……………………………………………………………………………………………………….. 
Farmer and Household Characteristics 
Age:   
18-30,     31-40,     41-50,      51-60,       61+ 
Formal education level:  




Children? (Please include ages) 






Number full-time employees: 




Number of cows currently in milk  
Number of dry cows  
Number of breeding bulls  
Number of in-calf heifers  
Number of yearling heifers  
Number of replacement heifers 8 weeks - 12 
months  
 
Number of replacement heifer calves 0-8 
weeks  
 
Number of other calves 0-8 weeks   
Number of male or beef-cross cattle 8 weeks 
– 12 months  
 
Number of male or beef-cross cattle over 12 
months 
 
Other cattle (beef) – detail age and breed  
 
Number of sheep/goats  
Number of pigs  
Number of horses/donkeys  
Number of alpacas  






Other businesses or diversification  
 
 
Grazing land available (hectares)  















Total annual milk sales  
Average 305-day milk yield (L)  
Annual yield/cow (L)  
Milk price (ppl) (average for last 12 month)  
Average Somatic Cell Count  
Average Bactoscan  
Average milk fat %  
Average protein %  




How many times are the cows milked daily?  















Housing – description 















Average age at first calving  
Average calving-to-conception interval 
(days) 
 
Dry cow period length  
AI or natural service? AI / Natural service 
Average no. serves/conception  
100-day in-calf rate  
200-day in-calf rate  
300-day empty rate  










Annual vet spend (£)  
Herd health plan? 




Health benchmarking Y/N 
 
 
Cull rate  
Death rate  
Describe dry cow management 
(blanket/selective) 
 
Blanket / Selective 




Where are cattle sourced from?  

















Are new stock quarantined? Y / N 
Does the herd have high health status? Y / N 
 








Respiratory disease in calves 
(cases/100/year) 
 
Gastrointestinal disease in calves 
(cases/100/year) 
 
Clinical mastitis (cases/100 cows/year)  







Appendix 6: Initial visit checklist 
 
      
 
Bin Audit Farm Enrolment Visit Checklist 
 
General:  
1. Clean boots and coveralls 
2. Bucket, brush and soap 
3. Pen & notebook 
4. Camera 
5. Consent form 
6. Extra copies of participant info sheet (will have been sent out before) 
7. 1-2 big bins plus 1 small bin for parlour (or as discussed) 
8. Sharps bin 
9. Medicine cupboard audit sheet 
10. Farm identification labels 
11. Questionnaire / laptop for structured questionnaire 
12. Signs and sticky tape 
 
On Farm: 
1. Place bins as agreed with farmer 
2. Stick up signs 
3. Audit medicines cupboard and anywhere else drugs may be stored 
4. Get farmer to complete consent forms and questionnaire 
5. Record day book/medicine book use 
 
On Return: 
1. Label all worksheets with farm identification 















PLEASE PLACE ALL USED MEDICINE CONTAINERS IN THIS BIN 
STOP!!! 
 






Please DO place in these bins: 
 
ALL empty medicine bottles  
ALL used intra-mammary tubes 
ALL used eye tubes 
ALL used medicine containers 
ALL expired or waste medicine 
ALL used vaccine bottles 















Appendix 8: Bin Audit Farm visit checklist 
 
      
 
Bin Audit Farm Visit Checklist 
 
General:  
13. Clean boots and coveralls 




18. Notebook for general comments/observations 
 
Drug Use Recording: 
1. Box of 12 plastic clinical waste binbags 
2. Farm identification labels (at least 12 per farm) 
3. Spare sharps container (in case needs exchanging) 
4. Bin Audit Tally Worksheet 
 
On Farm: 
6. Empty contents of bins into bags 
7. Check if sharps bin needs changing 
8. Record day book/medicine book use 
9. Check farmer happy with bin use and bin number/location 
 
On Return: 
3. Process binbags according to protocol 
4. Enter all medicine waste into dedicated farm spreadsheet 




Appendix 9: Semi-structured in-depth interview topic guide 
 
In-depth interview guide 
(Semi-structured – topic guides only) 
 
Introduction:  
“This is an informal conversation so that I can try to understand how you feel and what you think 
about medicine use on your farm, and on farms in general. I have some questions and areas I’d like 
to ask about, but at any point you may say anything you think is relevant and there is no fixed 
structure. It should take around an hour, and at the end you can add anything else you would like to 
say. This interview will be recorded using this dictaphone, but if you want it turned off at any time I 




General intro  
Did you always know you would be a dairy farmer? 
Can you tell me about some of the positive and negative things about farming? 
How do you see this farm looking in the future? 5 years, 10 years, 20 years? 
Animal Health 
How would you describe the health of the animals on the farm? 
How much of a difference do you think you make to the health and welfare of the animals on your 
farm? 
How do you assess the health of your animals? (Tools/ computer/ benchmarking/ “just know”/ 
veterinary input?) 
Can you describe the culling policy on your farm? 
Medicine use 
Who makes the treatment decisions on farm? 
How do you decide which medicines to use when? Do you get advice from anyone? 




Doses/ course length – how do you decide how much or how long? Do you ever change this 
depending on the situation? 
How full do you like to keep your medicine cupboard? Why? 
Where do you feel most of your medicine spend goes? And the most antibiotics? 
Do you think you could use less medicines? 
What are your thoughts about using vaccines? 
A lot of farms are using medicines that have gone out of date – what do you think about that? 
Do you use antibiotic footbaths? 
Veterinary relationship 
How often do you see the vet in a given year? Is this usually for routine visits or for emergencies? 
How would you describe your relationship with your vet? What do you use them for and how do 
they contribute to the running of your farm? 
• Just a conduit for medicine, or mostly for advice?  
• Health planning or emergency treatment 
• One vet or many? 
• What about new graduates 
What information does the vet provide about the medicines sold to you? Which to use, what dose, 
how long for? 
• Do you find this information useful?? 
• Is it clear? Easy to understand and utilise? 
• How would you prefer to get this information about the medicines? 
Medicine recording, storage, disposal 
How do you store medicine on your farm? Why? What about fridge goods? 
What about recording use? Where do you record what you use?  
Do you find the medicines book a useful way of recording medicine use? Does anyone look at it? 
Do you tend to use everything that the vet sells you, or does some go to waste? 
What happens to waste/excess drugs? 
In an ideal world, how would you like to record medicine use on the farm?  
Do you think technology will make a difference to this in the future? 
What would you do differently/change to improve recording medicine use?  
• Make it easier/ more accurate/more useful  
 





Appendix 10: Screenshot of prescription veterinary medicine 
database for medicines licensed for use in cattle, adapted from the 





Appendix 11: Screenshot example of farm medicine audit database 
developed for data entry of prescription veterinary medicines during 









                  
Medicine Use in Dairy study – Individual report FARM A 
 
Thank you once again for being part of the medicine use in dairy study, which has given us valuable 
data that can be used to inform medicine use policies and academic research in the future.  
Please find below some results showing where your farm lies when compared with the other farms 
enrolled on the project. Your farm ID is A. Please note this is for interest only, because all farms were 
very different, with different breeds, calving patterns and levels of production.  
At the end of this report is your farm’s individual report, showing the amount of each medicine used 
when recorded by vet sales data, by medicine waste bin and by on-farm medicine records.  





This is the total amount of antibiotic used per kg of animal on your farm for lactating cow tubes.  
 
 







Total use in 12 m
onths 
based on bins 
Total U
se in 12 m
onths 
based on vet sales












































































































 IS Injectable Solution Trim
ethoprim
 40 m
g and Sulfadiazine 200 m







ycin Spray, 25 m
g/m























































































































Tylan 200, 200 m
g/m
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